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Abstract
The intestinal epithelium is rapidly renewing throughout life. A population of stem cells ex-
ist within the intestinal crypt that drive rapid cell renewal and replace each other by a pattern
of neutral drift. Perturbation of these dynamics through oncogenic mutation can predispose
the epithelium to neoplastic transformation. Understanding the factors that govern these
dynamics will give insight into the early stages of oncogenesis.
Continuous clonal labelling, whereby DNA strand slippage leading to the contraction
or expansion of a microsatellite during mitotic replication, can be employed to enable the
detection of a single clone. Previous studies have shown that quantification of clone size
over time allows inference of the functional stem cell number and stem cell replacement
rate within intestinal crypts.
Current continuous labelling techniques require the introduction of a transgenic mi-
crosatellite into a model system genome, such as mouse, that leads to reporter expression
following mutation. This obviously precludes human studies. Alternative somatic alter-
ations techniques used for continuous labelling in humans requires spontaneous loss of a
protein, or change in methylation status, within a single clone that can act as a clonal mark.
Though these techniques have given insight into the spread of mutations within the intestinal
epithelium and enabled inference of adenoma clonality, the true neutrality of these changes
are currently unknown. We propose that the small changes in endogenous microsatellite
length will act as a neutral clonal mark within the intestinal epithelium and allow an unbi-
ased approach to quantifying intestinal stem cell dynamics in human intestinal tissues.
To overcome the many technical challenges associated with accurate measurement of
microsatellite length, a stepwise approach was taken to develop a technique for the multi-
plexed high throughput sequencing of up to 21 native dinucleotide repeats in hundreds of
single crypts. Furthermore, a novel method was developed for the quantification of clone
size from data generated from the targeted re-sequencing of microsatellites in single crypts.
This protocol was validated in vitro and in vivo in mouse. Furthermore, proof of prin-
vi
ciple sequencing in human crypts was performed to show that this method is suitable for
larger scale quantification of intra-cryptal clone size in human tissue.
This, and similar approaches, may be the only way to quantify intestinal stem cell dy-
namics within the healthy human colon or, dysplastic or adenomatous patient tissue. These
measurements should give a unique insight into the dynamics of healthy, pre-neoplastic and
neoplastic human intestinal stem cells.
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Chapter 1
Introduction
The early pioneers of modern cellular biology placed the cellula as the basic building block
of an organism, a central tenant of ’cell theory’. Subsequent observations of binary fission
of the cell and nucleus, particularly in injured tissues, lead to the formation of the first theo-
ries regarding regeneration of tissue via cell division pioneered by Walther Flemming [70].
These theories were bolstered by the work of Giulio Bizzozero in the late 19th century with
experiments showing an increase in ’a blood-cell-forming phenomenon in the bone marrow’
following controlled bleeding experiments in chickens and pigeons. Bizzozero went onto
catalogue many tissues of the body using the frequency of mitotic bodies as an indicator of
a tissue’s regenerative capacity. He categorised all tissues into three different types: ’labile’
to describe those undergoing continuous regeneration, ’stable’ to describe those undergoing
division up until birth and ’everlasting’ where no cell division was observed [62]. Even in
these early observations, it was very clear that the gut was extraordinarily proliferative and
so was categorised as ’labile’. However, the question still remained as to the origin of these
newly differentiated cells.
Early work by Ernst Haeckel in 1868 coined the term ’stammzelle’ or ’stem cell’ and
put forward the first biological definition of a stem cell being a cell that can give rise to all
cells of a multicellular organism. This work was built upon by August Weissman in the late
19th century in which he proposed his theory of the continuity of germ-plasm. Weissman
proposed that early in embryonic development there was segregation that lead to the devel-
opment of specialised germ cells that were distinct from the the rest of the somatic cells
of the body. This definition of a stem cell was developed further by Boveri in 1892 to in-
clude non-committed cells between the zygote and the germ cells. It would seem that these
early stem cell biologists were actually describing what we call primordial germ cells and
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germline stem cells today [80]. The existence of the adult stem cell was not fully appreciated
until decades later.
The concept of an adult stem cell was first applied by those studying the haematopoi-
etic system in the early 20th century. As early as 1957, the pioneering work of E. Don-
nall Thomas and others had brought bone marrow transplant to the clinic long before the
haematopoietic stem cell had been fully described [98]. The first definitive evidence of a
haematopoietic cell population with multipotent properties was not provided until the exper-
iments performed by Till and McCulloch in the early 1960s [5, 100, 101]. Inspired by this
work, biologists began the search for the adult stem cell of other tissues. Among the first
to be described outside the haematopoietic system were the muscle-derived satellite cells
[61, 63], bone marrow-derived mesenchymal stem cells [35] and intestinal stem cells [24].
Seminal experiments with 3H-thymidine treatment of mice by Cheng and Leblond in
the 1970s provided strong evidence for the crypt-base columnar cells (CBCCs) as the adult
stem cell of the small intestine and colon. Through use of labelled phagosomes within the
CBCC population, Cheng and Leblond were able to lineage trace from this population and
show that all four main epithelial cell types originated from this population. Furthermore,
these experiments enabled quantification of cell turnover within the gut epithelium, which
confirmed Bizzozero’s earlier observations that the gut epithelium has one of the highest cell
turnovers of any adult mammalian tissue with the vast majority of epithelial cells being lost
every 2-4 days [20–24]. This work clearly showed a common stem cell for most epithelial
lineages but it was not until the early 1990s that the presence of a separate neuroendocrine
progenitor was disproved [99] and a common stem cell for all intestinal epithelium lineages
was postulated. This work largely put to rest any theory pertaining to extrinsic cellular con-
tribution to cell turnover within the adult gut epithelium and paved the way for the molecular
and functional characterisation of the adult intestinal stem cell.
1.1 The intestinal epithelium
The intestinal epithelium is arranged in a monolayer consisting of multiple differentiated
cell types that together enable the co-ordinated digestion and absorption of ingested food
and the concomitant excretion of waste products. Juxtaposed to the intestinal epithelium
is supporting stroma consisting of myofibroblasts, immune cells, lymph vessels and vas-
culature. Together these cell types make up the core cellular components of the intestinal
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tract and their continued function are essential for mammalian life as we know it. Through-
out the intestinal epithelium there are regular invaginations that create structures known as
the crypts of Leiburkühn. The small intestine is well adapted to the absorption of nutri-
ents through massive increase in available surface area generated by folds of epithelium that
protrude into the intestinal lumen known as villi. The colon, in contrast, has a flat surface ep-
ithelium more suited to smooth transit of waste products and water absorption. The overall
structure and organisation of the gut epithelium is well adapted to sustain nutrient digestion
and absorption whilst maintaining remarkable proliferative and regenerative capacity.
The intestinal epithelium consists of four major cell types. The majority of cells are ente-
rocytes which are specialised for the absorption of nutrients as well as the expression of key
digestive enzymes on their apical surfaces. Within the crypt base, in the small intestine only,
are a population of Paneth cells that secrete bactericidal defensin peptides and lysozymes
that protect the gut epithelium from pathogenic bacteria. Additionally, the Paneth cells pro-
vide a source of Wnt ligands that support the multipotent intestinal stem cell population
within the crypt base [85]. In the colon, Paneth cells are not found and instead colonic
Crypt Base Secretory Cells are postulated to be Paneth-like cells that constitute the stem
cell niche [83]. The third major cell type is the goblet cell identified by mucous granules
that accumulate at the apical membrane for secretion. Secretion of mucous by these cells
protects the duodenum from acid damage and later aids the passage of stool through the
colon. The final major cell type is the enteroendocrine cell which is identifiable by a basal
build-up of secretory vesicles that co-ordinate systemic and local regulation of a variety of
different gastrointestinal functions including peristalsis and mucous secretion. These four
major cell types, alongside other cells with immune function such as M-cells and the Tuft
cells [39, 68], support rapid and efficient digestion and absorption of ingested nutrients.
The structure of the crypt provides an ideal niche for the intestinal stem cell. The mul-
tipotent CBCCs reside at the bottom of the crypt giving rise to differentiated progeny that
migrate away from the crypt base toward the gut lumen, Figure 1.1. The activity of Wnt
in the crypt base is critical to normal gut development and maintenance [33, 41, 55, 73]
and is thought to be provided by the surrounding Paneth cells in the small intestine and the
Crypt Base Secretory Cells in the colon. Further study of the intestinal stem cell niche has
revealed the crucial importance of Notch and Epidermal Growth Factor (EGF) signalling in
conjunction with Bone Morphongenic Protein (BMP) and ErbB signalling inhibition in the
maintenance of stem cell properties and determination of cell fate decisions [85, 103, 106].
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Though the work of Cheng and Leblond elegantly showed that CBCCs can display stem-
like properties, accurately defining the stem cell population within the intestinal crypt has
been a topic of intensive study.
In order to define a cellular population as possessing stem potential, the ability to self-
renew and to produce all differentiated lineages of that tissue must be demonstrated. The
gold standard for demonstrating this is through long-term in vivo lineage tracing from the
population in question. The most experimentally robust intestinal stem cell marker to date is
the Leucine-rich-repeat-containing G-protein coupled receptor (Lgr5). Lgr5 is a Wnt target
gene strongly expressed within the crypt base in a spatially restricted manner [4]. Long-
term lineage tracing from Lgr5+ cells produced distinctive ribbons of marked cells emerging
from the crypt base. Furthermore, Lgr5 appeared to mark a rapidly cycling population of
CBCCs that displayed increased resistance to radiation when compared with the quiescent
cell population found at the +4 position. Until this discovery it had been hypothesised that a
hallmark of stemness was quiescence [16] and the cells at the +4 position seemed the most
likely candidate for the stem cell population of the intestine.
However, Lgr5 is not the only marker capable of producing clonal ribbons in the in-
testine. Hopx encodes an atypical homeodomain-containing protein and specifically labels
cells at the +4 position along the whole length of the murine intestine. The Hopx+ popu-
lation display quiescent properties but also have the ability to interconvert with the Lgr5+
population [95]. Bmi1, a polycomb-repressing complex 1 (PRC1) component, has been
shown to be expressed in cells at the +4 position in duodenum and jejunum but not more
distally in the ileum [84]. Their stem cell capacity can be demonstrated through lineage
tracing despite Bmi1 and Lgr5 labelling two functionally distinct populations [108]. In-
corporation of synthetic nucleosides, such as bromodeoxyuridine (BrdU), can be used an
indicator of a proliferating cell. However, if a cell retains this mark in the long-term, named
a BrdU-retaining cell, this is indicative of a quiescent cell state. Mouse telomerase reverse
transcriptase (mTert) expression is the key regulatory step in telomerase complex activity
and has been shown to co-label with BrdU-retaining cells at the +4 position [11]. This
observation suggests high telomerase activity in quiescent stem cells within the crypt and
mTert expression could be a valid marker of a population of quiescent stem cells. The above
is not an exhaustive list of potential stem cell markers in the intestine but highlight some
of the key discoveries of recent years. Other notable markers not discussed here include:
Mcm2 has been shown to label a population of intermittently cycling crypt base cells [78]
1.1 The intestinal epithelium 5
Enterocyte
Enteroendocrine cell
Lgr5+ stem cell
Goblet cell
Tuft cell
Fig. 1.1 Schematic of a single colonic crypt depicting the key differentiated cell types. The
crypt base columnar cells are shown here as Lgr5+ cells.
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and Lrig1 has been shown to be key in maintaining a stable intestinal stem cell population
and labels a population of slowly cycling cells that can regenerate the intestinal epithelium
following damage [77, 106]. Intestinal stem cell markers have been invaluable to the isola-
tion, study and characterisation of stem cell state and the molecular mechanisms that govern
stemness. However, the question still remains as to whether cell fate is a cell autonomous
property or whether non-autonomous properties such as the location of the cell is more
influential.
Recent studies suggest stemness in the intestinal crypt may be a cell non-autonomous
property and that cellular plasticity is a pronounced feature of the crypt. One of the first
cell markers in the crypt to display this plasticity was Delta-like 1 (Dll1). Dll1 is a notch
ligand and is expressed by a subset of early stem cell daughters biased towards secretory
lineage commitment. However, following irradiation, these cells are able to revert to a more
primitive, multipotent state giving rise to all 4 major cell types of the intestine. Further
work by Tetteh et al [97], used the Alkaline phosphate intestinal (Alpi) gene as a marker of
well differentiated enterocyte precursors. During homeostasis Alpi+ cells are distinct from
Lgr5+ rapidly cycling cells and Dll1+ secretory precursors and do not form clonal ribbons.
However, when the Lgr5+ cell population is ablated, through engineered specific diptheria
toxin sensitivity, Alpi+ cells are able to transdifferentiate to a stem-like state giving rise to
both Paneth cell precursors and rapidly cycling CBCCs. This work provides strong evidence
of stemness not being a ’hard-wired’ property of cells within the intestinal crypt and instead
factors such as contact with the niche having more influence on stem potential [30].
Due to the phenomenon of plasticity and interconversion of different cell types within
the intestinal crypt, it appears that the existence of a single marker that specifically labels
the stem cell population of the intestine may not be possible. Even a panel of markers may
not adequately capture a pure intestinal stem cell population. Instead, a functional approach
to defining the stem cell population of the intestine coupled with probabilistic calculations
of stemness may yield more accurate definitions of what constitutes an intestinal stem cell.
An example of the potential of functionally defining stemness in the murine intestine is
the work of Buczacki et al [12]. Through the use of a novel dimerisable dicreAB construct,
lineage tracing only from cells that maintained histone protein H2B in the long-term, i.e.
showed functional properties of a quiescent cell, is possible. It was observed that in the
homeostatic state, quiescent label-retaining cells (LRCs) only contribute to the production
of secretory progenitors and, therefore, do not display multipotency. However, during injury,
1.2 Intestinal stem cell dynamics in health and disease 7
LRCs are able to revert to a multipotent state and contribute to epithelial maintenance. This
work clearly shows that it is possible to define the role of stem cell populations based solely
on the functional properties of those cells and without the need for a stem cell marker.
Furthermore, due to the label retaining nature of these cells, it is also possible to isolate them
through standard flow cytometry techniques for further downstream in vitro and molecular
analysis. Novel techniques such as these have the potential to give clear insights into the
functional and molecular characteristics of quiescent stem cells.
The dicreAB construct is a valuable tool in studying quiescent stem cells however, a
different approach is required for studying the rapidly cycling stem cell population within
the crypt base. Recent work by Kozar et al [54] propose a continuous labelling approach
that utilises an unbiased genetic marker that can label all proliferating cells of the gut at
random but at a low frequency. Only if a cell possesses true stem potential will it be able
to retain this mark in the long-term (self-renewal) and give rise to differentiated daughter
cells that contribute to epithelial maintenance (multipotency). Through quantification of
crypt clone size, the authors were able to infer the functional stem cell number and stem
cell replacement rate of homeostatic tissue and of dysplastic adenomatous tissue. Through
this approach it was shown that the functional stem cell number is variable throughout the
intestinal tract from 5 stem cells in the proximal small intestine through to 7 stem cells in the
colon: far less than the 16 Lgr5+ cells seen in the crypt base [89]. This functional approach
clearly shows that the gene expression stem cell markers currently used are only a surrogate
of stem cell potential and do not only mark cells contributing to epithelial maintenance.
This work is discussed further in Section 1.3.2.
1.2 Intestinal stem cell dynamics in health and disease
The continuing treadmill of differentiated cell types emerging from the crypt base before
eventually undergoing apoptosis is driven by two key dynamics shown in Figure 1.2. Firstly,
the rapid dynamics of the crypt-villus axis leads to differentiated cells moving away from the
crypt base towards the gut lumen. Secondly, the slower dynamics of competition between
equipotent stem cells in the crypt base leads to continual clonal conversion over time.
By understanding the rules by which intestinal stem cells replicate and maintain a stable
population within a homeostatic setting, differences within the pathological setting can be
inferred. One clear example of this is a dysplastic adenoma where glandular structures
1.2 Intestinal stem cell dynamics in health and disease 8
morphologically and functionally resemble the homeostatic intestinal crypt, Figure 1.3. Just
like the homeostatic crypt, the adenoma gland contains a clonal stem cell population at its
base that continuously replicate giving rise to differentiated progeny. These progeny are
then able to contribute to tumour repopulation and growth. By quantifying and comparing
the stem cell dynamics of the homeostatic crypt with the adneoma gland, it may be possible
to functionally and molecularly describe the processes that govern stem cell dynamics in the
healthy and diseased states. Ultimately, through characterisation of these differences, it may
be possible to design novel therapeutics that bias stem cell dynamics within the adenoma
toward stasis or, ideally, regression.
1.2.1 The crypt-villus axis
The exact mechanism driving differentiated cell migration from the crypt base to eventually
be shed into the gut lumen through apoptosis, either directly in the colon or via migration
along the villi in the small intestine, is not known. A leading hypothesis is the ’co-operative
model’ proposed by Julian Heath [48] which proposes that the combined mitotic pressure
provided by continuous cell division in the crypt base in combination with cell cohesiveness,
cytoskeletal structure and underlying mesenchymal cell activity force the differentiating
cells up the crypt-villus axis. Regardless, the rapid nature of this process is remarkable.
The average transition time, in mouse, of a differentiated cell from crypt base to being shed
into the gut lumen is 2-4 days including a rapid transit-amplifying state that lasts 2 days and
leads to 4-5 cell divisions [102]. Paneth cell migration is of note as it is in the only cell
type to escape the upward migration in the crypt and instead migrates toward the crypt base
where it forms a niche for the intestinal stem cells.
1.2.2 Neutral stem cell competition and niche succession
Early observations of clonal patterning in the intestine were achieved through 3H-thymidine
labelling of phagosomes within the CBCCs. Cheng and Leblond observed these labelled
phagosomes being passed onto all 4 differentiated cell types from the CBCC population
leading them to postulate the ’unitarian theory of the origin of the four epithelial cell types’
[24]. It was only in the late 1980s that the first conclusive evidence for a single cell of
origin within the adult intestinal crypt emerged. Studies conducted in mice chimaeric for
H-2 antigen and the Dolichos biflorus agglutinin (DBA) marker, showed that crypts either
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Clonal loss Clonal victory
Fig. 1.2 Cellular turnover within the crypt is driven by two key dynamics. Top row rep-
resents a longitudinal section through the crypt base. Bottom row represents a transverse
section through the crypt base at the level of the crypt base columnar cells. Centre panel
represents a hypothetically marked single cell in the crypt base. The rapid dynamics of the
crypt-villus axis generates a ribbon of differentiated cells above the marked cell within 2-4
days, in mouse. Simultaneously, the single marked cell is competing for space within the
crypt base niche. This process is far slower and can lead to either the marked cell being lost
from the niche leading to an unmarked crypt, as shown in the left panel, or clonal conversion
of the crypt, shown on the right panel, leading to all cells in the crypt being marked.
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Fig. 1.3 H&E stained section of normal human colonic epithelium (right) showing homeo-
static crypts and dysplastic adenoma (left) showing enlarged adenoma glands.
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fully expressed H-2 antigen or the DBA marker thus inferring that each crypt must descend
from a single progenitor [75].
Further studies observing loss of function at the Dlb-1 locus, which determines expres-
sion of the binding site for the lectin DBA, demonstrated the utility of DNA mutation in
observing niche succession. The approach required crossing of C57BL/6J mice that are
Dlb-1+/+ for DBA binding site expression in the intestinal epithelium with SWR mice that
are Dlb-1-/- for DBA binding site. Therefore, in the F1 cross, all offspring will be Dlb-1+/-
needing only a single inactivating hit in the Dlb-1+ locus to generate negative DBA peroxi-
dase staining on a DBA positive background [104]. The natural mutation rate ofDlb-1 locus
is relatively low thus requiring the observation of many mice in order to attain meaningful
results. Alternatively, administration of the mutagen ethylnitrosurea (ENU) leads to a burst
of mutations causing a massive increase in the number of DBA negative clones, in essence
generating a pulse-chase experiment. From this data, it was again possible to infer that all
crypt progeny descend from a single progenitor cell. However, the observation of segmen-
tal negative staining clones suggested a process of niche succession was at work with the
presence of an intermediate progenitor. Furthermore, little could be said about the exact
location of this mutant progenitor based on this data [105]. Further work would be required
in order to quantify the process of niche succession and a novel technique would be required
to determine the exact location of the intestinal stem cell population.
The use of female mice hetereozygous for reduced expression of the X-linked histo-
chemical enzyme, glucose-6-phosphate dehydrogenase (G6PD) has also been used as a
clonal marker. The carcinogen dimethyl hydrazine (DMH) was used to induce somatic mu-
tations. However, the authors did not observe any segmentally mutated crypts and, therefore,
concluded that there must be one master stem cell of the crypt [42]. Similar analyses using
X-inactivation alone, particularly in human tissue, has been confounded by the patch sizes
generated by X-inactivation earlier in development [67]. Furthermore, no information about
the precise location or nature of the intestinal stem cell could be inferred from this data and
the question of the intestinal stem cell location persisted.
The average number of stem cells within the crypt needs to remain fixed throughout the
life-time of an organism so as to prevent stem cell pool exhaustion or overgrowth. How-
ever, the observation of niche succession using the Dlb-1 reporter suggests that continuous
cellular replacement is a central component of crypt homeostasis. In order to reconcile this
apparent paradox a system of asymmetry must exist within the intestinal stem cell pop-
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ulation. This could be achieved through two different processes. Firstly, a mechanism of
intrinsic asymmetry whereby each daughter of a stem cell division is predetermined to either
continue as a stem cell or to move down the lineage hierarchy and form a transit amplifying
progenitor. Alternatively, a mechanism of population asymmetry could exist whereby lat-
eral competition between neighbouring stem cells leads to one stem cell forming two stem
cells whilst its neighbour differentiates to form two transit amplifying cells.
It was almost two decades after the initial observations of niche succession in the Dlb-
1 mutants that the process was fully described. Using low dose tamoxifen, an unbiased
marking system was utilised to mark single, actively dividing cells in approximately 2%
of all crypts throughout the gastrointestinal epithelium. By observing the crypt clone size
change over time, it was possible to model the most likely mechanism of stem cell renewal
within the intestinal crypt. This approach showed that the intestinal stem cell population
replaced itself through a majority of symmetrical stem cell divisions consistent with more
than one equipotent stem cell within the crypt. Furthermore, it was possible to show that this
replacement rate was closely linked to the cell cycle time within the crypt base [59]. This
work produced strong evidence in favour of an equipotent stem cell population central to
intestinal homeostasis that maintained itself through primarily symmetric cell fate decisions.
At the same time, an alternative technique was developed to study the same mecha-
nism. A Confetti cassette related to the Brainbow 2.1 construct was targeted to the Rosa26
allele[58, 89]. When induced by Cre recombination, one of four different coloured reporter
genes was expressed at random within the target cell. The authors restricted recombination
to the Lgr5+ population through targeting of the Cre recombinase ERT fusion to the Lgr5
locus coding region [4]. Through the use of short-term and long-term observations of clonal
evolution using the multicolour lineage tracing strategy, it was again shown that the stem
cell population within the crypt replaced themselves through symmetric fate decisions of
neighbouring equipotent stem cells [89]. Together these two studies showed that the adult
intestinal stem cell replacement followed a pattern of neutral drift [59, 89].
1.3 Lineage tracing
Lineage tracing experiments involve the labelling of single cells before observing their
clonal evolution over time. Through co-staining of single clones with differentiated cell
markers, it is possible to demonstrate the differentiation potential of that cell. Furthermore,
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by observing long-term clone production from that single cell, it is possible to demonstrate
self-renewal potential. Thus, the generation of a ribbon of differentiated cell types from
the crypt base is the gold standard for demonstration of a cell with multipotent properties
within the intestinal epithelium. Additionally, by observing the size of the clone over time
it is possible to infer the dynamics that govern the replacement and maintenance of the stem
cell population as discussed in Section 1.2.2. To date, the vast majority of lineage tracing
experiments have been within model organisms due to the need for genetic modification
and often the need for induction of reporters through tamoxifen, or similar compounds. The
most commonly used methods for in vivo lineage tracing in the intestinal epithelium has
been marker-based lineage tracing and more recently an alternative continuous labelling
strategy has been described [54].
1.3.1 Marker-based lineage tracing
The most common lineage tracing experiment is based upon induction via a putative stem
cell marker. Within the gut, the Leucine-rich repeat containing G-protein coupled receptor 5
(Lgr5) has been the most universally accepted intestinal stem cell marker to date. Through
expression of a tamoxifen-inducible Cre recombinase under the Lgr5 promoter it has been
possible to induce fluorescent protein expression in Lgr5 expressing cells, and all descen-
dants of that cell. As discussed in 1.2.2, the use of lineage tracing from this marker has
allowed inference of the mechanism of cell replacement within the intestinal crypt. Fur-
thermore, through flow cytometric isolation of Lgr5hi cells based on the level of fluorescent
protein expression, it has been possible to increase the efficiency of clonal expansion of sin-
gle intestinal stem cells into intestinal organoids [85, 86]. These experimental observations,
emphasise the utility and value of accurate stem cell markers. A schematic depicting the
generic marker-based lineage tracing approach is shown in Figure 1.4.
However, these experiments potentially lead to the labelling of overlapping populations
with varying stem cell potential. It also relies upon the assumption that all Lgr5+ cells
have equal stem cell potential and contribute equally to cell repopulation within the gut
epithelium. As stem cell potential is likely to be a continuous property and certainly not a
static nor binary state, tracing in such a manner is intrinsically biased and may not represent
the true stem cell population. In order to achieve more accurate quantification of stem cell
dynamics, an unbiased, functional approach to observing clonal evolution is required.
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Fig. 1.4 Diagrammatic representation of the commonly used marker-based lineage tracing
strategy. An inducible Cre recombinase (CreERT) is targeted to a putative stem cell marker
promoter. Mice with this construct are then crossed with mice containing a reporter gene
targeted to a housekeeping promoter contiguous with a transcriptional stop cassette flanked
by LoxP sites.
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1.3.2 Continuous labelling lineage tracing
Recent efforts have been focussed towards developing marker free approaches to infer stem
cell dynamics within the intestinal crypt. By removing the need for a putative stem cell
marker and instead lineage trace based on functional aspects of stem cells, any bias in the
observation is removed. Kozar et al utilised a novel transgenic system in mice to express a
histologically detectable protein at random within any proliferating cell of the gut [54]. This
was done by introducing a reporter gene under a housekeeping promoter but contiguous with
a [CA]30 microsatellite that shifted the reporter gene out of frame. Through continual cell
replication, errors are introduced into the highly mutable [CA]30 microsatellite that bring
the reporter gene in frame, Figure 1.5. If a single cell incurs an in-frame mutation and gives
rise to any progeny, they will also inherit the in-frame mutation. Only cells with multipotent
capacity will develop a ribbon of differentiated progeny in the intestinal epithelium. The
ability to maintain a clone in the long-term, which could become a clonal victor in ongoing
niche succession, requires self-renewal capacity. Therefore, any long-term clones observed
must have the definitive characteristics of a stem cell: multipotency and self-renewal capac-
ity. This strategy presents an unbiased, functional assay for studying clonal evolution within
the intestinal crypt.
By observing the clonal evolution of marked crypts in a continuous labelling experiment,
it is possible to infer stem cell replacement rate and functional stem cell number. Two basic
metrics are required to calculate this:
1. The frequency of partly populated crypts (PPC) in mice at different ages (Figure 1.6).
At any time during the lifetime of the mouse, there will be a small population of crypts
that have undergone partial conversion and are equally as likely to drift to whole
crypt conversion as they are to drift towards clonal extinction. The number of PPC
remains constant throughout the lifetime of the mouse and is directly proportional to
the average number of functional stem cells per crypt.
2. Wholly populated crypts (WPC) accumulate linearly with age (Figure 1.6). The rate
at which whole crypt conversion occurs is directly related to the average rate of stem
cell replacement.
The rate of both WPC accumulation and PPC frequency are also related to the rate of
mutation within the [CA]30 microsatellite.
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Fig. 1.5 Diagrammatic representation of the novel transgenic system used by Kozar et al
[54] to randomly label cells within the murine gut. A reporter gene is targeted to a house-
keeping promoter but is shifted out of frame by a [CA]30 microsatellite. Through replication
dependent strand slippage, the reporter gene can be brought in frame leading to expression
of the reporter protein.
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Fig. 1.6 Figure adapted from Kozar et al [54]. Plot depicts quantification of WPCs and PPCs
in murine colon at different ages. Images on the right show immunohistochemically stained
crypts from [CA]30:eYFP mouse.
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Using the model described above, it has been possible to quantify the stem cell dynam-
ics within the murine intestinal crypt. The number of functional stem cells per crypt has
been shown to be less than expected with around 6 stem cells per crypt. Furthermore, the
functional stem cell number varies along the intestinal tract with an average of 5 functional
stem cells per crypt in the proximal small intestine through to 7 per crypt in the colon. Ad-
ditionally, it was shown that the rate at which an individual stem cell is replaced is also
much slower than previously thought with an average of 0.1 per day in the proximal small
intestine through to 0.3 per day in the colon. The data fitted well with a neutral drift pattern
of stem cell replacement within the intestinal crypt thus regional difference in neutral drift
dynamics can be explained by functional stem cell number and replacement rate differences
alone. A similar analysis within adenoma glands also reveals smaller stem cell populations
(approximately 9 stem cells per adenoma gland) and very high rates of stem cell replace-
ment (each stem cell replaced approximately every day). This suggests that the majority
of stem cell divisions within an adenoma are used to replace stem cell loss with very few
clonal victors driving tumour growth and repopulation [54].
The findings of Kozar et al have far reaching implications for the study of intestinal stem
cell biology in health and disease. Firstly, the number of de facto stem cells within the crypt
is 50-70% lower than the number of Lgr5+ cells (16 Lgr5+ cells of which between 5 and 7
are functional stem cells). Though Lgr5 faithfully marks cells with stem cell characteristics
in homeostasis, there is redundancy to the marker and not all Lgr5+ cells possess stem cell
capability. Furthermore, the slower than expected stem cell replacement rate suggests that
not all stem cell fate decisions are symmetric and there must be a level of asymmetric or
asynchronous cell fate decisions within the stem cell population. Finally, the observation of
a remarkably high stem cell replacement rate within the adenoma gland suggests a very high
level of symmetric stem cell fate decisions in the dysplastic setting. Thus, in the dysplastic
setting, the majority of stem cell fate decisions must be symmetric to maintain the stem cell
population whilst the minority of cell fate decisions give rise to committed progenitors.
The observation of approximately 16 Lgr5+ stem cells per crypt contradicts the infer-
ence of 5-7 functional stem cells using unbiased continuous labelling. This paradox was
somewhat reconciled with the development of intra-vital imaging techniques that allow in
vivo imaging of various internal organs in the mouse [82]. Through the insertion of an
abdominal imaging window in Lgr5:GFP mice, it was possible to perform near real time
imaging of intestinal stem cell dynamics in vivo. Using this technique, it was shown that the
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3D spatial positioning of the Lgr5+ cells had a quantifiable effect on stem cell dynamics.
The crypt base can be split into two rings termed ’central cells’ located from cell 0 to the +2
position and ’border cells’ located in the +3 and +4 position. Through intra-vital imaging
of the crypt, it was shown that central cells are three times more likely to fully colonise a
crypt compared to the border cells and gives reason as to why Lgr5+ cells show differential
stem potential [81]. These studies demonstrate how the combination of advanced imaging
techniques of stem cell markers combined with functional, unbiased labelling techniques
allows for accurate quantification of intestinal stem cell dynamics and the cellular processes
driving it.
The use of transgenic mouse models has been invaluable to our understanding and quan-
tification of intestinal stem cell biology. Translation of these techniques to human samples
would allow for direct comparison and improved understanding of human intestinal stem
cell dynamics. By understanding the homeostatic intestinal stem cell dynamics in humans,
it may be possible to compare with various pathological states including inflammatory bowel
disease and oncogenic predisposition. The techniques discussed thus far require transgenic
manipulation of the test organism or induction using tamoxifen, ENU or similar compounds.
Efforts to develop an effective tool for quantification of human stem cell dynamics are dis-
cussed in the following section.
1.4 Existing approaches to lineage tracing in the human
intestinal crypt
The majority of attempts to perform lineage tracing in human intestine have come from
observing the stochastic loss of clonal marks within the stem cell pool and detection by im-
munohistochemistry or similar techniques. By following the clonal behaviour over time, it
is possible to approximate stem cell dynamics within the human intestine. These approaches
have many benefits such as amenability to high throughput screening of thousands of single
crypts and relatively low cost of implementation. However, the validity of these proteins as
truly neutral clonal marks has not been assessed and the techniques do not lend themselves
well to observations of multiple clonal marks in a single tissue and therefore restrict these
studies largely to singleplex assays.
One such staining technique is the mild periodic acid-Schiff (mPAS). mPAS selectively
stains non-O-acetylated sialomucins. Most individuals in the human population contain O-
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acetylated sialomucins within their colonic epithelial cells therefore the cells do not stain for
mPAS. However, some individuals are homozygous for an unknown polymorphic autoso-
mal gene responsible forO-acetylation and, therefore, stain positive for mPAS. Of interest in
colonic clonal biology are those individuals heterozygous for this polymorphism that have
a high chance of generating sporadic mPAS+ clones. Histological analysis of the colons of
heterozygous individuals display sporadic mutant crypts, that are increased following radio-
therapy, and can be used to show that there is a common stem cell within the human colon.
Furthermore, these observations have shown that the clone stabilisation time is greater than
one year in humans compared to four weeks in mice. The difference in clearance time is
probably due largely to a difference in stem cell number, crypt kinetics and the rate of crypt
fission [17]. This technique is of great interest for the characterisation and quantification of
intestinal stem cell dynamics in the human gut. The challenges lie in: 1) accumulating a
large enough bank of tissue with heterozygote individuals and 2) identifying the polymor-
phic locus involved in mPAS+ staining and ensuring that loss of function does not effect
normal stem cell dynamics.
Methylation patterns provide an alternative clonal mark that could be used to trace clones
in human tissue. Restricted bisulphite sequencing of loci presumed to be neutral revealed
increased methylation mosaicism with age and single crypt heterogeneity of methylation
consistent with multiple adult stem cells replacing each other through regular symmetrical
divisions [66, 109]. The clone stabilisation time was also shown to be far longer in humans
than in mouse at over 8 years and perhaps as long as 15-40 years for some crypts.
An alternative approach is the use of mutations in the mitochondrially encoded cy-
tochrome C oxidase (CCO) which leads to a biochemical defect that can be detected by
the loss of enzyme-linked immunohistochemical staining [96]. This technique was applied
to human tissue to infer the stem cell dynamics of the colonic crypt. Due to the low number
of samples obtained for this study, the findings relied upon the assumption that the "wiggle"
in the resulting ribbon of progeny from the crypt base represents a natural history of stem
cell competition. Using this method, an estimate of 6 functional stem cells per crypt was in-
ferred. This number is similar to the number of functional stem cells inferred in the murine
crypt despite the 8-fold difference in crypt size and 2-fold difference in the mean number of
cells in the crypt base circumference.
Furthermore, using inferences from the wiggle data, the authors suggest that stem cell
competition in the crypt base follows a pattern of neutral drift described by the same one-
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dimensional random walk model used to describe murine intestinal stem cell dynamics.
The average crypt base to gut lumen transit time in humans is estimated to be 82-100 hours
[57, 76] with the cell cycle time within the crypt base to be in the order of 24-48 hours
[76]. Given that the observed wiggles, show multiple changes in clonal make-up, it seems
unlikely that the wiggle solely constitutes a record of stem cell competition in the crypt base
and most likely captures cell dynamics within other areas of the crypt such as the transit-
amplifying compartment, where the majority of mitotic activity occurs within the crypt.
The true utility of wiggle data in determining stem cell dynamics within the intestinal crypt
remains to be seen.
Nonetheless, using observations of wholly converted CCO- crypts, an overall increase
in CCO- patch size was seen in APC deficient tissue when compared with normal colonic
epithelium. A further increase in fission rate was observed in dysplastic adenomas [2]. This
ties in with previous observations suggesting crypt fission may be the key driver in mutation
spread in the gastrointestinal epithelium [40]. This highlights the utility of CCO marking
in determining clonal patterning of crypt units and epithelial sheet as a whole, both in the
homeostatic and dysplastic setting.
There are also some caveats to using CCO as a clonal mark. Firstly, as this is a mitochon-
drially encoded gene, there are 1000s of copies of the gene in each cell and the threshold
at which enough mutant copies are present to display a CCO- mark is unknown. It also
relies upon the assumption that mutated mitochondial DNA (mtDNA) has an equal chance
of propagation within the cell compared to wild-type mtDNA. Secondly, the effect of CCO
deficiency on a cell is unknown. As the final component of the electron transport chain, it
seems unlikely that the loss of CCO would not lead to perturbed cellular metabolism, as has
ben reported in other systems previously [26, 79], the effect of which on stem cell competi-
tion is unknown. Regardless of the effect of CCO on the cell, a valid mouse model to assess
the effect of CCO deficiency would be technically difficult due to the difficulty in stably
editing the mitochondrial genome. Nonetheless, CCO has a valuable role in detecting clon-
ally related single crypts and has already been applied to assessing the clonal relationship
of distant and adjacent glands in adenomas [50].
Overall, the current repertoire of in vivo lineage tracing techniques in the human intesti-
nal crypt remains limited and their caveats substantial. Developing a clonal mark that has
the ability for high throughput screening and a priori knowledge of neutrality is essential to
accurately quantifying the stem cell dynamics of human gastrointestinal tissues.
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1.5 Utilising microsatellite sequencing for lineage tracing
in the human intestinal crypt
As a result of studies into human crypt cell dynamics, it has emerged that intestinal stem
cells undergo far more divisions than previously expected; approximately one division every
2-3 days [76]. This leaves the population susceptible to mutation due to replication error
as well as large scale chromosomal rearrangements and aneuploidy. Furthermore, observa-
tions in mouse show random chromosome segregation during intestinal stem cell genome
replication thus leaving the genome susceptible to accumulation of these mutations [29, 87].
The tissue architecture segregates individual clones thus somewhat reducing the impact of
deleterious clones. However, mutation accumulation cumulatively increases the stem cell
population’s risk of oncogenic transformation over time.
Genomic changes within the crypt can predispose the tissue to malignant transforma-
tion but the majority of genomic changes are likely to have little, if any, effect on tissue
homeostasis. These neutral genomic changes can be used as mark of the natural history of
cellular lineage within the crypt and could be used to detect age-related clone size change.
Kozar et al showed that microsatellites can be used as reporters of clonal lineage (albeit us-
ing a transgenic microsatellite contiguous with a reporter). This method could be translated
to humans by isolating single human crypts, extracting the genomic DNA and sequencing
endogenous microsatellites as a means of quantifying the size of mutant clones. Due to
the relatively high mutation rate in microsatellites and no known phenotypic effects as a
result of intergenic microsatellite length change, tracking endogenous microsatellite length
change presents an ideal opportunity to track clone size in humans over time. By combin-
ing technologies associated with the amplification of low template copy DNA such as the
polymerase chain reaction (PCR) with massively parallel DNA sequencing as described in
Section 1.7, it should be possible to sequence microsatellites within a single crypt and detect
mutations in endogenous loci. A highly simplified workflow is presented in Figure 1.7.
The vast diversity of microsatellite loci provides ample potential for multiplexed geno-
typing of cells to generate unique cellular ’barcodes’ that could be used for clone size esti-
mations and lineage heirarchy analyses. The potential for single cell genotyping based on
microsatellite variability could be extended further when considering the biallelic presence
of microsatellites and even higher levels of variability within longer repeats or in microsatel-
lites more prone to mutation due to flanking region composition.
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Fig. 1.7 Schematic showing the transgene-free approach to determining clone size in single
intestinal crypts using endogenous [CA]30 sequencing. Single crypts would be isolated
using a micropipette, the DNA extracted and endogenous microsatellites amplified using
primers that produce amplicons with sequencing adaptors at either end of the molecule.
These amplification products would be prepared for Illumina sequencing and the data used
to infer clonal status of the crypt. The data collected from this method would be amenable
to the same analysis performed by Kozar et al [54] to infer functional stem cell number and
stem cell replacement rate.
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1.6 Microsatellites
Microsatellites are stretches of DNA that contain highly repetitive nucleotide units between
1 and 6 nucleotides in length ranging from 5 up to 50 contiguous units. Due to the highly
repetitive nature of these regions they are highly prone to error due to polymerase slip-
page and deficient detection of mismatches by the mismatch repair pathway. As a result,
regions containing microsatellites are more prone to mutation accumulation. Estimates of
microsatellite mutation are in the region of 10-5 errors per cell division though this varies
widely depending on tract length, nucleotide composition of the microsatellite and nu-
cleotide composition of the flanking regions [3]. This rate is orders of magnitude higher
than the germline mutation rate for single nucleotide variants estimated at approximately
2.3x10-8 per human generation, which takes into account multiple cell divisions between
zygote and germ cell that is inherited by the next generation [65].
The rate of genomic mutation accumulation is variable between individuals, between
tissues and across the genome. The spectrum of accumulated mutations leave a ’finger-
print’ of single nucleotide variants (SNVs), insertions and deletions (indels) and large scale
rearrangements, duplications and deletions. It has been estimated that 7% of non-coding
and 14% of coding SNVs have phenotypic effects with larger scale changes hypothesised to
have the potential for more significant effects [32]. Microsatellites have been demonstrated
to be hypermutable due to polymerase error during replication, particularly in individuals
with defects in mismatch repair pathways. It has been well demonstrated that large scale
changes in these regions, particularly in coding regions, can lead to a range of pathologi-
cal conditions such as Huntington’s Disease, Fragile X Syndrome and Freidrich’s Ataxia.
However, small scale changes, outside coding regions are thought not to have any effect on
gene expression or function.
Microsatellites, therefore, provide a unique opportunity to perform transgene-free, un-
biased approaches to genotyping of restricted cell populations. Approximately 3% of the
human genome at approximately 1 million unique loci, equivalent to 90M base pairs, is
covered by microsatellites of varying composition and length [28, 93]. The majority of mu-
tations within microsatellite regions are small scale and larger scale changes in microsatel-
lite length are hypothesised to be as a result of smaller stepwise mutations. Large scale
deletions of microsatellites are thought to be rarer events and lead to loss of surrounding ge-
nomic information as well as the microsatellite. Thus small scale changes in microsatellites
could be used as a potential clonal mark at a high mutation rate with negligible effect on
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cell function.
The rate of microsatellite change is inextricably linked to the length of the repeat.
Through transgenic approaches, work in our lab determined that the [CA]30 microsatellite
provides a good balance between a high event rate coupled with a extremely low probability
of reversion or doublet labelling within a single crypt. Through in vitro and in vivo esti-
mation, the mutation rate at the [CA]30 microsatellite has been shown to be approximately
1.1x10-4 mutants per mitosis [54] and estimations of similar mutations in [CA]8 and [CA]17
are 3.7x10-6 and 2.4x10-5 respectively [107]. These estimates clearly show the link between
microsatellite length and mutation rate.
The mechanism of mutation for microsatellites is hypothesised to be as a result of
insertion-deletion loops leading to skipping of repeat units; this process can lead to in-
sertion or deletion of repeat units [46, 107]. This process is summarised in Figure 1.8. The
insertion-deletion loops are proposed to occur in series as described by the stepwise mu-
tation model [69]. In the homeostatic setting, most slippage events are repaired through
the mismatch repair (MMR) pathway. However, if the mismatch repair pathway becomes
defective, the mutation rate at microsatellites is massively increased. This is seen in in-
herited MMR component defects such as Lynch Syndrome or in the neoplastic setting in
microsatellite instable tumours.
The MMR pathway is essential for the repair of microsatellite mutations. The first de-
scription of mammalian homologues of the MMR pathway was made in Sacchamroyces
cerevisiae initially indicating the importance of MLH1, MSH2 and PMS1 [92]. Later stud-
ies showed involvement of other components of the MMR complex with major contribu-
tions from MLH1, MSH2 and MSH6 [9] confirming the earlier observations with a novel
implication of MSH6. The mismatch repair pathway is the key repair pathway for correcting
insertion-deletion loop mutations [71]. Loss of components of this repair complex have now
been definitively shown to predispose to the most common form of inherited cancer, heredi-
tary non-polyposis colorectal cancer (HNPCC), which shows an autosomal dominant pattern
of inheritance with over an 80% lifetime risk of developing colorectal cancer [91]. Defects
in MLH1, MSH2 and MSH6 are the most commonly defective loci inherited in Lynch Syn-
drome. All three form core components of the complex involved in the recognition of base
mismatching, along with MSH3 and PMS2 (shown in Figure 1.9). An MSH2/MSH6 het-
erodimer complex is the most common form of the complex used to detect and repair single
nucleotide mismatches and small extrahelical loops. MSH2/MSH3 heterodimers are more
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commonly seen during the detection and repair of larger extrahelical loops. The role of
MSH2 in both small-scale and large-scale repairs explains the increased severity of the phe-
notype seen in humans and in mouse models [51, 91]. Taken together, it can be seen that
knockout of MSH2 in a mouse model is an opportunity to raise the microsatellite mutation
rate.
Analysis of the mouse reference genome (mm9), performed by our lab, revealed 254
[CA]30 microsatellites spread across all chromosomes; 244 on autosomes, 9 X-linked and
one on the Y-chromsome. The availability of microsatellites around this length can be ex-
tended further by considering [CA]29 and [CA]31 microsatellites which extends the total
number to 822 [CA]29 31 microsatellites of which 793 are autosomal, 27 are X-linked and
2 are on the Y-chromosome. Analysis of the human reference genome, again performed by
our lab, revealed far fewer [CA]30 microsatellites; totalling only 10 across all chromosomes.
When extending the analysis to look for [CA]n microsatellites between [CA]28 and [CA]32
there are a total of 63 microsatellites and between [CA]25 and [CA]35 there are a total of
395 microsatellites. A comparison of mouse and human [CA]n microsatellites is shown in
Figure 1.10. These results are consistent with previously published results describing sig-
nificantly fewer microsatellites in primate populations compared with rodent populations
[28].
1.7 Next Generation Sequencing
Massively parallel DNA sequencing, more commonly termed Next Generation Sequenc-
ing, enables high throughput, high depth sequencing of DNA for a multitude of different
analyses. Many forms of technology exist that utilise different methods for determining
nucleotide sequence. As a result each technology possess differing benefits from longer
reads through to improved detection of epigenetic modifications. Illumina’s proprietary se-
quencing by synthesis (SBS) method [6], remains the leading technology used for most high
throughput sequencing projects and, as such, will be the focus for this discussion.
Library preparation for Illumina sequencing begins with addition of specific adaptors to
short DNA molecules targeted for sequencing (typically <1000bp in length). Addition of
adaptors allows for annealing of target molecules to complementary oligonucleotides bound
to a glass ’flow cell’. In a process known as bridge amplification, each target molecule is
isothermally amplified to produce a clonal patch of molecules known as a ’cluster’. Each
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Fig. 1.8 Diagram depicting the hypothesised mechanism of loop insertion-deletion of mi-
crosatellite mutation. The mutation rate is massively increased by mismatch repair pathway
deficiency though mutations can also occur as a result of stochastic infidelity of the mis-
match repair pathway.
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Fig. 1.9 Schematic depicting the core components of the mismatch detection and repair
complex. MSH2, MSH3 and MSH6 form a ring structure around the DNA and can detect
base mismatches and insertion-deletion loops. MLH1 and PMS2 form a ternary complex
with mismatched DNA and possess the ATPase activity required for complex binding to
DNA [51].
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Fig. 1.10 Histogram displaying the number of [CA]n microsatellites at differing lengths in
the mouse (mm9) and human (hg38) reference genomes including all autosomes, X and
Y chromosomes. The abundance of microsatellites in mouse compared with the human
genome is consistent with previously published results describing increased microsatellite
frequency in rodent species compared with primates.
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cluster is then denatured leaving only one strand of the target molecule attached to the
flow cell. Through the use of a reversible chain terminating nucleotide, it is possible to
add a single complementary nucleotide to the single stranded DNA before reversing the
chain terminating group to allow the addition of another single nucleotide. Each time a
nucleotide is added, it can be identified through a chemically conjugated, nucleotide-specific
fluorophore. This process is repeated until up to 300 nucleotides are added thus giving read
lengths of up to 300 base pairs for low read libraries (performed on the Illumina MiSeq) or
up to 150 base pairs for high read libraries (patterned flow cells on the HiSeq 4000, NextSeq
or HiSeq X Ten).
Furthermore, through the addition of adaptors at the 5’ and 3’ ends of the target molecule,
it is possible to then repeat the sequencing process once more but from the opposite end of
the molecule. This is known as ’paired-end’ sequencing creating a forward and reverse read.
This can be beneficial in two key ways: 1) for non-overlapping paired reads, it allows for
more accurate read alignment to the reference genome and 2) for overlapping reads, you can
generate two estimates of the nucleotides that are read twice thus increasing the confidence
of each nucleotide call. The development of paired-end sequencing enables the generation
of far more information from a sequencing library and can allow for more accurate read
alignment and reference genome construction.
Due to the development of larger flow cells with more efficient sequencing chemistry, it
has been possible to generate more reads for a given library far beyond what is necessary for
sample analysis. This has motivated the development of indexing approaches that allow for
the multiplexing of many sequencing libraries onto a single lane of the flow cell. Overall,
this reduces the cost of sequencing, as the cost of sequencing a flow cell is split across
multiple samples, and allows quicker turnaround, as more than one library can be sequenced
each time a flow cell is run. To date, many indexing protocols have been developed allowing
for the multiplexing of up to thousands of libraries onto a single flow cell. The use of
such large indexing panels reduces the overall robustness of the pooled library as some
indexes will perform better than others. However, very consistent and robust indexing panels
containing 384 indexes have been developed and were used for this sequencing project.
1.8 Existing strategies for determining microsatellite length 29
1.8 Existing strategies for determiningmicrosatellite length
Microsatellite sequencing is often termed short tandem repeat (STR) genotyping and is
most commonly used in forensic sciences and population genetics. The most widely used
technique for STR genotyping is multiplexed PCR followed by capillary electrophoresis
(CE)-based separation. This technique is both time and cost-effective but lacks full sequence
determination and is only semi-quantitative [10, 14, 15]. Therefore, use of this system for
accurate quantification of mutant clone size from single crypts is not feasible.
Techniques utilising Illumina sequencing technology to ascertain microsatellite length
have been developed with the objective of human identification [10, 111]. However, these
techniques utilised PCR to generate 1000-1500 base pair amplicons before fragmenting and
tagging the DNA in preparation for sequencing. Typically the simultaneous fragmentation
and tagging process is done using a transposon-based system known as the ’transposome’
[1, 94]. The use of a transposome requires a large amount of input DNA (at least 50ng);
when compared with the DNA content of a single crypt (approximately 1.5ng per mouse
crypt and 15ng per human crypt) is not a feasible means of library preparation. Further-
more, mixture experiments done using this technique, though often accurate, sporadically
produced spurious results [10].
Other multiplexed, targeted sequencing protocols have been developed for genotyping
purposes. A modified target enrichment protocol was used to pull down over 6000 STR loci
before Illumina HiSeq sequencing however, a minimum of 2µg of high molecular weight
human genomic DNA was required [44]. Molecular inversion probes have also been used
to perform single molecule capture and molecular barcoding so as to account for PCR am-
plification bias during STR amplification. However, this protocol also requires large input
amounts, this time 750ng of the A. thaliana genome, equivalent to approximately 2x106
genome copies [18]. The above gave ample reason to develop a custom quantitative STR
genotyping protocol optimised for low template copy input.
In addition to the development of a protocol to generate accurate sequencing data from
microsatellites, a computational method would also be required to analyse this data. Re-
cently, computational pipelines such as lobSTR, RepeatSeq and STR-seq, have been devel-
oped that can utilise short-read, whole genome sequencing data to determine miscrosatellite
length based on flank region mapping. Through the use of the STR-seq algorithm, a nine-
fold increase in STR length calling error rate was observed in PCR-based library prepa-
ration methods when compared with PCR-free library preparation. Furthermore, analysis
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of microsatellite length effect on mutation rate showed a direct correlation, as expected
[37, 45, 49]. Similar algorithms have previously been developed for application to popula-
tion genetics in Drosophila [34]. Aside from presently being financially prohibitive for this
project, whole genome library preparation protocols currently require large input template
requirements and often requiring whole genome amplification prior to preparation. How-
ever, once reliable whole genome library preparation is available for low template input,
without the need for whole genome amplification, and the cost of sequencing reduced fur-
ther, a computational pipeline could allow for genome wide genotyping of clones allowing
the interrogation of multiple loci and achieving single cell resolution in clone size estimates.
For the purposes of this project, custom tools for measurement of microsatellite length and
inferring clone size from microsatellite sequencing data were developed, as described in
Chapter 4.
As can be seen from the above, the development of a PCR-based Next Generation Se-
quencing solution for STR genotyping optimised for low template copy input has potential
use beyond that of a neutral mark in areas such as forensic science and population genetics.
1.9 Project outline
In this dissertation, I describe the development of a novel, transgene-free method for intesti-
nal crypt clone size estimation through multiplexed sequencing of endogenous microsatel-
lites. In addition, I describe the computational method for determining clone size using
microsatellite sequencing data as well as provide in vitro and in vivo validation of the pro-
tocol. This validated protocol was then used to observe expected age related clone size
changes in murine colon. Finally, I present proof of principle data showing the application
of this method to human tissues.
Chapter 2
Materials and methods
2.1 Animals
2.1.1 C57BL/6
Animals used for ageing studies were members of the C57BL/6 strain. Many of these an-
imals were retired from existing breeding programmes so genotyping (Section 2.2.1) was
performed to ensure that the relevant transgenes were not present. Animals were then aged
in the Cancer Research UK Cambridge Institute Biological Resource Unit (BRU) until re-
quired.
2.1.2 Rosa26-[CA]30-eYFP
The Rosa26-[CA]30-eYFP mouse contain a dinucleotide repeat with a contiguous enhanced
yellow fluorescent protein (eYFP) reporter gene targeted to the Rosa26 locus as previously
described by Kozar et al [54] and depicted in Figure 1.5. Rosa26-[CA]30-eYFP mice were
subsequently maintained on the C57BL/6 background in a hemizygous state.
2.1.3 Villin-CreER2
The Villin-CreER2 construct contains a 9kb regulatory element of the Villin gene contigu-
ous to a tamoxifen-inducible Cre recombinase construct. On induction with tamoxifen, Cre
recombinase activity is induced throughout the intestinal epithelium as described by el Mar-
jou et al [27]. The Villin-CreER2 mice were maintained as heterozygotes on a C57BL/6
background.
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2.1.4 Msh2 flox
TheMsh2 flox mouse contains LoxP sites targeted to either side of exon 6 in theMsh2 locus.
Recombination is driven by Cre recombinase leading to loss of exon 6 and Msh2 function.
These mice were obtained from Dr. Paul Potter at MRC Harwell (MGI: 101816). The Msh2
flox mice were maintained in a homozygous state on a C57BL/6 background.
2.2 Genotyping and [CA]30 Sanger sequencing
2.2.1 Transnetyx genotyping
Genotyping of the C57BL/6, Villin-CreER2 andMsh2 flox mice was outsourced to Transne-
tyx Inc. (Cordova, TN, USA). Ear biopsies for genotyping were loaded into a 96-well plate
and shipped directly to Transnetyx where genotyping was performed using a Taqman-based
assay. A full list of the primers used for genotyping can be found in Table 2.1.
Target Forward primer Reverse primer Probe
Msh2 WT GCGCTGGGTTGTTAATGGAAAT CCTTCAGAGGGTGTGGAAACATTAATT CAAAGCCACTAGAATAAG
Msh2 Flox CCCGTGTCTCAAAATCTCTGATGT CAGAGGGTGTGGAAACATTAATTATGACT CCACTCTTGTGCAATGTA
eGFP CGTCGTCCTTGAAGAAGATGGT CACATGAAGCAGCACGACTT CATGCCCGAAGGCTAC
Rosa26 WT
CTCTTACACTAAGCAATAA-
AGAAATAAAAATTGAACTTCT
CTGCAGACTTAGCTTTCAGCTTTG ACTGCTAGCTTTACTTAACTTT
ER GAGCTGGTTCACATGATCAACTG AGAAGGTGGACCTGATCATGGA AAAGCCTGGCACCCTC
Table 2.1 Primers used by Transnetyx for genotyping. The ER probe was used to detect the presence of the CreER2 locus. The eGFP probe was used to detect the
presence of the eYFP locus
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2.3 Animal care
All animals were cared for in the Cancer Research UK Cambridge Institute Biological Re-
source Unit (BRU) according to UK Home Office guidelines.
2.4 Treatment of animals
2.4.1 Tamoxifen administration
Tamoxifen was administered intraperitoneally to theMsh2fl/fl;Villin-CreER2;Rosa26-[CA]30-
EYFP mice at 4mg/kg.
2.5 Intestine dissection
Mice were killed by cervical dislocation. Dissection was carried out through a ventral,
midline incision. The small intestine was initially separated distal to the pyloric sphincter
and dissected along the mesenteric border down to the ileocaecal junction. Caecum and
colon are then dissected along the mesenteric border as far as the anus. Once dissected
out, the first 3cm of proximal small intestine is discarded. 3cm to 15cm of proximal small
intestine (12cm length) is then isolated. The distal 12cm of the small intestine closest to
ileocaecal junction is then isolated. The caecum is separated from the colon. The middle
small intestine section and caecum are discarded. The 12cm proximal intestine, 12cm distal
intestine and colon are flushed with cold PBS using a blunt 10ml syringe.
2.6 Long-term storage of intestinal tissues
Occasionally, tissue was stored long-term at  20 C by first processing as described in
Section 2.5 before flushing the tissue with RNAlater stabilization solution (Thermo Fisher,
AM7020). The flushed tissue was then transferred to a 50ml centrifuge tube and suspended
in 25ml of RNAlater. The suspended tissue was then stored at  20 C until required.
Once required, the tissue was removed from RNAlater and transferred to a petri dish
containing PBS at room temperature. The tissue was flushed with room temperature PBS
using a blunt 10ml syringe. Once the tissue had lost its rigidity, it was used for downstream
processing and analysis.
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If the tissue was to be used for fractionation, it must be noted that the crypt layer detaches
as a single layer in fraction 1 and 2 following storage in RNAlater. Fractions containing
crypt layers were centrifuged at 1500rpm for 5 minutes then the layers were broken up by
gently pipetting with 20ml of cold PBS until a single crypt suspension was formed. The
total volume was made to 50ml with cold PBS to dilute any cell free DNA present.
2.7 Crypt isolation
Crypt isolation is performed using a process known as ’fractionation’. Fractionation is the
term used to describe the detachment of the epithelial cell layer from the underlying stroma.
As differentiated cell types including villus structures detach in early stages of the protocol
whilst crypts and lower layers of the intestinal epithelium detach later, the protocol allows
for ’fractioning’ of the different cell types for separate analysis. The protocol relies upon the
incubation of the intestinal tissue in an alkaline EDTA solution before mechanical shearing.
However, due to the structural differences in the specimens isolated in human and in mice,
slightly differing techniques are required, as detailed below.
2.7.1 Murine intestinal tissue fractionation
Intestinal crypts were isolated from murine tissues based on a method developed by Bjerk-
nes and Cheng [7]. 1.86g of Na2EDTA and 500µl 10M NaOH were added to 500ml HBSS
w/o Ca2+ or Mg2+ (Gibco). Proximal, distal and colon segments were everted so the luminal
epithelium faced out and fed onto a 4mm diameter glass rod spiral. Each spiral was then
submerged in 50ml of the pre-warmed modified HBSS solution and pulsed twice using a vi-
brating stirrer (Chemap AG, model CH-8604) at a high frequency with low amplitude so as
to shake off the epithelium. The HBSS was then discarded. The spirals were re-submerged
in 50ml pre-warmed HBSS solution and incubated for 10 minutes at 37 C. Each spiral was
then given 10 short pulses and the HBSS solution was then collected in a 50ml Falcon tube
and immediately transferred to ice. This process was repeated five times giving a total of
six fractions. Of which, the fourth and fifth fractions were enriched in single crypts.
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2.7.2 Human intestinal tissue fractionation
Intestinal crypts were isolated from murine tissues based on a method developd by Fuji-
moto et al [36]. A 5-cm piece of normal colonic tissue was isolated from distal margins of
patients undergoing resection for colon cancer at Addenbrooke’s Hospital, Cambridge. The
resections were performed by a consultant histopathologist to ensure important diagnostic
specimens were not used and the tissue looked macroscopically normal. The specimens
were incubated for 15 minutes in 0.04% sodium hypochlorite in PBS at room temperature
to sterilise the surface. The colonic tissue was then washed in PBS and incubated in 3
mmol/l ethylenediaminetetraacetic acid (EDTA) plus 0.5 mmol/l dithiothreitol in PBS for
75 minutes at room temperature. The tissue was washed once with PBS, 10 ml of PBS
was added, and the tube was shaken vigorously for 15 seconds. The crypts detach from the
underlying mucosa during this shaking. The PBS containing the crypts was transferred to
a 50ml centrifuge tube, and fresh PBS was added to the colonic tissue. The shaking step
was repeated 4 times until the crypt yield diminished. The centrifuge tubes containing the
crypt suspension were topped up to 50ml with cold PBS and kept on ice until ready for
downstream processing.
2.7.3 PBS wash of crypt fractions
The single crypt enriched suspension was pelleted at 1200rpm for 2 minutes. Once pelleted,
media was removed and the crypts were re-suspended in 50ml cold PBS.
2.7.4 Paraformaldehyde fixation of fractionated crypts
The same process as described in Section 2.7.3 is repeated twice. After the second pelleting,
4% PFA was then used to re-suspend the crypts and they were stored at 4 C indefinitely.
2.8 Micropipette crypt picking
The following protocols can be performed using either a fluorescence or Brightfield dissect-
ing microscope dependent on the requirements of the crypt isolation.
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2.8.1 Alkaline lysis and neutralising buffer
The alkaline lysis buffer used to lyse single crypts was made as follows: 100mg NaOH
was dissolved in 90ml of deionised water in an autoclaved 100ml bottle. 400µl of 50mM
Na-EDTA was added before topping the solution up to 100ml.
The neutralising buffer used to neutralise the alkaline lysis buffer following single crypt
lysis was made as follows: 484.4mg Tris-base was dissolved in 90ml deionised water in an
autoclaved 100ml bottle. The solution was adjusted to pH 5 and topped up with deionised
water to 100ml.
2.8.2 Standard technique
Under a low power dissecting microscope, 400µl of enriched crypt suspensions were spread
on a siliconised (Sigmacote, Sigma-Aldrich, SL2-25ML) glass plate. Single crypts were
then drawn into a micropipette using a mouth syphon. Drawing in small volumes of PBS
interspersed with air optimised control of suction. Once drawn into the pipette, single crypts
were then expelled into 3µl of alkaline lysis buffer. This was repeated a further seven times
giving eight 3µl volumes of lysis buffer each containing one crypt. Each 3µl spot was then
flooded with a further 3µl of alkaline lysis buffer and carefully transferred to an 8-well PCR
strip.
2.8.3 Low adherence technique
As in Section 2.8.2 except single crypts were expelled directly into lobind PCR strips con-
taining 6µl of alkaline lysis buffer. Observation under the microscope was used to confirm
the transfer of the single crypt into the PCR strip for downstream processing.
2.8.4 Human crypt picking technique
The preparation was generated as in Section 2.8.2 except a hand held EZ-grip micropipette
was used to isolate single crypts with a 170µm EZ-tip (both supplied by Research Instru-
ments, UK). Crypts were transferred directly to lobind PCR strips as described in Section
2.8.3.
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2.8.5 Crypt washing
Later experiments utilised crypt washing as a means of reducing the amount of cell free
DNA contamination and diluting the amount of EDTA transferred into the final PCR reac-
tion. For each crypt picked, 4 droplets of approximately 5µl of PBS were dispensed onto
the siliconised glass plate. Once picked, each crypt was then moved from one droplet to the
next whilst visually inspecting for any cell contamination. Finally, the crypt was transferred
to the lysis buffer.
2.8.6 Crypt lysis protocol
Crypts in 6µl alkaline lysis buffer were then lysed via the following temperature cycling:
50 C 3 hours, 75 C 20 minutes, 80 C 5 minutes, 4 C hold. The alkaline lysis buffer was
neutralised using an equal volume of neutralising buffer (6µl in this case). Crypt lysates
were then stored at  20 C for at least 48 hours before being transferred to  80 C for
long-term storage.
2.9 Polymerase chain reaction
All polymerase chain reactions were carried out on BioRad thermocycling blocks in either
BioRad 8-well PCR strips (BioRad, TLS0801) or BioRad 96-well PCR plates (BioRad,
HSS9601) sealed with BioRad Microseal ’B’ adhesive seals (BioRad, MSB-1001). The
same cycling conditions were used for each reaction condition: the key cycling conditions
are outlined in Table 2.2. In this dissertation, the number of cycles is denoted in the PCR
protocol name e.g. TS_66_35 is the TS_66 protocol with 35 cycles of PCR.
2.9.1 Standard Phusion reaction
Routine PCR was carried out using New England Biolabs Phusion High-Fidelity DNA poly-
merase (New England Biolabs, M0530S) using the high fidelity buffer. Buffer was diluted
to 1x with dNTPs to a final concentration of 80nM and the required primer pairs to a final
concentration of 400nM were added along with 0.2U of DNA polymerase. The required
amount of template was diluted using nuclease free water to bring the whole reaction mix
to 10µl.
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2.9.2 Standard Q5 reaction
The Q5 high fidelity DNA polymerase (New England Biolabs, M0491S) was used to carry
out some PCRs where indicated. The Q5 reaction buffer was diluted to 1X with dNTPs
to a final concentration of 200nM and the required primer pairs to a final concentration of
400nM were added along with 0.2U of DNA polymerase. The required amount of template
was diluted using nuclease free water to bring the whole reaction mix to 10µl.
2.9.3 Multiplexed Phusion reaction
Following multiple rounds of optimisation, the final mix for multiplexed Phusion PCR was
as follows: NEB High Fidelity buffer diluted to 1x with dNTPs to a final concentration of
400nM, additional MgCl2 to a final concentration of 1mM, pooled primer pairs to a final
concentration of 0.25µM per primer pair, 1.6U of Phusion Hot Start Flex DNA polymerase
(New England Biolabs, M0535S) made up to 10µl total volume with nuclease free water
and template.
2.9.4 Indexing reaction
The Phusion High-Fidelity DNA polymerase (New England Biolabs, M0530S) was used to
carry out indexing reactions. The high fidelity buffer was diluted to 1x with dNTPs to a final
concentration of 80nM, either M13 of Fluidigm indexing primers to a final concentration
of 0.1µM along with 0.2U of the Phusion DNA polymerase. Products of the initial TS_66
PCR protocol, were diluted 10x by adding 1µl of the reaction product to 9µl of nuclease
free water and 4µl of the 10x dilution were added with nuclease free water to bring the
whole reaction mix to 10µl.
2.10 PCR primers
All primers were synthesised by Sigma-Aldrich and purified by desalting. All vials were
centrifuged at >10,000g for 30 seconds before dilution with nuclease free water to form a
100µM stock. Primers were stored at 20 C in a designated pre-PCR area. Before opening
any primer stock, a UVP UV HEPA PCR system hood was UV irradiated at full power for
30 minutes and all handling was done within the hood.
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2.10.1 Primer design
A custom Perl script was developed to identify the location of all [CA]30 microsatellites
within the reference mouse and human genomes. The output of this script also created a
plain text file that was formatted for input into the online primer design tool BatchPrimer3
[110] with input of the 70bp sequence flanking either side of the [CA]30.
The default BatchPrimer3 variables were used for all primer design except for stipulating
that the forward and reverse primers must be no closer than 20bp and no further than 70bp
from their respective end of the [CA]30 tract. As a result, the maximum amplicon length was
set at 200bp and the minimum amplicon length was set at 100bp with the optimal amplicon
length stipulated as being 180bp. This ensures that the amplicon produced is suitable for
paired-end 150bp sequencing and reduces amplicon length diversity within the library thus
overcoming any significant length amplification bias.
2.10.2 NGS adaptors
Initially, the CS1/CS2 NGS adaptor system was added to the end of all primer pairs to
allow compatibility with the Fluidigm barcoding system (Fluidigm, PN 100-3771) allowing
pooling of up to 384 sequencing libraries. All primer pairs containing these adaptors will
have their name prefixed with ’ADAP_’ and will be indicated where relevant in the text.
The sequence of these adaptors can be found in Table A.1.
In later experiments, an in-house designed NGS adaptor system was used named ’M13’
adaptors. It was found that these adaptors reduced primer-dimer formation in multiplex
PCR. These adaptors are compatible with an in-house designed barcoding system allowing
the pooling of up to 384 sequencing libraries. The sequence of the indexing primers and
the adaptor sequence can be found in Tables A.1 and A.2. All primer pairs containing these
adaptors will have their name prefixed with ’M13’ and will be indicated where relevant in
the text.
2.10.3 Multiplex group design
All primers designed using the methods described in Section 2.10.1 were screened in dupli-
cate and run on a 2% agarose gel to observe the presence of a single product at the expected
size. All successful primers were taken forward for trial in multiplex PCR groups. The
online tool MultiPLX 2.1 [52] was used to determine optimal multiplex PCR groups.
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Each time a multiplex group was used in a sequencing experiment the balance of total
reads for each amplicon was assessed. If an amplicon was found to have significantly higher
total reads, the concentration of primer added to the initial pool was reduced. Equally, if an
amplicon was found to have significantly reduced total reads, the concentration of primer
added to the pool was increased. The final pooled concentration are indicated, along with
the sequence of each primer pair, in Table A.3 for the mouse multiplex group and in Table
A.4 for the human multiplex group.
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2.11.1 Cloning of synthetic [CA]n loci
Endogenous loci were amplified frommouse genomic DNA isolated from tail samples using
the Q5 polymerase (New England Biolabs, M0491S) as described in Section 2.9.2. The
samples were cycled through the following conditions: 98 C for 30 seconds then 60 cycles
of 98 C for 10 seconds, 59 C for 20 seconds then 72 C for 20 seconds before a final
extension of 72 C for 2 minutes. The primers used in this reaction are detailed in Table 2.3.
The product of the PCR reaction was cleaned and concentrated using the Zymo Research
Clean and Concetrator-5 (Section 2.13.2) before being digested with BamHI (New England
Biolabs, R0126S) and HindIII (New England Biolabs, R0104S) at 37 C for 1 hour to create
sticky ends for cloning. Digestion of the pUC19 plasmid (Addgene, GenBank: M77789)
with BamHI and HindIII was also performed. The PCR product was ligated into the pUC19
plasmid using the Quick Ligation kit (New England Biolabs, M2200S).
Ligated plasmid was transformed into XL-1 Blue Competent Cells (Agilent, 200249)
by heat shock. Transformed bacteria were grown on agar plates under ampicillin selection
at 37 C overnight. Colonies of surviving cells were picked and the plasmid purified using
the Qiagen Spin Miniprep kit (Qiagen, 27106). Purified plasmid was screened by Sanger
sequencing the pUC19 cloning region using M13 primers (Table 2.3) and the number of
[CA] repeats counted manually. Sanger sequencing of this region was outsourced to Source
BioScience (Nottingham, UK).
Selected clones at desired lengths were in vivo amplified further and purified using the
Qiagen Plasmid Maxi kit (Qiagen, 12162). Final stocks of the plasmid were Sanger se-
quenced once more using Sanger validation primers (Table 2.3) and the number of [CA]
repeats manually counted to ensure the length was as expected. Finally, the plasmids were
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linearised as described in Section 2.11.2 and quantified using the Qubit dsDNA broad range
assay (Section 2.14.1).
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Type Abbreviation Step Action Cycles
1 95 C for 10 minutes
2 95 C for 15 seconds
3 66 C for 30 seconds
4 72 C for 1 minute
Back to step 2
for 20-50 cycles
5 72 C for 3 minutes
Initial PCR TS_66
6 4 C hold
1 98 C for 2 minutes
2 98 C for 10 seconds
3 66 C for 10 seconds
4 72 C for 20 seconds
Back to step 2
for 10-15 cyclesBarcode BC_66
5 4 C hold
Table 2.2 Key PCR conditions used for PCR amplification from single crypt lysate.
Loci Use Forward primer Reverse primer
a4_1365
Cloning
amplification
GCGCTAGGATCCTCCCATGACTACTTCCTCCA GGAGAGAAGCTTTCGCAAACTCAAATCCGGTG
s9_8328
Cloning
amplification
GCGCTAGGATCCAACCCCTGTCTACCTTCAGC GGAGAGAAGCTTCTCCCTCCCATGCCTCTATG
pUC19
M13
sequencing
TGTAAAACGACGGCCAGT CAGGAAACAGCTATGACC
a4_1365
Sanger
validation
amplification
AACTCTATAAAACAACCCCTTCTGG TATGTGCTCCCAGTGTGGAA
s9_8328
Sanger
validation
amplification
ACTTTAAGAGACAGGAGAAGCTC GCTGGAGTCTGAGAACCACT
a4_1365
Sanger
validation
sequencing
AACTCTATAAAACAACCCCTTCTGG TATGTGCTCCCAGTGTGGAA
s9_8328
Sanger
validation
sequencing
ACCTCAGCAAAGAAACTATGTCT TGGCTGCAGTATTTCGCAAA
Table 2.3 Sequences of primers used for screening and validation of synthetic loci length.
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2.11.2 Plasmid linearisation
For more accurate quantification of the pUC19 plasmid and better simulation of the en-
dogenous loci in vitro state, the pUC19 plasmid was linearised using ScaI restriction en-
zyme (New England Biolabs, R3122S). The reaction mixture contained 20U of rectriction
enzyme, 5µg of plasmid template and 1X NEBuffer made up to 50µl with nuclease free
water. The samples were incubated at 37 C for 1 hour.
To avoid re-circularisation of the plasmid, the samples were treated with Calf Intestinal
Alkaline Phosphatase (CIP) (New England Biolabs, M0290S). 2µl of CIP was added to
each reaction sample and incubated at 37 C for 1 hour. Plasmids were visualised using
gel electrophoresis (Section 2.12) to ensure linearisation had occurred and were quantified
using the Qubit dsDNA broad range assay (Section 2.14.1).
2.12 Gel electrophoresis
Agarose gels were made from 1x TAE buffer and laboratory grade agarose with 4µl of
Ethidium Bromide added per 100ml of agar. 10µl of amplified DNA was removed from test
reactions and 2µl of 6x loading buffer added. Samples were then run on 2% agarose gels
for 45-75 minutes at 90V alongside a DNA ladder (New England Biolabs, N0467S). Gels
were visualised and photographed using a UVP ultraviolet transilluminated system.
2.13 DNA purification and concentration
2.13.1 DNA extraction
DNA was extracted and purified from tail samples or crypt pellets using the Qiagen DNeasy
Blood and Tissue Kit (Qiagen, 69504) as per manufacturer’s instructions.
2.13.2 DNA concentration
DNA clean-up and concentration post-PCRwas performed using the Zymo Clean and Concentrator-
5 kit (Zymo Research, D4004) as per manufacturer’s instructions. For larger initial volumes
of DNA suspensions, the Millipore Amicon Ultra-2 Centrifugal Filter Unit with Ultracel-30
membrane (Millipore, UFC203024) as per manufacturer’s instructions.
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2.14 DNA quantification
2.14.1 Qubit dsDNA broad range assay
Qubit dsDNA broad range assay (Thermo Fisher Scientific, Q32853) was used to quantify
bulk DNA solutions at 10ng/µl or above as per manufacturer’s instructions. Infrequently,
Qubit dsDNA high sensitivity assay (Thermo Fisher Scientific, Q32854) was used to quan-
tify low concentration bulk DNA solutions as per manufacturer’s instructions. In both cases,
the Qubit 2.0 fluorometer (Thermo Fisher Scientific, Waltham, MA, USA) was used with
Qubit 500µl assay tubes (Thermo Fisher Scientific, Q32856) to ascertain readings.
2.14.2 Quant-IT dsDNA high sensitivity assay
Purified DNA samples were quantified on the PHERAstar DNA quantification system (BMG
Labtech, Aylesbury, UK) using the Quant-IT dsDNA high sensitivity assay (Thermo Fisher
Scientific, Q33120) as per manufacturer’s instructions. This assay was used to ensure sam-
ples within a library were adequately balanced and allowed for approximate sample normal-
isation.
2.15 MagJET NGS library size selection
The MagJET system is designed to size select NGS libraries using a magnetic bead suspen-
sion in a 1.5ml microcentrifuge tube with the ability to size select a maximum of 8 samples
at a time. In order to increase the throughput of the kit, all the volumes of solution suggested
in the manufacturer’s instructions were halved so that size selection can be done in a 1.2ml
MIDI 96-well plate (Thermo Scientific, AB-0564) using the Ambion Magnetic Stand-96
(Thermo Scientific, AM10027). Using the manufacturer’s instructions as a guide, the kit
was further improved for maximal recovery in a 96-well format. The optimised protocol is
described below.
2.15.1 Size selection calibration
Before size selecting a DNA amplicon pool, it is necessary to calibrate the size selection
buffer volume to maximise product capture and minimise adaptor binding to the capture
beads.
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To begin, binding mix was prepared at the required volume in multiples of 1600µl using
576µl of 100% isopropanol and 1024µl of binding buffer. If the amount of binding mix
exceeded 16,000µl, calibrated scales were used to measure out 4.53g of 100% isopropanol
and 11.02g binding buffer per 16,000µl of binding mix. Two 1.2ml MIDI 96-well plates
were prepared: the first with variable volumes of binding mix (recommended ranges in
Table 2.4) and the second plate containing 50µl of binding mix per well. The magnetic
beads were vortexed well and 2.5µl of magnetic bead suspension stock was added to each
well of plate 1 and plate 2.
For size selection calibration, 50µl of fragment mix provided in the kit was added to
each well of plate 1. The mixture was then shaken at 1500rpm for 15 seconds using the
Illumina High Speed Microplate Shaker (BioSurplus, 3002322) before incubating at room
temperature for 5 minutes. The plate was then placed on the magnetic plate and incubated
at room temperature for a further 5 minutes. This step removed larger fragments by binding
them to the magnetic beads: the target DNA is in solution.
The supernatant from plate 1 was transferred to plate 2 whilst keeping plate 1 on the
magnetic plate. Plate 2 was vortexed on the plate shaker for 15 seconds at 1500rpm before
being incubated at room temperature for 5 minutes. Plate 2 was then incubated at room
temperature on the magnetic plate for 5 minutes. The desired product was bound to the
magnetic bead and fragments smaller than the desired size were in solution.
Supernatant from plate 2 was discarded; plate was taken off the magnetic plate and add
15µl of elution buffer was added. Plate 2 was vortexed on the plate shaker for 15 seconds
at 1500rpm and incubated at room temperature for 1 minute. Plate 2 was placed on the
magnetic plate and incubated for 3 minutes. The supernatant was transferred to a fresh 96
well plate.
The products of the size selection were analysed on a 2% agarose gel or on the the
Agilent Bioanalyser DNA high sensitivity kit (Section 2.16.1). The selected fragments were
compared with the size of the library to be selected and an optimal binding mix volume was
selected. This volume was used in the size selection protocol (Section 2.15.2).
2.15.2 Size selection protocol
To begin the size selection protocol, binding mix was prepared at the required volume in
multiples of 1600µl using 576µl of 100% isopropanol and 1024µl of binding buffer. If the
amount of binding mix exceeded 16,000µl, calibrated scales were used to measure out 4.53g
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of 100% isopropanol and 11.02g binding buffer per 16,000µl of binding mix. In addition,
600µl of wash buffer were made per sample adding 3 parts 100% ethanol to 1 part wash
buffer provided in the kit.
Three 1.2ml MIDI 96-well plates were prepared: the first with 350µl of binding mix;
the second plate with the volume of binding mix determined in the calibration step to select
the desired fragment range and the third plate containing 50µl binding mix per well. The
magnetic beads were vortexed well and 2.5µl of magnetic bead stock was added to each
well of plate 1, 2 and 3.
Exactly 50µl of sample was added to plate 1; samples with less than 50µl volume were
topped up with nuclease free water. Plate 1 was then vortexed on the plate shaker for 15 sec-
onds at 1500rpm; incubated at room temperature for 5 minutes before a 5 minute incubation
on the magnetic plate. The target DNA was bound to the beads and shorter fragments were
in the solution.
Plate 1 was kept on the magnetic plate and the supernatant discarded. Plate 1 was taken
off the magnetic plate and 52.5µl elution buffer was added. Plate was then vortexed on
the plate shaker for 15 seconds at 1500rpm then incubated at room temperature before a 1
minute incubation of the magnetic plate. 50µl of supernatant was transferred from plate 1
to plate 2. Plate 2 was vortexed on the plate shaker for 15 seconds at 1500rpm; incubated at
room temperature for 5 minutes before being incubated on the magnetic plate for 5 minutes.
Larger fragments were bound to the beads and the desired DNA fragments were in solution.
With plate 2 on the magnetic plate, the supernatant was transferred from plate 2 to plate
3. Plate 3 was vortexed on the plate shaker for 15 seconds at 1500rpm; incubated at room
temperature for 5 minutes before being incubated on the magnetic plate for 5 minutes. The
target DNA was bound to the beads.
Plate 3 was kept on the magnetic plate and the supernatant discarded. With plate 3 still
on the magnetic plate, 300µl of wash buffer was added and incubated at room temperature
for 30 seconds. The was buffer was discarded and the wash step was repeated for a total of
two times with plate 3 on the magnetic plate at all times. The bead pellet was allowed to air
dry for up to 5 minutes.
10-50µl of elution buffer was added to the bead pellet off the magnetic plate. Plate
3 was vortexed for 15 seconds at 1500rpm; incubated at room temperature for 1 minute
before being incubated on the magnetic plate for 3 minutes. The size selected library was
in solution. Samples were transferred to a fresh 96-well plate for storage or downstream
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analysis.
2.16 NGS library quality control
Before submission, all NGS libraries were analysed to ensure the library was present at the
expected size range with no adaptor-dimer contamination. The library was submitted to the
Cancer Research UK Cambridge Institute Genomics core facility either between 10nM and
20nM or at exactly 4nM, as quantified by qPCR.
2.16.1 Agilent Bioanalyser library analysis
For products expected at low concentration (5-500pg/µl), the Agilent DNA High Sensitivity
kit (Agilent Technologies, 5067-4626) was used. For products expected at higher concen-
trations (0.1-50ng/µl), the Agilent DNA 1000 kit (Agilent Technologies, 5067-1505) was
used. In both instances, the kits were used with the Agilent 2100 Bioanalyser system (Agi-
lent Technologies, Santa Clara, CA, USA).
2.16.2 qPCR quantification of NGS library
A serial dilution of libraries was first done to obtain 1 in 10,000 and 1 in 100,000 dilution
of libraries quantified on the Agilent Bioanalyser (Section 2.16.1) to be between 10nM and
20nM. Each of these dilutions was done in triplicate.
The Kapa Biosystems qPCR library quantification kit for ABI Prism (Kapa Biosystems,
KK4844) was used to quantify the libraries. 6µl of master mix (with added primer pair mix)
was added to each required well of a 384-well plate including 24 wells for triplicates of 8
standards. 4µl of each replicate of the 1 in 10,000 and 1 in 100,000 dilutions were added to
the master mix and 4µl of standard was added to the master mix in triplicate. The plate was
sealed with an optical seal and spun down at 280g for 1 minute.
qPCR analysis was performed on the ABI 7900HT instrument (Fisher Scientific - UK
Ltd, Loughborough, UK). qPCR cycling conditions were as follows: 95 C for 5 minutes
then 35 cycles of 95 C for 30 seconds then 60 C for 45 seconds. An optional melt curve
from 60 C to 95 C would be performed at this stage.
Threshold value for Ct was manually adjusted to fall within the exponential part of each
Ct-fluorescence curve. The standard curve was checked to have a slope between -3.1 and
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-3.4 and have an R2 value of over 0.98 for log(fluorescence)-Ct. Any outliers to the standard
curve were removed.
Exported data was analysed in a Microsoft Office Excel spreadsheet generated by the
Cancer Research UK Cambridge Institute Genomics Core Facility. The spreadsheet used
the exported data and standard curve to calculate the median Ct for each triplicate dilution
of each library. A standard deviation was also calculated to flag any triplicates with a large
variance around the median value. Any outliers within a triplicate were removed from
downstream analysis. Using the median Ct value for both dilutions of each library and the
standard curve Ct values along with average fragment size calculated from the bioanalyser,
it was possible to infer the concentration of the initial input library.
Using the inferred concentrations, each library was diluted to 4nM before submission
to the Cancer Research UK Cambridge Institute (CRUK-CI) Genomics Core Facility for
Illumina MiSeq or HiSeq 4000 sequencing.
2.17 Computational methods
2.17.1 FASTQ file demultiplexing
FASTQ files generated by the Illumina MiSeq or HiSeq 4000 systems in the CRUK-CI
Genomics Core Facility were demultiplexed by the CRUK-CI Bioinformatics Core Facility
using the demuxFQ tool.
2.17.2 FASTQ quality filtering
The fastq_quality_filter (part of the FASTX toolkit: http://hannonlab.cshl.edu/fastx_toolkit/)
was used to filter all reads within each FASTQ file only keeping reads that had 80% or more
of the read at Q20 or above.
2.18 Digital PCR
The Fluidigm 12.765 digital PCR array (Fluidigm, BMK-M-12.765) was used to perform
digital PCR as per manufacturer’s instructions using the Fluidigm IFC Controller MX and
Fluidigm Biomark HD instruments (Fluidigm, San Francisco, CA, USA). A probe for the
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FoxD3 locus on chromosome 4 with a FAM reporter (TaqMan, Mm02384867_s1) was du-
plexed with a copy number reference assay probe for the Tfrc locus on chromosome 16
with a VIC reporter (ABI, 4458366). ROX acted as a passive control. Together these probes
acted as quantitative indicators for the number of copies of each of those loci as they detect
intra-genomic regions. The two loci should show high levels of correlation as these cells are
highly likely to be in a diploid state. Therefore, the number of copies of each of these loci
will be equivalent to the number of genome copies within each lysate.
Per reaction, 5µl of TaqMan Gene Expression Master Mix (ABI, PN 4369016), 0.5µl
of 20X gene expression loading buffer, 0.5µl of FoxD3-FAM assay, 0.5µl Tfrc-VIC assay
and 3.5µl of template DNA were added. The DNA template was first heated to 95 C for
1 minute before addition to the reaction to generate single-stranded DNA template and,
therefore, increase the number of detectable molecules.
2.19 SYBR green qPCR assay
The Life Technologies SYBR Green PCR Master Mix (Life Technologies, 4309155) was
used to identify any amplification bias between microsatellites of differing lengths. The kit
was used as per manufacturer’s instructions including an optimisation reaction to identify
the optimal forward and reverse primer concentrations for each loci. The primers used for
qPCR analysis had the CS1/CS2 sequencing adaptors attached and were first diluted to 5µM
before addition to the reaction. Full details of the primers used can be found in Table A.3.
For loci s9_8328, 0.12µl of forward primer and 0.72µl of reverse primer was added to each
12µl reaction. For loci a4_1365, 0.12µl of forward primer and 2.16µl of reverse primer
was added to each 12µl reaction. These volumes were determined to be optimal through
melt curve analysis and agarose gel electrophoresis visualisation of products generated from
varying forward and reverse primer volume combinations.
Each reaction was performed in a 384-well plate with 6µl of SYBR master mix, 1.2µl
of linearised plasmid at 1pg/µl, primers at the optimised volume and made up to 12µl total
volume with nuclease free water. The analysis was performed on the Life Technologies
QuantStudio 4 (Thermo Fisher Scientific Inc, Waltham, MA, USA) with the following cy-
cling conditions: 95 C for 10 minutes then 40 cycles of 95 C for 15 seconds followed by
60 C for 1 minute. A melt curve was performed each time to check for any primer-dimer
contamination.
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Average desired DNA
fragment length Binding mix, µl
200bp 400µl , 450µl , 500µl , 550µl , 600µl
300bp 300µl , 350µl , 400µl , 450µl , 500µl
400bp 250µl , 300µl , 350µl , 400µl , 450µl
500bp 200µl , 250µl , 300µl , 350µl , 400µl
700bp 150µl , 200µl , 250µl , 300µl , 350µl
Table 2.4 This table was adapted from the MagJET size selection manufacturer’s instruction
manual. For a given desired fragment length, the range of binding mix volumes to be tested
during size calibration is shown.
Chapter 3
Development of multiplexed
microsatellite sequencing protocol
To quantify clone size distributions using microsatellite sequencing, a PCR protocol needed
to be optimised to balance the requirements of: 1) faithfully reflecting the original distribu-
tion of microsatellite lengths, 2) amplify the original crypt DNA enough to meet sequencing
concentration requirements and 3) ideally include multiple loci in a single reaction. Existing
quantitative approaches to Illumina sequencing of microsatellites have not been optimised
for low template copy input nor have attempts been to made to quantify and ameliorate any
effect of in vitro polymerase slippage during microsatellite amplification using the poly-
merse chain reaction (PCR) prior to sequencing.
Based on the observations made by Kozar et al [54], calculations can be done to approx-
imate the incidence of clones. In the colon of a 300 day old mouse, around 60 crypts would
require sequencing in order to observe one WPC and 218 crypts in order to observe one
PPC, Table 3.1. As the current method for crypt isolation takes a full day for one person to
isolate 100-200 crypts, simply analysing one microsatellite will significantly limit the num-
ber of clonal events observed. By amplifying up to 20 microsatellites from a single crypt, it
should be possible to observe more events and increase the power of the method. Therefore,
a method utilising a multiplexed amplification and sequencing protocol to measure multiple
microsatellites per crypt is required. However, the use of multiplexed PCR produces addi-
tional challenges to attaining adequate amplification from low template copies largely due
to non-specific generation of primer-dimers and allele dropout.
A summary of the proposed pipeline for the library preparation of single crypts for mul-
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tiplexed microsatellite sequencing is summarised in Figure 3.1. A single crypt suspension
was obtained using existing methods of intestinal epithelium fractionation adapted from the
method described by Bjerknes and Cheng [7] and fully described in Section 2.7. A mouth
syphon attached to a micropipette was used to isolate single crypts under a dissecting mi-
croscope. The single crypts were then lysed in individual wells. The resulting lysate entered
a multiplexed PCR to amplify endogenous loci before sequencing initially on the Illumina
MiSeq before larger scale sequencing on the Illumina HiSeq 4000.
The proposed workflow appears simplistic but major technical challenges are associated
with each step. The key challenges are discussed below.
3.1 Microsatellite sequencing from low template copies
Each intestinal crypt is a discrete clonal unit. The cell number per crypt is significantly
higher in human colonic crypts at approximately 2000 cells compared to approximately 250
cells per mouse ilieal crypt [53] i.e. 4000 and 500 genome copies respectively. Amplifying
hypermutable regions, such as microsatellites, from such low template copies renders the
protocol susceptible to many sources of error and noise. The key sources of error are: 1)
DNA contamination in crypt lysate, 2) in vitro polymerase slippage, 3) allele dropout and
4) sequencing error. Each of these sources of error are discussed below.
3.1.1 DNA contamination during crypt isolation
Initially, the isolation of single crypts must be validated to ensure the entire DNA content of
the crypt is isolated without the transfer of contaminating DNA. In this context, contaminant
DNA would include any DNA included in the analysis that has originated from anywhere
other than short-lived daughter cells generated from the stem cell population at the base of
the crypt. This would include stromal cells, immune infiltrate, long-lived Paneth cells, cells
from adjacent crypts and cell free DNA transferred along with the crypt during the exper-
imental protocol. Minimisation of contaminant DNA is imperative to ensure consistency
and accuracy between samples. It is important that the degree to which contaminating DNA
effects the accuracy and resolution of the protocol is determined. If this is shown to be an
issue, steps will be taken to try and reduce this effect.
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Crypt Status Frequency 1x [CA]30 8x [CA]30 20x [CA]30
WPC 1680 per 105 crypts 1 per 60 crypts 1 per 8 crypts 1 per 3 crypts
PPC 458 per 105 crypts 1 per 218 crypts 1 per 27 crypts 1 per 12 crypts
Table 3.1 Estimates of the number of WPCs and PPCs observed in multiplex groups of
differing sizes. The estimates are adapted from Kozar et al [54] for colon of a 300 day old
mouse. The estimates account for autosomal loci being biallelic but only include the rate
for in-frame mutations thus likely represents a conservative estimate.
1. Epithelial isolation
+ crypt enrichment
2. Micropipette isolation
of single crypt
3. Crypt lysis
4. Multiplex PCR of different
native microsatellite loci
Adaptor Adaptor[CA]30
Adaptor Adaptor[CA]30
Adaptor Adaptor[CA]30
Adaptor Adaptor[CA]30
Adaptor Adaptor[CA]30
Loci 1
Loci 2
Loci 3
Loci 4
...
Loci n
5. Paired-end 150bp Illumina
MiSeq sequencing
Single crypt
(~250 cells)
Fig. 3.1 A stepwise schematic showing the approach to sequencing multiple endogenous
[CA]30 microsatellites from a single intestinal crypt.
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3.1.2 In vitro polymerase slippage
Key to the use of microsatellite sequencing as a means of quantifying clone size is gen-
eration of consistent microsatellite length calls with maximised signal-to-noise ratios. By
amplifying a region containing a microsatellite, using PCR, the polymerase has no exter-
nal mechanism for mismatch repair and relies solely upon the intrinsic replication fidelity
and proofreading activity of the enzyme to detect and repair error whilst amplifying the mi-
crosatellite. As a result, the in vitro microsatellite mutation rate is thought to be far higher
than the in vivo mutation rate. It has also been observed that the ’stutter bands’ formed
from PCR produce a bias towards contraction of microsatellites, particularly in dinucleotide
and mononucleotide tracts [47, 64, 88]. As a result the sequencing data produced from the
PCR amplified product is a ’blurred’ representation of the parental copies of DNA. To gain
sequencing data that accurately represents the actual microsatellite length and maximises
the signal-to-noise ratio, the PCR protocol must be optimised to reduce polymerase error.
Central to this is: 1) reducing the number of PCR cycles required to produce a sequenc-
ing library from single crypts; 2) screening many different DNA polymerases to determine
polymerases with the lowest microsatellite mutation rate in vitro.
In addition to a PCR protocol for single microsatellite amplification, any method re-
quires optimisation for multiplexing. Key to optimising a successful multiplex PCR assay
is reducing the amount of off-target annealing events that occur leading to primer-dimer for-
mation. Further, caution must be taken when using multiplex PCR assays in NGS protocols
as primer-dimers are able to undergo barcoding reactions and generate sequencing reads on
the Illumina platform. Due to their shorter length, they are able to form sequencing clusters
far more effectively than the target amplicons leading to large losses of usable data from
each sequencing run. Reduction of primer-dimer with the potential need for a size selection
step therefore is crucial to developing this multiplexed NGS method.
The balance of representation of different locus specific amplicons must also be opti-
mised. Particularly well performing primer pairs may amplify their target very effectively
and lead to a massive over representation of that amplicon in the sequencing data. Thus,
through an iterative process of sequencing and re-calibration, the concentration of each
primer pair within the multiplex PCR reaction must be altered to balance the representation
of all amplicons in each crypt amplification reaction.
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3.1.3 Allele dropout
A commonly reported issue in any low template copy sequencing project is the phenomenon
known as ’allele dropout’. This is a process by which stochastic non-amplification of cer-
tain alleles during early rounds of PCR leads to under-representation of that variant and
over-representation of other variants [13]. If microsatellite sequencing is to be an effective
method for quantifying clone size, it is necessary that the proportional representation of each
allele is maintained throughout amplification. Previous reports have described methods for
accounting for PCR bias and allele dropout using molecular barcoding: a process by which
individual primer-template annealing events are tagged with a unique nucleotide sequence.
During analysis, it is possible to account for over and under represented unique identifiers
thus removing PCR bias. These techniques, though incredibly powerful, have only recently
been optimised for multiplex use in low copy number samples [72, 90] so were not used in
this project.
The polymerase selected for this project will also require high amplification efficiency
so as to reduce the incidence of allele dropout in early cycles of PCR. Allele dropout rates
will also be closely associated with careful primer design and titring of primer pair concen-
tration so as to maximise annealing events whilst limiting primer-dimer formation and the
occurence of false positives. Experiments were also performed to demonstrate the effect of
allele dropout on clone size estimates.
3.1.4 Illumina sequencing of repetitive DNA
The final major technical challenge in this protocol is sequencing highly repetitive DNA on
the Illumina sequencing platform. As the Illumina sequencing protocol requires an isother-
mal amplification step, further errors in microsatellite length may be generated. Further-
more, sequencing by synthesis is susceptible to a process known as ’phasing’, this occurs
when an additional nucleotide is added during synthesis leading to the read ’jumping’ one
nucleotide ahead. The combination of these two error modes is hard to detect when sequenc-
ing highly repetitive stretches of DNA and would be particularly accentuated when sequenc-
ing very simple repeats such as mononucleotide and dinucleotide repeats. At the time this
project began, only one paper had been published showing that it may be feasible to use
short-read Illumina technology to sequence microsatellites [10] but the longest microsatel-
lite studied was a 26 unit tetranucleotide repeat and no dinucleotide repeats were studied.
Therefore, when we set out to develop this protocol, the feasibility of accurately sequenc-
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ing dinucleotide repeats using an Illumina sequencing platform was unknown. Subsequent
studies have shown the utility of Illumina sequencing platforms in STR genotyping based
on whole genome sequencing data [111] but did not use the Illumina platform for ultra-high
depth, targeted sequencing of microsatellites. To the best of my knowledge, this work rep-
resents the first described targeted resequencing protocol for dinculeotide microsatellites on
the Illumina sequencing platform.
3.1.5 Use of crypt equivalents
The eventual intention for this protocol is to sequence endogenous microsatellites within
human tissues, however all of the data in this chapter was obtained from work with murine
crypts and mouse reference DNA.
For the majority of optimisation experiments, crypt equivalents were used to simulate a
single crypt lysate. These were made by diluting mouse reference DNA, extracted from ear
or tail clippings, with the lysis buffer used for extracting DNA from single crypts. The dilu-
tion created lysis buffer containing mouse DNA at the concentration that would be expected
if a single crypt were lysed in 12µl of buffer, as per the crypt picking protocol (Section 2.8).
The same calculation was performed when optimising the protocol for human crypts. The
steps used to calculate these concentrations are shown in Table 3.2. The use of either crypt
equivalents or real crypt lysates will be indicated where relevant throughout this dissertation.
This chapter discusses the key optimisation steps taken and describes the optimal li-
brary preparation method for the multiplexed amplification of multiple [CA]30 microsatel-
lites from a single murine crypt.
3.2 Optimising the isolation of single murine intestinal crypts
Creation of a suspension of single crypts from mice can be accomplished by incubation
of whole gut in alkaline, EDTA solution before applying mechanical shearing to detach
crypts from the underlying stroma. This method is fully described in Section 2.7. Once
in suspension, it is possible to isolate single crypts using a mouth syphon attached to a
micropipette. An initial method of single crypt isolation was performed as described in
Section 2.8.2. Through rational re-development, many aspects of the picking technique were
altered to reduce the chance of losing crypt material; this re-designed protocol is described
in Section 2.8.3 and was named the ’low adherence’ technique. The two key changes were:
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1) using plastics coated with DNA repellent so as to prevent DNA sticking to the plastic and
being lost during transfer and 2) expelling picked crypts directly into the lysis buffer whilst
visually inspecting the transfer through a dissecting microscope. In addition to improving
DNA isolation from single crypts, the effect of 4% PFA fixation on crypt fractions was
assessed with the aim to store the crypts long-term and allow multiple days of crypt picking
to be performed. This was performed as described in Section 2.7.4. Crypts were then taken
out of PFA and picked using the low adherence technique.
To determine the most effective method of crypt DNA isolation, digital PCR was utilised
to accurately quantify the amount of DNA isolated by: the standard technique, the low
adherence technique and following PFA fixation. Figure 3.2 shows the variable amount of
DNA isolated using standard crypt capture techniques and the lack of DNA detection after
4% PFA incubation (none detected). However, using the novel low adherence technique,
the reproducibly captured the genome equivalent of approximately 200-350 cells (250 cells
= 500 genome equivalents = 1.5ng DNA) from multiple crypts. Therefore, all crypts used
in this project were picked using this improved picking technique.
3.3 Quantifying and reducing cell free DNA contamina-
tion
During the fractionation process, cells can undergo lysis and apoptosis leading to the release
of cell-free DNA (cfDNA). Due to the majority of crypts within the single crypt suspension
containing wild-type [CA]30 microsatellites, capture of this DNA in single crypt lysate will
lead to under-estimates of mutant clone size.
To determine a baseline value of cell free DNA within the fraction media, the amount
of cfDNA was quantified. To do this, mouse colon underwent the epithelium isolation and
crypt enrichment protocol described in Section 2.7. The single crypt suspension in fractions
4 and 5 were then pelleted, re-suspended in PBS and left on ice. At time 0 and at 1 hour, 2
hours and 3 hours, the crypt suspension was re-pelleted and 2ml of the PBS was removed.
To observe the effects of re-suspending the crypt fractions in different volumes of PBS,
two mice were used and fractions 4 and 5 from these animals were suspended in either
25ml or 50ml PBS before quantification. At one hour intervals, the crypts were pelleted
and a 2ml volume of the PBS suspension was sampled. The PBS containing cfDNA was
concentrated using the large volume concentrator, Section 2.13.2, and accurately quantified
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Mouse Human
One genome 2.7x109 base pairs 3.3x109 base pairs
One base pair 650Da 650Da
Mass one genome 1.8x1012 Da 2.2x1012 Da
Weight one genome 3.01pg 3.67pg
# genomes in one crypt 500 4000
DNA content of one crypt 1.5ng 14.7ng
Concentration in 12µl buffer 0.125ng/µl 1.2ng/µl
Table 3.2 Table displaying steps taken to calculate crypt equivalent concentration.
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Fig. 3.2 Histogram summarising digital PCR quantification of DNA isolated by standard
techniques, an improved low adherence technique and after 4% PFA fixation from murine
crypts in the proximal small intestine, distal small intestine and colon. Based on this data,
it was decided to only use the low adherence technique for all future crypt picking experi-
ments.
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using the Qubit dsDNA HS kit, Section 2.14.2. The results of this quantification are shown
in Figure 3.3. As expected, re-suspending in 50ml of PBS rather than 25ml of PBS has a
significant effect on reducing the concentration of cfDNA seen in the fractionation media.
Furthermore, fraction 5 appears to contain less cfDNA when compared with fraction 4. This
is likely due to the reduced crypt density seen in fraction 5. The amount of cell free DNA
increases with time and is likely a result of cell lysis. Crypts should, therefore, be picked as
soon after fractionation as possible. From these results, only fraction 5 was used for crypt
picking after re-suspension of the crypts in 50ml PBS. This condition also displays the least
change in cell free DNA concentration with time allowing a larger time frame for picking.
3.4 Minimising cell debris contamination
Single cells become dislodged from crypts and surrounding stroma during fractionation and
are visible throughout the single crypt suspension. These single cells can be accidentally
isolated along with the single crypt. Due to the majority of these single cells containing
wild-type [CA]30 microsatellites, isolation of these single cells along with the crypt will
again lead to an under-estimate of the mutant clone size.
As there is no efficient way of removing single cell debris or clumps of cell debris from
the single crypt suspension, the most effective way of minimising this effect is through
visual inspection of the crypt as it is being picked. By passing the crypt through droplets of
PBS before final transfer to the lysis buffer, it is easy to visualise and exclude single cells
during transfer. Furthermore, this method allows the amount of cfDNA and EDTA content
of the media to be minimised thus further improving downstream analysis.
3.5 Amplifying endogenous [CA]30 loci
Primer pairs were designed as described in Section 2.10.1. A key aspect of the primer design
is the addition of a 20-70 nucleotide flanking sequence at the 5’ and 3’ ends of the [CA]30
tract. Sequence complexity within these flanking sequences are key to highly specific primer
binding and amplicon generation. From a technical perspective, high sequence complexity
in the first 5 nucleotides of the amplicon is particularly important for adequate calibration
of the Illumina sequencing instrument. If sequence complexity is low early in the read, this
can effect the sequencing quality for the remainder of the sequencing run.
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Fig. 3.3 Plot showing the concentration of cfDNA in different fractions of single crypts and
showing the effects of varying the volume of PBS used for re-suspension. As expected, re-
suspending in 50ml of PBS reduced the amount of cfDNA observed. Furthermore, fraction
5 appears to contain less cfDNA when compared with fraction 4.
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In addition to sequence complexity, the length of the flanking region is also important.
This is because each amplicon is ideally suited for paired-end 150bp sequencing by allowing
a maximum of 70bp prior to the tract plus 60bp within the wild-type microsatellite therefore
only 130bp reads are actually required giving a 20bp buffer at the 3’-end of the read. Fur-
thermore, by having each amplicon length restricted to between 100bp (20bp at each flank
plus 60bp tract) and 200bp (60bp at each flank plus 70bp tract), the length diversity within
the library is restricted thus reducing any bias towards shorter amplicons. Before submitting
for synthesis, each primer pair was manually curated for sequence diversity and primer pairs
that produced amplicons at the extremes of the 100bp to 200bp range were avoided, where
possible.
In addition to locus specific sequences, NGS adaptors were added to the 5’ ends of both
the forward and reverse primers to produce amplicons with sequencing adaptors at both the
5’ and 3’ ends. One of two sets of adaptors were used and are described fully in Section
2.10.2.
Primer pairs for 80 [CA]30 microsatellites spanning all the chromsomes in the mouse
genome were selected. Primer pairs were then tested for efficacy using a standard Phusion
polymerase reaction in the TS_66_35 cycling protocol, Section 2.9. All primer pairs were
tested in duplicate and assessed for the presence of a product at the expected length using gel
electrophoresis. Out of 80 primer pairs, 63 primer pairs generated a product at the expected
length (a 79% success rate). These 63 primer pairs were taken forward for further testing.
3.5.1 Preserving native [CA]30 length during the Polymerase Chain
Reaction
The first attempt at amplifying and sequencing [CA]30 microsatellites from the mouse genome
required 50 cycles of PCR and utilised the New England Biolabs Q5 DNA polymerase fol-
lowed by Illumina HiSeq 4000 sequencing. This initial protocol lead to significant slippage
of the microsatellite in vitro with the majority of reads in the [CA]25 read bin instead of
the [CA]30 bin. Furthermore, the blurring effect was significant with many reads present
at lengths different to that of the modal tract length, Figure 3.4A. It was obvious from this
initial work that significant optimisation was required to maintain native tract length during
amplification and sequencing.
In contrast, the final protocol required only 35 cycles of PCR, utilised the New England
Biolabs Phusion DNA polymerase and could be sequenced using either the Illumina MiSeq
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or HiSeq sequencing platforms. The outcome of this optimisation can be seen in Figure
3.4B. Below is a description of the key optimisation steps used to produce this sequencing
data.
3.5.2 Selection of DNA polymerase for microsatellite amplification
The ideal DNA polymerase would have perfect fidelity, would never lead to an incomplete
amplification reaction and would capture every amplicon during each cycle of the reaction.
For this project, high efficiency and fidelity in amplification are key. By first identifying the
polymerases with the highest efficiency i.e. the highest yield of product, the fidelity of these
enzymes can be subsequently tested by sequencing of their products.
The majority of polymerases tested were thermostable polymerases (used in thermo-
cycling reactions) but two thermolabile polymerases, that utilise isothermal amplification,
were also tested. A range of polymerases were selected with varying characteristics that
included 3’-to-5’ exonuclease activity and the addition of an Sso7d domain that increases
the polymerase-DNA interaction area.
The selected polymerases were trialled using the reaction conditions recommended by
the manufacturer with an input of mouse reference DNA equivalent to the content of a
single mouse crypt (1.5ng). Each reaction underwent 35 cycles of PCR or, in the case of
the isothermal reaction, 90 minutes of incubation for the IsoAmp kit or 40 minutes for the
TwistDx kit. The full list of polymerases trialled including key characteristics and results of
gel electrophoresis assessment of are shown in Table 3.3.
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Fig. 3.4 (A) Scatter plot with line annotation showing initial attempts at trying to amplify an
endogenous [CA]30 microsatellite with the majority of reads slipping to [CA]26 and a sig-
nificant blurring effect present. (B) Scatter plot with line annotation showing the reduction
in error as a result of PCR optimisation leading to the majority of reads being preserved at
[CA]30 with minimal distribution blurring.
Manufacturer Polymerase Type Key features Result
New England Biolabs Q5 Thermostable 3’-to-5’ exo, Sso7d domain Moderate amount ofproduct
New England Biolabs Phusion Thermostable 3’-to-5’ exo, Sso7d domain Good amount ofproduct
New England Biolabs Taq Thermostable 5’-to-3’ exo, 5’-flap endonuclease No product detected
New England Biolabs Vent Thermostable 3’-to-5’ exo No product detected
Kapa Biosystems HiFi Thermostable Taq developed by mutagenesisscreen for amplicon balance No product detected
TwistDx TwistAmp Basic Thermolabile
Recombinase polymerase
technology, isothermal
amplification at 37 C
No product detected
BioHelix IsoAmp IIUniverstal tHDA Thermolabile
Helicase-dependent amplification,
isothermal amplification at 65 C No product detected
Table 3.3 Table of DNA polymerases tested for [CA]30 amplification either using 35 cycles of thermocycling PCR or, for the isothermal amplifica-
tion, 90 minutes for the IsoAmp kit or 40 minutes for the TwistDx kit. All reaction were assessed by gel electrophoresis for presence of a product.
Amount of product was assessed qualitatively by visual inspection of band brightness.
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An intriguing observation from the testing of various polymerases was the improved
product formation in the presence of the Sso7d domain. The Sso7d domain is a protein
domain that was discovered in Sulfolobus solfataricus and has been shown to be highly
stable at a high temperatures [38]. This domain has been added to many new generation
polymerases as it increases the enzyme’s interaction with target DNA from approximately
7-9 nucleotides in standard Taq to 12-14 nucleotides thus improving processivity [31, 88]. A
potential consequence of this is that the polymerase is able to deal more readily with highly
repetitive DNA sequences. At the very least, this data suggests the presence of the Sso7d
domain improves amplification efficiency of microsatellites from low template copies.
From this screen, it was decided that the fidelity of the Q5 and Phusion enzymes (both
manufactured by New England Biolabs) would be tested. Libraries were prepared using
supra-optimal amounts of DNA, 10ng of input DNA (equivalent to 6.7 mouse crypts) with
singleplex reactions targeted at 7 different loci so as to observe the efficacy of these en-
zymes at different genomic loci. The effect of the number of PCR cycles and the annealing
temperature of the reaction were tested. To vary the amount of PCR cycles, all samples
were initally amplified with 20 cycles of PCR followed by either 5 barcoding cycles or 15
barcoding cycles totalling 25 or 35 cycle of PCR respectively. To test the effect of annealing
temperature, samples were run on a temperature gradient ranging from 66.2 C to 71 C.
This totalled 168 reactions:
• 7 different loci = 7 samples
• Phusion versus Q5 = 2 test conditions
• 25 cycles versus 35 cycles = 2 test conditions
• 6 different annealing temperatures = 6 test conditions
• 7 samples x 2 enzymes x 2 cycling totals x 6 annealing temperatures = 168 reactions
The Q5 and Phusion polymerases both show significant improvement on previous at-
tempts to amplify [CA]30 microsatellites and both performed comparably in terms of read
length distribution and consistency of error, Figure 3.5. Overall, both enzymes could theo-
retically be used for genotyping of wild-type loci. However, the Q5 enzyme was not able
to generate adequate read depth for 3 of the 7 loci tested whilst the Phusion enzyme had a
100% success rate, Figure 3.5. This is further exemplified when the read depth spread of
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these two polymerases is assessed, Figure 3.6. The Phusion enzyme produces significantly
more reads per sample than the Q5 polymerase indicating superior amplification efficiency.
Annealing temperature was shown to have little effect on the performance of the Phusion
polymerase, Figure 3.7. The lowest annealing temperature (66 C) was used for all subse-
quent reactions so as to reduce the likelihood of extension reactions during the annealing
step.
Finally, an assessment of the effect of PCR cycles was done comparing the samples that
underwent 25 cycles of PCR compared with 35 cycles of PCR. The results of this are shown
in Figure 3.8. As can be seen from the read length distributions, the samples undergoing
25 cycles of PCR have a modestly tighter read length distributions, as would be expected,
and show that the final 10 cycles of PCR do have a slight blurring effect on the overall read
length distribution. However, the number of reads per sample produced from 25 cycles of
PCR is significantly lower than compared with 35 cycles of PCR, Figure 3.9, and for 3 of the
7 loci tested, there were not enough reads to generate an adequate read length distribution.
The read depth is so low that generating a library with samples produced from 25 cycles of
PCR alone is highly unlikely to be of high enough concentration to be suitable for Illumina
sequencing. This issue could potentially be worked around by spiking in extra DNA to
increase the overall library concentration. However, this would lead to significant data loss
and be a highly inefficient method for generating crypt sequencing data. For this reason, the
decision to use 35 cycles of PCR for future reactions was made.
From this data, the Phusion DNA polymerase can be seen to be the enzyme with the
highest amplification efficiency and fidelity at repetitive stretches of DNA. Furthermore, an
annealing temperature of 66 C would be used with 20 cycles of initial PCR followed by 15
cycles of barcoding PCR.
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The initial optimisation was done using DNA concentrations above that expected to be con-
tained within a single crypt. To ensure that the protocol was also able to effectively amplify
the genomic DNA content of a single murine crypt, amplification and sequencing of lysate
containing a single murine crypt was performed. Furthermore, it was necessary to know if
the presence of additional contaminants contained within crypt lysate would inhibit PCR.
46 primer pairs were selected from the successful panel of 63 primer pairs and amplified
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Fig. 3.5 Scatter plot with line annotation showing the read length distributions of the Q5
polymerase versus the Phusion polymerase at 7 different mouse loci. The distributions
vary between different loci and between the forward and reverse reads generated by paired-
end sequencing. The enzymes perform comparably in terms of read length distribution
consistency and ’peakiness’. However, the Q5 polymerase did not produce adequate read
depth at loci a6_1418, s1_6289 and s5_1215 suggesting poor amplification efficiency at
these loci.
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Fig. 3.6 Boxplot depicting the median read depth along with upper and lower quartiles
and lowest and highest values across the 7 tested loci using either Phusion polymerase or
Q5 polymerase for the library preparation. The Phusion polymerase produces substantially
more reads across all loci indicating superior amplification efficiency.
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Fig. 3.7 Scatter plot depicting read length distributions at different loci whereby technical
repeats were amplified at differing annealing temperatures. The read length distribution
does not differ significantly between annealing temperatures.
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Fig. 3.8 Scatter plot showing the read length distributions generated from samples undergo-
ing differing amounts of PCR cycles. The read length distributions of the 25 cycle samples
are generally tighter indicating a small effect of an additonal 10 cycles of PCR on the blur-
ring effect of the read length distributions. Dropout of reads at certain loci are due to read
depth being too low to generate a read length distribution.
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Fig. 3.9 Boxplot depicting the median read depth along with upper and lower quartiles and
lowest and highest values across 7 different loci. Significantly fewer reads per sample are
observed in samples undergoing 25 cycles of PCR compared with 35 cycles of PCR. This
significant reduction in read depth will limit the feasibility of using low amounts of PCR
cycles to generate sequencing data from single crypts.
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92 crypts in singleplex, with each primer pair in duplicate. The products were assessed us-
ing gel electrophoresis showing 45 out of the 46 primer pairs had successfully amplified a
discrete band at the appropriate size for the locus.
To ascertain any effect of the contents of the crypt lysate on read length distribution, the
same primers applied previously to amplify crypt equivalents were used to amplify lysate
containing a single crypt. As can be seen in Figure 3.10, the read length distributions for
both the crypt equivalents and real crypts had a high degree of similarity. However, there
are some subtle differences between the read length distributions generated. The possible
sources of this are: a) additional contaminants present in the crypt lysate effecting poly-
merase fidelity, b) batch effects as a result of the crypts being run on a separate lane of se-
quencing to the crypt equivalents or c) normal error seen between technical replicates. The
effect of additional contaminants could be overcome by optimisation of the PCR conditions
and batch effects can be controlled for by supplying separate reference samples for each se-
quencing run to allow the building of reference distributions unique to each sequencing lane.
However, a concern is that this error is a normal consequence of stochastic polymerase error
such that a crypt distribution may differ from its reference distribution based upon stochastic
effects alone. This is tested further in Section 3.8.
In addition to comparing the read length distributions generated by crypt equivalent
samples compared with single crypt lysate, we hypothesised that microsatellites displaying
length variation in the germline may have higher somatic mutation rates. Reference samples
from 6 different mice were isolated and 63 loci were amplified from each sample. Out of
the 63 loci studied, 58 loci were called as having the same length in all 6 mice. However, 5
loci showed variation between the 6 individuals, Figure 3.11. It is likely that the difference
in microsatellite length at these loci is due to germline mutations however, the possibility of
crossing with a contaminating polymorphic strain cannot be ruled out. Wherever possible,
these loci were included in future analyses to see if an increase in somatic mutability was
observed.
3.7 Estimating minimal read depth requirements
An important metric to ascertain from sequencing of microsatellites is the effect of read
depth on signal-to-noise ratios. The signal-to-noise ratio can be assessed by taking samples
that have a length call of [CA]30 and dividing the number of reads at [CA]31 by the number
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Fig. 3.10 Scatter plot with line annotation comparing the read length distributions generated
from crypt equivalent samples versus real crypt samples. The read length distributions in
the real and crypt equivalents appear very similar.
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Fig. 3.11 Scatter plot with line annotation showing the read length distributions of refer-
ence templates from 6 different mice. 5 of the loci show differing length calls across the
individuals and were hypothesised to be more somatically mutable.
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of reads present at [CA]30. By plotting this metric against the total number of reads within
the distribution (i.e. between [CA]20 and [CA]35), the lower limit of read depth can be
determined. As can be seen in Figure 3.12, the lower limit of read depth appears to be
1000 reads within the distribution. Therefore, to ensure consistent signal-to-noise, a filter
was added to the analysis pipeline to remove all loci with less than 1000 reads within the
distribution.
3.8 Testing consistency of polymerase error
A high in vitro polymerase error is an inevitable consequence of amplifying microsatellites
without the presence of mismatch repair mechanisms. In order to accurately quantify the
mixture of wild-type and mutant microsatellite lengths within a crypt lysate, the level of
variance in the error made by the polymerase must be consistent between technical repli-
cates. Minimal variance between technical replicates will enable confident separatation of
biological variance (i.e. the presence of a mutant clone) from technical noise. To test the
level of variance between technical replicates, 15 loci were amplified from 1.5ng of DNA
(equivalent to one murine crypt) in 8 technical replicates. The read length distributions show
remarkable similarity at all loci in both read directions, Figure 3.13, showing that the level
of technical noise is very low and that detecting biological deviance from these distributions
should be possible.
An intriguing observation from this test was the loci and read direction specific nature
of the polymerase error. Each loci appears to have a different error distribution and is likely
due to a combination of polymerase error during PCR and sequencing error on the Illumina
platform. The only variable between the different loci is the flanking region sequence and
thus must be the determinant of polymerase and sequencing error. The exact property of
the flanking sequence that determines the level of error remains unknown. Furthermore,
the error distributions between the forward and reverse reads at a given locus also differs
significantly. A key example of this is the forward and reverse read distribution differences
seen at locus s15_7506 in Figure 3.13. This distribution is so significantly different that the
loci could not be used in any downstream analysis. As the forward and reverse reads are
generated from the same molecule, the only determinant of the difference in forward and
reverse read length distributions must be sequencing error. Whether this is a consequence of
sequencing chemistry infidelity or a loop-hole in the sequencer’s read building algorithms
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Fig. 3.12 Scatter plot showing the ratio of reads at [CA]31 to reads at [CA]30 in samples
with a length call of [CA]30 as a function of total reads between [CA]20 and [CA]35. The
vertical line intercepts the x-axis at 1000 reads. (A) All samples shown with a wide range
of signal to noise at low read depth. (B) All samples with less than 1000 reads are removed,
signal to noise is far more stable.
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is unknown. Regardless, the key finding is that the read length distributions, and therefore
the level of error, is consistent between technical replicates and should allow detection of
biological differences. Furthermore, the need for analysing each loci and each read direction
separately is highlighted.
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Fig. 3.13 Scatter plot with line annotation showing read length distributions at 15 different loci in the forward and reverse direction. Each distribution
was generated from 1.5ng of mouse DNA with 8 technical replicates for each. The read length distributions show remarkable consistency in error
across all 15 loci in both read directions.
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MiSeq HiSeq 4000
Maximum read
length 2x300bp 2x150bp
Maximum reads
per lane 25M 625M
Cost per megabase
(based on 2x150bp) 8.8p 0.7p
Table 3.4 A comparison of the key parameters between the Illumina MiSeq and HiSeq 4000
sequencing platforms.
3.9 Comparison of sequencing error on the MiSeq plat-
form compared with the HiSeq 4000 platform
Illumina have a large repertoire of sequencing platforms commercially available. The key
difference between each platform is the number of reads generated per lane, the length of
read available and the associated per base cost of sequencing. Initially, the Illumina MiSeq
platform was used for optimisation of the protocol. This was due to its rapid sequencing
time and amenability to high read depth sequencing of amplicon libraries. In later exper-
iments, the HiSeq 4000 platform was used. This platform generates a large amount of
sequencing data with 8 lanes per flow cell and a slightly longer run time. Prior to the HiSeq
4000, the longest read length available for high yield sequencing was 125bp. Fortunately,
with the introduction of the HiSeq 4000, read lengths of up to 150bp became available al-
lowing libraries generated from the same primer pairs used for MiSeq library preparation
to be loaded. The key features of the MiSeq platform compared with the HiSeq 4000 are
summarised in Table 3.4.
As all of the optimisation data was generated on the MiSeq platform, it was important to
test the consistency in read length distribution when the same library was sequenced on the
MiSeq and HiSeq 4000. As the HiSeq 4000 generates approximately 10-fold more reads
than the MiSeq, the use of the HiSeq will ensure maximal read depth for all loci in all crypts
sampled whilst also driving down the cost of analysing each crypt. As can be seen in Figure
3.14, the read length distributions are very similar when sequencing the same library on the
HiSeq when compared with the MiSeq.
In addition, there is a slight improvement in the tightness of the peaks generated when
sequencing on the HiSeq as well as greater consistency between samples (for example,
locus s8_2733, forward read). It is likely that the improved consistency is as a result of
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Locus Lengths isolated
a4_1365 [CA]27, [CA]28, [CA]29, [CA]30
s9_8328 [CA]30, [CA]31, [CA]33
Table 3.5 Summary of synthetic loci generated from the plasmid cloning protocol outlined
in Section 3.10 and depicted in Figure 3.15
markedly increased sequencing depth on the HiSeq (mean number of reads within each
locus distribution on the HiSeq and MiSeq was 29,050 and 7,291 respectively). However, it
seems unlikely that the increased read depth will be contributing to the improved tightness
of the distributions observed at some loci on the HiSeq. This improvement in read length
distribution is likely to be caused by reduced sequencing error on the HiSeq when compared
with the MiSeq revealing that some of the read length distribution blurring is caused by the
sequencer and is not due to the initial PCR polymerase error alone.
3.10 Validation of PCR method using synthetic loci
A potential caveat of using mutant microsatellites as clonal marks is the known bias in PCR
amplification for shorter molecules. A consequence of this is that a mutant microsatellite,
e.g. [CA]28, would be over amplified with respect to the wild-type [CA]30 microsatellite
leading to an over-estimate of the mutant clone size. A method for dealing with this is to
only use small changes in microsatellite length as clonal marks thus reducing the probability
of amplification bias. As an added control measure, two synthetic loci were generated with
varying [CA]n lengths so as to assess any amplification bias using qPCR. To do this, two
endogenous [CA]30 loci were amplified using PCR to obtain a range of [CA]n repeat lengths.
The pool of [CA]n molecules were then ligated into a pUC-19 plasmid and transformed
into E. coli. This process is depicted in Figure 3.15 and described in Section 2.11. In
total, 7 different lengths of microsatellite were generated representing two different genomic
contexts, these stocks of synthetic loci are summarised in Table 3.5. Maxi preps of plasmid
containing microsatellites of the desired length were validated by Sanger sequencing.
3.10.1 Synthetic loci distributions are comparable to endogenous loci
Before using the synthetic loci further, it is important to observe that the synthetic loci
generate comparable distributions following amplification and sequencing to loci amplified
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Fig. 3.14 A scatter plot comparing the read length distributions generated from the Illu-
mina HiSeq 4000 and MiSeq sequencing platforms. The HiSeq 4000 displays improved
consistency of read length distributions between technical replicates and tighter read length
distributions at some loci. The improved consistency is likely to be as a result of increased
read depth generated on the HiSeq (mean number of reads within the read length distribu-
tion on the HiSeq 4000 and MiSeq was 29,050 and 7,291 respectively). It is unlikely that
the tighter read length distributions are caused by improved read depth and is likely to be
as a result of higher fidelity of sequencing microsatellites using the HiSeq 4000 sequencing
chemistry.
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Fig. 3.15 PCR was used to generate a range of [CA]n loci before using high fidelity bacterial
cloning to expand loci of varying lengths.
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directly from genomic DNA. This was done by linearising and accurately quantifying the
concentration of pUC-19 plasmid before diluting and adding 500 plasmid copies (equiva-
lent to the number of genome copies per murine crypt) to a PCR reaction. These plasmid
copies were put through the identical amplification and sequencing protocol to that used
for amplifying crypt lysate. The resulting comparison of distributions from plasmid and
genomic DNA can be seen in Figure 3.16. For locus a4_1365, the distributions are near
identical. Surprisingly for locus s9_8328 the plasmid produced a far tighter distribution
when compared to the same loci being amplified and sequenced from its genomic context.
The cause of this difference is unknown but could be due to the chromatin context of the
loci reducing polymerase fidelity in the early stages of amplification or, less likely, is the
possibility that a single nucleotide polymorphism is present in the genomic DNA leading to
reduced primer efficiency at this locus when compared with the plasmid DNA. Regardless
of the cause of the difference, the results from locus s9_8328 should be approached with
some caution whilst locus a4_1365 in the plasmid appears to behave in a similar manner to
its genomic counterpart.
3.10.2 qPCR comparison of synthetic loci at different lengths reveals
no PCR amplification bias
PCR bias towards smaller amplicons is well documented. If changes in the length of the
[CA]n microsatellite were to lead to bias toward the shorter of the microsatellite amplicons,
this would lead to the shorter amplicon being overrepresented and an over-estimate of the
size of that clone. To quantify any PCR amplification bias, real-time quantitative PCR (RT-
qPCR) was performed, as described in Section 2.16.2, on the 7 different lengths of [CA]n
microsatellite representing two different loci. The result of this analysis can be seen in
Figures 3.17 and 3.18.
As can be seen, in Figures 3.17 and 3.18, there appears to be no PCR amplification bias
present between microsatellites of varying lengths at locus a4_1365 nor at s9_8328. How-
ever, the key difference between this analysis and the amplification of loci from the single
crypt lysate is the number of loci copies. As qPCR analysis requires high template input,
the number of copies added to each qPCR reaction was approximately 106 fold higher than
the content of a single murine crypt. It is therefore possible that when the number of loci
copies is reduced further any amplification bias may be exaggerated, particularly during the
early rounds of PCR. A way of addressing this question is to perform a mixing experiment
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Fig. 3.16 Scatter plot showing the read length distribution following amplification and se-
quencing of the same [CA]30 within a plasmid versus within genomic DNA.
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to observe any bias in amplification when low amounts of template are amplified; this is
discussed further in Section 4.3.
3.11 Multiplex PCR
As can be seen in Table 3.1, in order to adequately empower the study, over 8 microsatellites
from a single crypt need to be amplified. The frequency of mutation represented in Table
3.1 is the frequency with which a single [CA]30 tract mutates to bring the eYFP reporter in
frame with small changes in length being far more likely than large alterations e.g. [CA]30
to [CA]31 being far more likely to occur than [CA]30 to [CA]13. However, the estimates
from Kozar et al’s data is based upon the observation of a single [CA]30 loci present hem-
izygously. Using endogenous microsatellite sequencing as a clonal mark allows the use of
biallelic loci and the detection of mutations that do not cause in-frame changes. The cal-
culations shown in Table 3.1 take into account a doubling in mutation rate as a result of
biallelic loci but do not take into account the possibility of detecting mutations that would
not cause an in-frame shift. Overall, these estimates provide a conservative estimate of the
expected number of WPCs and PPCs that will be observed using microsatellite sequencing.
Due to primer-primer interactions within the PCR reaction, the critical roadblock to ef-
fective multiplex PCR is the formation of primer-dimers. Due to their significantly shorter
length when compared with the specific product size, the primer-dimer products are pref-
erentially amplified during the PCR process. It is therefore necessary to optimise the mul-
tiplex PCR to increase specificity for the desired product. As these primer-dimers contain
sequencing adaptors, once barcoded, these DNA fragments preferentially bind to the se-
quencing flow cell and significantly reduce the amount of sequencing data obtained from
the flow cell. Furthermore, due to the relatively low complexity of primer-dimer molecules,
their presence will reduce the quality of all sequencing being produced from the flow cell.
Therefore, even small amounts of primer-dimer, generally >1% of the total molecules in
the sequencing library, can significantly reduce sequencing data yield and overall sequenc-
ing quality. As a quality control measure, all libraries produced from multiplex PCR were
checked for primer-dimer content using the Agilent Bioanalyser described in Section 2.16.1
and size selection performed using the optimised MagJET NGS size selection kit described
in Section 2.15. Overall, an optimised multiplex PCR protocol with specific product ampli-
fication and reduced primer-dimer generation provides a good option for the sequencing of
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multiple loci from a single crypt.
3.11.1 Optimisation of Phusion for multiplex PCR
This section describes the iterative series of experiments used to develop an optimised mul-
tiplex PCR protocol. Due to its superior performance in singleplex PCR, an initial attempt
to optimise the Phusion DNA polymerase for use in a multiplex reaction was performed.
The online tool, MultiPLX2.1 [52], was used to design optimal multiplex PCR groups using
the primer pairs previously optimised for singleplex PCR. This yielded 6 different multiplex
groups with 7 or 8 primer pairs per group which, when trialled on crypt equivalents contain-
ing 1.5ng of mouse DNA, produced adequate amounts of product but additionally produced
large amounts of primer-dimer that required size selection prior to barcoding each sam-
ple. In addition, when trying to expand the multiplex groups beyond 8 primer pairs, large
amounts of primer-dimer were produced preventing size selection entirely therefore making
library preparation impossible. Therefore, a stepwise development process to optimise the
Phusion DNA polymerase for the multiplex PCR of dozens of [CA]30 microsatellites was
performed. The guidance of Markoulatos et al [60] was invaluable in designing this devel-
opment protocol. The steps taken in this optimisation are summarised in Table 3.6 and the
final reaction mixture is described in Section 2.9.3.
3.11 Multiplex PCR 89
0
10
20
30
[CA]27 [CA]28 [CA]29 [CA]30
Repeat length
Ct
 va
lue
RT−qPCR analysis of a4_1365 locus of varying lengths
Fig. 3.17 Scatter plot showing the mean Ct value for differing microsatellite lengths at locus
a4_1365 with error bars indicating standard deviation of replicates (N = 8).
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Fig. 3.18 Scatter plot showing the mean Ct value for differing microsatellite lengths at locus
s9_8328 with error bars indicating standard deviation of replicates (N = 8).
Parameter tested Conditions tested Optimal result
Polymerase Phusion vs Phusion HotStart Phusion HotStart
Sequencing adaptor CS1 vs M13 M13
Mg2+: 1.5mM, 2.0mM, 2.5mM, 3.0mMMg2+:dNTP ratio dNTP: 0.1mM, 0.2mM, 0.5mM, 1.0mM, 1.5mM 2.5mM Mg
2+ : 1.0mM dNTP
Buffer concentration 1x, 1.5x, 2x, 2.5x 1x
Primer pool concentration
(8 primer pairs) 4µM, 2µM, 1µM, 0.5µM, 0.3µM 2µM (0.25µM per primer pair)
Annealing temperature 56.0
 C, 56.4 C, 57.4 C, 58.6 C, 60.5 C, 62.8 C,
65.5 C, 67.8 C, 69.5 C, 70.8 C, 71.7 C, 72.0 C 65.5
 C
Polymerase amount 0.2U, 0.4U, 0.6U, 0.8U, 1.0U 0.8U
Additional glycerol 0%, 1%, 2%, 5%, 7.5%, 10% 0%
Betaine additive 0M, 0.5M, 1.0M, 1.5M, 2.0M 0M
Table 3.6 Table summarising the parameters that were varied to optimise the Phusion DNA polymerase for use in multiplex PCR. All
of the above conditions were tested in the order that they are presented and were tested using a multiplex group containing 8 primer
pairs. The final multiplex PCR conditions were able to simultaneously amplify up to 24 amplicons, a 3-fold increase when compared
to multiplex group size before optimisation.
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As a result of this optimisation process, it was found that the HotStart version of the
Phusion DNA polymerase significantly reduced primer-dimer formation. Though the PCR
reaction setup is done on ice, there is an inevitable basal level of DNA polymerase activity
prior to thermocycling. The HotStart version of the polymerase utilises a haptamer-based
enzyme activity blockade until the enzyme is heated beyond 55 C. To ensure that the struc-
tural differences within the HotStart enzyme did not effect the ability of the polymerase to
amplify [CA]30 microsatellites, analysis of multiplex amplification of 6 technical repeats of
murine crypt equivalents with 13 primer pairs was performed. This was compared with loci
previously amplified using the standard polymerase but, due to the smaller multiplex group
sizes in standard Phusion multiplexing, the loci were drawn from different multiplex groups.
A comparison of the read length distributions generated by standard Phusion versus Phu-
sion HotStart can be see in Figure 3.19. Both the standard Phusion and Phusion HotStart
enzymes produced highly consistent read length distributions. The standard Phusion en-
zyme does produce slightly tighter read length distributions but the overall benefit of larger
multiplex groups with the HotStart enzyme outweighs any benefit gained from tighter read
length distributions using standard Phusion thus the HotStart enzyme was taken forward for
future use.
As well as allowing larger multiplex groups and consistently performing well at mi-
crosatellite length calling, the Phusion HotStart enzyme also displays good amplicon bal-
ance within multiplex groups. The multiplex group chosen for future use was M13_33 as it
displayed good read balance between 14 primer pairs (or 15 primer pairs when primers were
added to amplify the [CA]30 transgenic microsatellite). Each time the multiplex group was
used, the concentration of each primer pair was adjusted to try and balance the read depth
between amplicons within the group. The final concenrations of each primer pair is shown
in Table A.3 and the resulting amplicon balance is compared with the initial amplicon bal-
ance in Figure 3.20. Further information about each of the loci amplified can be found in
Appendix B.
3.12 Discussion
In this chapter, the stepwise development of a protocol for the multiplexed amplification
and sequencing of [CA]30 microsatellites from the genomic content of a single murine crypt
has been described. This technique should allow for the accurate quantification of mutant
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Fig. 3.19 Scatter plot showing the read length distribution following amplification and se-
quencing in a multiplex PCR of the standard Phusion enzyme compared with the Phusion
HotStart. Both enzymes produce highly consistent plots across technical replicates with
the standard Phusion producing tighter distributions. However, the Phusion HotStart was
favoured as a result of its ability to amplify more primer pairs in multiplex.
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Fig. 3.20 Boxplot displaying spread of read depth across all amplicons in M13_33 before
and after primer concentration was optimised to balance amplicon representation.
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clone sizes within a single crypt. The protocol has been developed such that the analysis of
hundreds of crypts is feasible. Furthermore, based on the data produced by Kozar et al, a
multiplex group allowing the amplification and sequencing of over 8 microsatellites should
give enough data from approximately 100 crypts to observe age related change in clone size.
The final optimised multiplex group (M13_33) amplifies 14 endogenous microsatellites in
a single reaction and can be expanded to 15 microsatellite when primer pairs amplifying the
transgenic [CA]30 microsatellite.
A notable success of this protocol development is the high degree of consistency in
polymerase error between technical replicates. This significantly reduces the amount of
technical noise generated by the protocol and allows for accurate generation of reference
distributions formed from sequencing of reference material e.g. tail clipping or pooled ep-
ithelial samples. By generating a reference distribution, any deviation from that distribution
observed at a crypt loci would indicate the presence of a mutant microsatellite. Due to the
high level of error consistency between reference samples, the protocol should be able to
detect relatively small mutant clones, seen in partly populated crypts, that lead to small per-
turbations from the reference distribution. In addition, the detection of a mutant clone that
has drifted towards monoclonality should be easily detectable.
The inclusion of contaminating DNA in the single crypt lysate would lead to under
estimation of the mutant clone size due to over represented wild-type DNA. By quantifying
the level of cell free DNA present within the fractionation media, it was possible to identify
the optimal preparation of the single crypt suspension prior to picking. Furthermore, with
the addition of a crypt washing step prior to addition to the lysis buffer, it was possible to
visually inspect for any contaminating single cells and ensure that the single crypt alone
was transferred. Due to cellular make-up of the crypt, it is near inevitable that there will
be a small amount of contaminating DNA and steps can only be taken to account for this
contamination during distribution analysis.
The key breakthrough in the development of the sequencing protocol was the discovery
of the NEB Phusion DNA polymerase’s ability to amplify [CA]30 microsatellites with high
fidelity and efficiency. Furthermore, the availability of a HotStart version of this enzyme
allowed for optimisation of the enzyme for multiplex PCR. A notable observation in the
trialling of multiple DNA polymerases was the presence of the Sso7d domain in improving
product yield from amplification of low copy genomic DNA. A hypothetical consequence
of this is that the increased interaction area between the microsatellite DNA and the DNA
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polymerase not only improves processivity but may also improve the enzyme’s ability to
amplify highly repetitive stretches of DNA. Furthermore, the observed increase in amount
of product generated by the Phusion enzyme compared to all the other polymerases tested,
suggests a high efficiency in amplification which would theoretically indicate a reduced al-
lele dropout rate. When developing this protocol further in the future, it would be interesting
to trial other polymerases that are known to have large interaction areas with target DNA to
see if this has an effect on polymerase fidelity at amplifying highly repetitive stretches of
DNA.
Each DNAmolecule has a certain probability of incurring an error during every round of
PCR therefore, reducing the number of PCR cycles is likely to have a substantial effect on
the ’blurring’ of the read length distribution for a given microsatellite locus. Initial attempts
at amplifying [CA]30 microsatellites utilised 50 cycles of PCR and showed significant error
within the read length distribution. The trial of 25 and 35 cycles of PCR showed a modest
improvement in the tightness of the read length distribution when using 25 cycles compared
with 35 cycles. This would suggest that later cycles of PCR i.e. cycles 26 to 35 have a
minimal effect on the error within the read length distribution with only a small amount of
additional blurring seen. When using low copies of template, early errors tend to be over
represented within the final amplicon pool which is the likely cause of this reduced effect
in later cycles of PCR. The large difference in the read length distribution seen between 35
cycles of PCR and 50 cycles of PCR is likely due to the different polymerases used for the
two reactions and is unlikely to be an effect of cycles 36 to 50. In addition to the minimal
improvement in read length distribution using 25 cycles of PCR, the use of 25 cycles of PCR
was not sufficient to generate a sequencing library alone thus 35 cycles of PCR was chosen
as the optimal number of PCR cycles required. When using human crypt material, there is an
8-fold increase in genome copies therefore it would be theoretically possible to use 3 cycles
less of PCR (23) and generate the same number of amplicons in the final library. Given
the relatively minor improvement in read length distribution when reducing the number of
PCR cycles by 10, the advantage of a reduction of 3 PCR cycles seems unlikely to be worth
pursuing.
Prior to this study, the performance of the Illumina sequencing platform at accurately
sequencing microsatellites was unknown. Direct assessment of the sequencing chemistry
contribution to the overall error incurred in the microsatellite read length distribution was
not performed. However, it is highly likely that there is some contribution as a result of
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the Illumina sequencing chemistry. This can be seen when comparing the read length dis-
tributions generated between the HiSeq 4000 and MiSeq, that utilise different sequencing
chemistry. It would appear that HiSeq sequencing chemistry performs slightly favourably.
Furthermore, when comparing the forward and reverse reads at a given locus, the read length
distributions differ. This can only be caused by differential sequencing error between the
forward and reverse reads as each sequencing cluster represents a clonal representation of a
single molecule.
Motivated by the need for consistency between replicates, the majority of optimisation
experiments were performed with crypt equivalents generated by diluting reference DNA
down to the concentration expected within a single crypt lysate. Once optimisation had
been performed, comparison with the read length distributions generated from real crypt
lysate compared favourably illustrating the utility of using crypt equivalents as a means of
iteratively optimising a single crypt sequencing protocol.
In addition to using crypt equivalents to optimise the protocol, crypt equivalents were
used to generate dozens of singleplex reactions targeting different microsatellites in 6 dif-
ferent mice. From this, 5 different loci were shown to be germline variable. It is possible
that these loci have a higher mutation rate within the germline and, therefore, may have a
higher mutation rate somatically. Though it cannot be ruled out that the variance may be due
to contamination from crossing with another strain. Regardless, these 5 loci in the M13_33
multiplex group were included in future analyses to see if these loci do display an increased
event rate somatically. As well as being a potential method for identifying somatically mu-
table loci, this experiment also displays the ability of this protocol to differentiate between
highly inbred individuals. This bodes well for the application of this protocol to genetic
identification of humans for forensic purposes or to calculate phylogenetic relatedness in
population and evolutionary genetics.
Using plasmid cloning of murine genomic loci containing microsatellites, loci contain-
ing varying lengths of microsatellite were generated. Using these templates it was possi-
ble to show that there is no detectable amplification bias towards microsatellites of shorter
lengths. This provides an important control ruling out any possibility of over estimation of
clone size when mutant microsatellites are at a shorter length compared to the wild-type
length. One caveat to this approach was the 106 fold increase in the amount of template
copies input into the qPCR reaction when compared with the genomic copy content of a
single murine crypt. Thus the possibility that there are biases towards shorter microsatel-
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lites in early rounds of PCR that would be exaggerated in low template copy reactions cannot
be ruled out.
Using a rational stepwise protocol, the Phusion DNA polymerase was optimised for
use in multiplexed amplification of up to 15 amplicons from a single murine crypt. This
approach allowed the gradual expansion of the number of primer pairs per multiplex group
whilst continuing the use of the high fidelity Phusion enzyme. To try and improve the ampli-
con balance within each reaction, every time the multiplex group was used in a sequencing
experiment, the amplicon balance was assessed and the concentration of each primer pair
added to the reaction was adjusted to improve amplicon balance. This dramatically im-
proved amplicon balance and, as a result, reduced the sequencing depth requirements for
each crypt.
Intriguingly, the read length distribution for different templates does differ at some loci,
for example using microsatellites contained within linearised plasmids compared within
genomic DNA generates a far tighter read length distribution from plasmid DNA at locus
s9_8328. The source of this difference is currently unknown but could be due to chromatin
accessibility at that particular locus in the genomic DNA.
A single murine crypt contains approximately 500 genome copies, the adaption of this
technique to a human colonic crypt, which contains approximately 4000 genome copies,
should be theoretically possible. The main challenge to overcome in the adaption of this
protocol to human crypts is the design of primer pairs amenable to multiplex PCR using
the developed protocol. The developed computational pipelines for the identification and
design of primer pairs for [CA]30 microsatellites are applicable to any reference genome
thus should allow for straightforward design of human specific primers.
The motivation for developing this protocol was the application of microsatellite muta-
tions as neutral marks for studying intestinal stem cell dynamics. However, this protocol has
potential for wider application. STR genotyping is widely used in evolutionary and popu-
lation genetics to track relatedness of individuals within and across species. The ability to
multiplex different microsatellites from such low amounts of DNA would allow for easy ap-
plication of this technology to these fields. STR genotyping is also widely used in forensic
sciences, particularly using highly degraded samples that are only available at low amounts.
The ability of this protocol to work at low template concentrations in a highly quantitative
manner with the potential to deconvolute the presence of different microsatellite species at
very similar lengths makes this protocol highly amenable to forensic purposes.
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Furthermore, this protocol lends itself well to further expansion. The crypt picking
protocol currently only allows the isolation of 100-200 crypts per day per person picking.
With the use of a microfluidic device or a large particle flow sorting protocol, it may be
possible to isolate far more single crypts from the single crypt suspension. It may also be
worthwhile exploring whole genome amplification effects on allele bias so as to increase
the amount of template DNA to work with. This would allow the use previously published
multiplex PCR protocols allowing the simultaneous amplification of 1000s of loci. With
such a large array of microsatellites, it would be theoretically possible to infer clone size
at a single cell resolution. As some effect of PCR bias cannot be ruled out, inclusion of
molecular barcoding to account for any PCR bias would also be a valuable addition to this
protocol. Nonetheless, the current protocol provides a powerful method for the accurate
quantification of microsatellite length at up to 15 loci in a single murine crypt.
It is next necessary to develop an analysis tool for the detection of mutant microsatel-
lite species. Furthermore, the synthetic loci produced to assess amplification bias in this
chapter are ideally suited to mixture experiments. Mixing experiments would allow for in
vitro validation of the microsatellite sequencing protocol and analysis to detect mutant mi-
crosatellites. These validation steps are essential to show that this method has the ability to
accurately quantify clone size.
Chapter 4
Development and validation of an
analysis pipeline for quantifying crypt
clone size from microsatellite sequencing
data
As described in the previous chapter, the optimised microsatellite sequencing protocol pro-
duces highly consistent read length distributions between technical replicates. This allows
for the generation of reference distributions amenable to comparison with crypt loci distri-
butions such that deviations from reference can be interpreted as biologically meaningful.
Due to in vitro polymerase slippage and sequencing error, the signal generated from mi-
crosatellite sequencing is a distribution peaking at the native microsatellite length. The
analysis of the data, therefore, must take this distribution into account to allow an accurate
inference of the proportion of reads contributing to the distribution that are wild-type and
those contributed from mutant microsatellites.
Previously published methods for the analysis of microsatellite sequencing data, utilise
either low read depth whole genome sequencing data [37, 45, 49] or use in silico designed
reference genomes that utilise existing alignment tools to call microsatellite length from
targeted re-sequencing experiments [10, 18]. Though the use of tools designed for the anal-
ysis of whole genome sequencing data would be able to confidently call the length of the
dominant microsatellite, most likely the wild-type [CA]30, it would not be useful for de-
tecting minority microsallite lengths. The use of tools for microsatellite length calling from
101
whole genome sequencing data is better suited to retrospective population analyses that re-
quire information from many loci to infer kinship. For the inference of mutant clone size,
the contribution of microsatellites of differing lengths to the overall distribution must be
inferred. Thus using tools that extract the dominant microsatellite length are not suitable for
our needs and a novel tool that allows inference of mutant microsatellite length contribution
is required.
The first challenge to overcome in the generation of this tool is to take the raw Illumina
sequencing data and generate a matrix representing each crypt, each locus amplified from
that crypt and the information generated from both read directions. For each of those data
points, each read must be assessed for the length of microsatellite represented. This anal-
ysis should lead to a counts matrix that displays the number of reads represented at each
possible length of microsatellite, split into a crypt specific, locus specific and read direction
specific matrix. The computational method used to generate such a matrix is described in
this chapter.
Once a counts matrix is generated, the read distribution resulting from amplification
and sequencing error will be observable in the spread of reads seen at different microsatel-
lite lengths. Here lies the second challenge in analysing such datasets. In order to quantify
clone size, a computational method for the inference of mutant microsatellite contribution to
the overall read distribution is required. The use of mixture modelling and least squares es-
timation to infer the relative proportions of wild-type and mutant distributions at each locus
was opted for. In order to make such estimations, a wild-type distribution and various mu-
tant distributions were required. Wild-type distributions were formed from the sequencing
of reference material (such as tail or ear clippings from mice or, in human studies, pool-
ing of colonic epithelium) and mutant distributions were predicted by shifting the wild-type
distribution to differing extents to estimate distributions resulting from varying lengths of
mutant microsatellite.
To validate this computational approach, as well as estimate the level of sensitivity of
the sequencing protocol, a mixing experiment will be performed using the synthetic loci
previously described. Using this approach it will be possible to deconvolute the relative
proportions of mutant and wild-type microsatellites matched to a priori knowledge of the
actual mixed proportions. This mixing experiment will provide validation of the sequencing
protocol and computational approach for the quantification of mutant clone size. Further-
more, by varying the copies of synthetic loci added to the initial reaction, it will be possible
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to assess the effect of copy number on the sensitivity of the method.
4.1 Determining [CA]n count distribution from FASTQ file
As existing tools for the assessment of microsatellite sequencing data do not quantify rela-
tive proportions of microsatellites of differing lengths, a custom tool for counting of [CA]
length in each read was required so that length distributions could be ascertained. Further-
more, as loci specific and read direction specific distributions had been observed, it was
necessary to have this count data represented as a matrix displaying locus specific and read
direction specific information. After sequencing, each crypt sample produced two FASTQ
files, one containing forward reads and the other containing the paired reverse reads. Each
FASTQ file contained the sequence representation of up to 15 amplicons, depending on the
multiplex group used. Each FASTQ file was filtered to ensure 80% of every read was at
Q20 or above. A custom Perl script was written to analyse each quality filtered file inde-
pendently. To separate all of the reads into locus specific groups, the locus specific primer
sequence present at the 5’ end of each read was used to separate reads into locus specific
groups. For each read within a locus specific group, the [CA] repeat length is determined by
comparison of the [CA] repeat with a [CA] standard of differing lengths. Once a given read
matches the length of the [CA] repeat standard, the [CA] repeat length can be called and
the next read is assessed. Through this iteration a read distribution can be generated that is
locus specific. As the forward and reverse reads are contained within separate FASTQ files,
it is also possible to generate locus specific and read direction specific read distributions,
Figure 4.1. Finally, this tool outputs a count matrix that can be used for mixture modelling
and least squares inference of relative proportions of wild-type and mutant reads, described
in the next section.
4.2 Mixturemodelling to infer proportions of [CA]nmutant/wild-
type mixtures
Once a counts matrix detailing locus specific and read direction specific microsatellite length
distributions had been generated, a method for determining the proportion of wild-type ver-
sus mutant reads was required. One of the most effective ways of achieving this is through
predicting mutant clone distributions using mixtures of wild-type data with theoretically
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Fig. 4.1 Schematic of process used by the custom Perl script to count the length of [CA]
repeats in demultiplexed FASTQ sequencing files. Reads are first grouped based on their
locus specific sequences. Each read is then compared with a [CA] repeat standard of varying
length to determine the [CA] length present in each read. From this data, read distributions
can be generated for each locus present. As the demultiplexing pipeline separates forward
and reverse reads, the script generates locus and read direction specific microsatellite length
distributions.
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predicted mutant data, before comparison with the actual crypt distribution. This mixture
modelling approach can be described as such:
mix(x,F,shi f t) = (1 F)re f (x)+(F)re f (x  shi f t) (4.1)
Therefore, to estimate mix(x), a reference distribution, ref(x), and mutant distribution,
ref(x - shift), must be generated. The reference distribution was generated by sequencing
reference DNA samples, isolated from ear or tail samples in mice or colonic epithelium
samples from humans, diluted to the equivalent of a single crypt. A minimum of 8 technical
replicates per reference dataset were performed and the median value from these replicates
was used as a reference for downstream analysis. To account for lane to lane variation in
reference distribution, reference samples matched to each mouse were included in every
lane of sequencing and crypts were only analysed using reference datasets generated on the
same lane of sequencing.
This median reference distribution was then shifted to generate mutant distributions rep-
resenting mutant microsatellites of different lengths. Mixing of a proportion of the mutant
distribution (denoted as F) with a remaining proportion of wild-type distribution (1 - F)
simulates the distribution formed from a crypt with a F proportion of mutant reads shifted
by the value represented as shift. This principle is depicted in Figure 4.2.
The predicted model of loop insertion-deletion mutagenesis at these loci leads only to
small changes in microsatellite length. Therefore, maximum shifts used were a loss of 5
repeat units or a gain of 5 repeat units. In addition, the use of only small alterations in
microsatellite length meant that a shifted wild-type distribution was more likely to accu-
rately represent a mutant read distribution. For example, the polymerase fidelity at a [CA]5
microsatellite is almost certainly going to much higher than that at a [CA]30 thus simply
shifting the [CA]30 distribution 25 units leftward will not accurately simulate a [CA]5 distri-
bution. Instead limiting the shifts to between -5 and +5 shift from the reference distribution,
the mixture modelling is likely to be more accurate.
In order to ascertain the shift value and F value that most accurately described the dis-
tribution generated from crypt sequencing, least squares was used to determine the mixture
that most accurately predicts the real crypt data. A least squares value is ascertained by
calculating the difference in y-value across a range of x-values, squaring these differences
and summing the total. A low least squares value indicates a high similarity between the
predicted and actual read distributions whilst a high least squares value indicates the con-
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Fig. 4.2 A reference distribution is generated by taking the median value of 8 technical
replicates of reference material from the same individual as the crypts were isolated from.
Mutated distributions are then predicted by shifting the reference distribution either left-
ward or rightward. Mutated distributions are then mixed with wild-type distributions at
proportions determined by the value F. This iterative process generates many different pre-
dicted mutant distributions; the distribution that most closely matches the crypt distribution
is called as the correct shift value and the correct value of F. This information is used to
determine if the crypt is partly populated, wholly populated or wild-type. In the example
given above, the crypt would be called as having a F value of 0.5 with a loss of one [CA]
unit.
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verse. The shift and F value that leads to the lowest least squares value can be inferred as
the parameters that best describe the microsatellite length distribution.
4.3 Use of synthetic loci to validate optimised PCR and
analysis method in vitro
To independently validate the sequencing and analysis method, a mixing experiment was
performed using the synthetic loci previously generated in Section 3.10 and summarised
in Table 3.5. The mixing experiment simulated samples containing 100% wild-type reads,
75% wild-type reads, 50% wild-type reads, 25% wild-type reads, 10% wild-type reads and
0% wild-type reads, as summarised in Figure 4.3. The template containing a [CA]30 mi-
crosatellite was always used as the wild-type template with the mutant template varying in
length. Each sample was amplified and sequenced with 6 technical replicates.
To test the effect of template copy number on mutant clone size quantification, the mix-
ing experiment was performed with differing amounts of template input. The total number
of template copies per sample tested were: 165 copies (equivalent to 1/3 of murine crypt),
500 copies (equivalent to one murine crypt), 4000 copies (equivalent to one human crypt)
and 106 copies (to test the effect of excess copy number). The results of these experiments
are discussed below.
4.3.1 Mixing of reference and mutant microsatellite species to deter-
mine limits of mutation detection
A comparison of the F estimate with the actual mixed proportions of mutant and wild-type
template are shown in Figures 4.4 and 4.5 for mouse crypt equivalent and human crypt
equivalent respectively. Even at only 500 plasmid copies, there is a good agreement of the
F value and the actual mixed proportions at both loci, at 5 differing lengths of mutant loci
and at a wide range of mixed proportions. This clearly shows the ability to detect clones of
varying sizes, regardless of mutant microsatellite length, at template copies equivalent to a
single murine or human crypt.
Locus a4_1365 shows particularly good agreement between F estimate and known
mixed proportions. On the other hand, locus s9_8328 agrees less well, particularly at mix-
tures with lower levels of wild-type DNA. This error is a result of the assumption that a shift
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Fig. 4.3 Schematic of the protocol used to simulate partly mutated crypts with synthetic
loci. This was done with 7 different lengths of microsatellite representing two different
genomic loci. [CA]30 was always used as the wild-type template with the length of the
mutant template being varied.
4.3 Use of synthetic loci to validate optimised PCR and analysis method in vitro 108
in the reference distribution would accurately predict a mutant microsatellite distribution.
This can be seen when the length distributions for the pure plasmid populations are plotted,
Figure 4.6 . It can be seen that there is a slight change in the shape of the read distribution
as the microsatellite length changes. This is most likely due to a change in the polymerase
and sequencing error rate as a result of a change in microsatellite length. The change in dis-
tribution shape with length is particularly pronounced at locus s9_8328, where the largest
error in F estimates is observed. In order to accurately interpret each F value, it is going to
be necessary to take these observations into account. Methods to deal with this disparity are
discussed in Section 4.5.
4.3.2 Variable copy number in synthetic loci mixtures reveals stochas-
tic effects as a source of estimation variation at low copy number
To ascertain the effect of template copy on accurate clone size quantification, the mixing
experiment described in Section 4.3.1 was repeated with lower template copy (165 copies)
and higher template copies (106 copies). To assess the level of variation seen at different
plasmid copies, the mean standard deviation in F estimate was calculated across all mutant
lengths and all technical replicates in the mix containing 50% wild-type and 50% mutant
template. As can be seen in Figure 4.7, when approximately 500 plasmid copies are added to
a reaction, the mean standard deviation is very low (0.040 at a4_1365 and 0.033 at s9_8328).
However, when 165 plasmid copies are added, the mean standard deviation is far higher
(0.140 at a4_1365 and 0.143 at s9_8328) indicating a large increase inF estimate variability
at plasmid copy numbers close to 165. Massive excess of template does not have the same
effect thus the most likely cause of variability at low template copies is allele dropout. It can
be concluded from this analysis that the template copy input at which allele dropout begins
to have a large effect is between 165 and 500 plasmid copies with large amounts of DNA
having little effect on estimate variation.
4.3.3 Stochastic error in 50:50 mixes of low copy wild-type and mutant
templates supports absence of amplification bias
Previous analysis in Section 3.10.2 showed no bias in PCR amplification of microsatellites
of different lengths. However, due to the addition of 106-fold more plasmid copies to the
qPCR reaction than what would be seen in a single murine crypt reaction, the possibility of
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Fig. 4.4 Jitter scatter plot showing the estimated F values from 6 technical replicates of
plasmid mixing at 0% wild-type, 10% wild-type, 25% wild-type, 50% wild-type, 75% wild-
type and 100% wild-type template proportion. In each reaction, there was 500 plasmid
copies, equivalent to the number of genome copies expected in one murine crypt.
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Fig. 4.5 Jitter scatter plot showing the estimated F values from 6 technical replicates of
plasmid mixing at 0% wild-type, 10% wild-type, 25% wild-type, 50% wild-type, 75% wild-
type and 100% wild-type template proportion. In each reaction, there was 4000 plasmid
copies, equivalent to the number of genome copies expected in one human colonic crypt.
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Fig. 4.6 Scatter plot with line annotation showing mean read proportion of read distributions
of 7 different lengths of [CA]n microsatellites representing two different genomic loci. It
can be seen that at the same locus in the same read direction, the read distribution differs.
This is likely to be due to changes in polymerase and sequencing error rate for different
lengths of microsatellite. As a result using a shifted reference distribution as simulation of
a mutant microsatellite distribution leads to a slight inaccuracy in F estimates.
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Fig. 4.7 Scatter plot with line annotation showing standard deviation of F estimate with
changing amount of template input. Each standard deviation was calculated from 50%
wild-type template mixtures and averaged across all technical replicates and all different
mutant template lengths. As the number of template copies is reduced below 500 copies per
reaction, the standard deviation of theF estimate significantly increases. It is likely that this
is due to allele dropout effects.
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amplification bias at low template copies could not be ruled out. An interesting observation
from experiments containing 165 plasmid copies was the consistent nature of the variability
around the median, Figure 4.8. It is highly suggestive that the allele dropout effects are
entirely stochastic and there is no bias towards microsatellites of different lengths, at least
between microsatellite length changes of -3 repeats and +3 repeats which are represented in
this experiment. This would again indicate that allele dropout should have negligible effects
on clone size estimates and the largest sources of error are from read distribution changes
when microsatellite length shifts from the wild-type length. Furthermore, if a crypt lysate
were split into two halves and amplified separately, though the number of plasmid copies
entering the reaction would be reduced, two F estimates would be ascertained the average
of which is likely to be an accurate estimate of F.
4.4 Validation of crypt washing as an appropriate method
for minimising DNA contamination
The plasmid mixing experiments demonstrated the ability to deconvolute proportional mu-
tant microsatellite in vitro using synthetic loci. To demonstrate the ability at detecting mu-
tant clones in an in vivo setting, the Rosa26-[CA]30-eYFP mouse was used to identify crypts
containing a mutation in the transgenic [CA]30 microsatellite by observation of YFP pos-
itivity. Using a dissecting microscope with a fluorescent bulb, it was possible to identify
YFP+ crypts during micropipette isolation, Figure 4.9. Primers were designed to amplify
the transgenic [CA]30 microsatellite within the Rosa26-[CA]30-eYFP construct in a single-
plex reaction. In Figure 4.10, it can be seen that there is a clear distinction between YFP+
and YFP- crypts. However, the variability of F estimates for the YFP+ crypts was unex-
pected. As this variability was not observed in the YFP- crypts, it was hypothesised that the
variability may be due to wild-type DNA contamination in the YFP+ crypt lysate.
To test whether wild-type DNA contamination was leading to YFP+ F variability, the
experiment was repeated but each single crypt was washed 4 times in PBS before transfer-
ring to the lysis buffer (Section 2.8.5). As can be seen in Figure 4.11, this had a significant
effect on the level of variability in F estimates for the YFP+ crypts. As a result, all further
crypt picking utilised this washing technique to minimise wild-type DNA contamination.
There were two unexpected results from this experiment. Firstly, the YFP+ WPCs do
not lie at a F value of 1 and cluster around a F value of approximately 0.8. Though this
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Fig. 4.8 Jitter plot showing technical replicates of low template copy reactions (approx. 165
copies per reaction) at varying proportions of mutant to wild-type and varying mutant mi-
crosatellite length. The median F estimate is represented by the cross. Individual replicates
are shown varying either side of the median with no distinct pattern. This random varia-
tion in error is suggestive of a stochastic process determining whether either the wild-type
or mutant microsatellite predominates. This supports the absence of amplification bias and
suggests that taking multiple estimates of F using more than one low template reaction
could give an accurate estimate of overall F despite individual reaction error.
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Fig. 4.9 Schematic showing method used for picking YFP+ crypts for comparison of read
distribution with YFP- crypts.
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Fig. 4.10 Scatter plot with error bars indicating standard deviation of F estimates of YFP+
and YFP- crypts. Without PBS washing each crypt, the error is very large for YFP+ crypts
and estimates are far from a F value of 1, as would be expected from YFP+ crypts.
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Fig. 4.11 Scatter plot with error bars indicating standard deviation of F estimates of YFP+
and YFP- crypts. With PBS washing of each crypt, the level of error between crypts is
much lower when compared with Figure 4.10 and the F values are much closer to 1 in
YFP+ crypts, as would be expected.
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clearly distinguishes them from the wild-type crypts that remain close to aF value of 0, in an
experiment with no a priori knowledge of clonal status, it would be difficult to differentiate
between WPCs and PPCs, particularly those containing large clones. There are likely to
be two main sources of this error: 1) there is an inevitable amount of wild-type DNA that
will contaminate any mutant crypt as a result of transfer of stromal cells. 2) The mixture
model relies upon an assumption that the predicted mutant distribution takes the exact shape
of a shifted reference distribution. As can be seen in Figure 4.12, though the distributions
are relatively similar in shape, there is a difference that would mean that a shifted reference
distribution would not exactly predict the mutant distribution but a contribution of wild-type
stromal cells cannot be ruled out. Overall, it would seem that the error in F estimate is a
result of distribution shape change at different lengths of microsatellite and an inevitable
amount of wild-type DNA contamination from associated wild-type cells. This inaccuracy
can be accounted for by estimating the F value generated by WPCs at a given locus, for
example at the YFP locus a F value of 0.75 and above is likely to be a WPC, and a value
of less than 0.1 is likely to be a wild type crypt with any crypt with a F value between 0.1
and 0.75 likely being a PPC. Thus this first unexpected result can be accounted for whilst
interpreting the F estimates for each locus.
The second unexpected result was the presence of 3 anomalous F estimates (Crypt 26,
43 and 48). It was expected that these crypts have aF value of 0.75 or higher, based on their
YFP status, insteadF values consistent with a wild-type crypt (Crypt 26, F = 0.05) and two
PPCs (Crypt 43 and 48, F = 0.55 and 0.65 respectively) were inferred. As can be seen in
Figure 4.12, the F values inferred appear correct and the anomalous result is likely due to a
real signal difference and is not a consequence of a flaw in the computational approach. The
YFP+ crypts are picked under a low power dissecting microscope that only observes the
crypt in one plane thus it is possible to miss small unmarked YFP- clones in a background
of YFP positivity. It is, therefore, likely that the two crypts with a F value of between 0.1
and 0.75 were correctly called as PPCs. The YFP+ crypt called as having a F value of 0.05
is possibly a YFP- crypt picked in error. Alternatively, a small false negative rate may be
present in the protocol. Regardless, the error appears to be present at a low level and should
not have a major influence on the overall power of this protocol in quantifying intestinal
stem cell dynamics.
An additional interesting observation from sequencing YFP+ crypts was that all muta-
tions were caused by a +1 expansion in microsatellite length. This is consistent with the
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predicted loop insertion-deletion mechanism of microsatellite mutagenesis leading to small
scale changes in microsatellite length with large scale changes being far rarer. This fur-
ther supports the decision to only use small scale changes in microsatellite length as clonal
marks.
4.5 Discussion
In this chapter, I describe an alternative computational method for the calling of microsatel-
lite length from high read depth targeted re-sequencing data. In contrast to previous methods
for calling microsatellite length from sequencing data, this approach allows for the build-
ing of a reference distribution that is both locus and read direction specific. Furthermore,
by using a mixture modelling and least squares analysis it is possible to detect mutant mi-
crosatellites within a mixed population. Previous methods produce summary data that is
not conducive to such analysis. To test the combined amplification, sequencing and anal-
ysis protocol, various mixing experiments were performed using synthetic loci of known
microsatellite length to validate the method as a feasible means of identifying mutant mi-
crosatellites within a population composed of two different microsatellite lengths. It was
also shown that this method can be used to identify mutant clones in vivo and confirm that
crypt washing is a necessary step to ascertain accurate clone size estimates.
The development of a computational method that directly utilises the FASTQ file gener-
ated by Illumina sequencing for the building of loci and read direction specific read distri-
butions allows for rapid analysis of microsatellite sequencing data. Through the use of loci
specific sequences, the counting script is readily scalable to much larger panels of primer
pairs. In addition to the feasibility of scaling for [CA] repeats, this analysis method is readily
transferable to the analysis of any sequence repeat e.g. STRs commonly used for identifi-
cation in forensic sciences or STR loci used for study of evolutionary dynamics in ecology.
This method of microsatellite length calling is flexible, scalable and has the potential for
wide application.
The use of mixture modelling allows for the generation of predicted mutant mixed dis-
tributions which can then be used to infer the mutant microsatellite contribution (F) and the
number of [CA] repeat units gained or lost in the mutant microsatellite (shift). This anal-
ysis is particularly important given the need to account for distribution generation during
microsatellite amplification and sequencing. Though the optimised microsatellite sequenc-
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Fig. 4.12 Scatter plot displaying YFP+ and YFP- reference distributions with error bars
indicating standard deviation of the estimates. Three further read distributions are indicated
in black (Crypt 26, F = 0.05), green (Crypt 43, F = 0.55) and orange (Crypt 48, F = 0.65).
The method of calling a F value would appear correct and the read distributions represent a
real signal change likely cause by human error and/or inability to observe small YFP- clones
during picking.
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ing protocol has improved fidelity and replicate consistency, the need to account for length
distribution is essential for accurate estimate of mutant microsatellite populations within a
single crypt sample. The development of a mixture modelling method combined with a least
squares inference of mixture parameters, allows for the accounting of such distributions and
a significant improvement in mutant clone size estimations. Furthermore, these models are
well described, routinely used and can be easily implemented.
Mixture modelling relies upon the assumption that a shifted reference distribution ac-
curately predicts a mutant distribution. As presented in this chapter, this is not always
true and the mutant distribution shape can change as a function of the length change, at
some loci. Generally, mutations leading to an expansion of the microsatellite length gen-
erated distributions representing greater error with a wider, less peaked distribution whilst
mutations leading to a contraction in microsatellite length generated tighter, more peaked
distributions. Based on previous data suggesting that small loop insertion-deletion events
are the main drivers of microsatellite mutation, it would be predicted that the majority of
mutations observed in [CA]30 microsatellites will be small scale changes. Thus restricting
observations of mutations to between [CA]25 and [CA]35 is unlikely to significantly reduce
the number of events observed. Furthermore, by restricting the length change mutations
used as clonal marks to between a gain of 5 [CA] repeats and a loss of 5 [CA] repeats, the
wild-type and mutant distributions are likely to have similar distributions, further reducing
any F estimate inaccuracy.
Nonetheless, it is still necessary to account for this slight inaccuracy in F estimation
when interpreting the data. There are two possible ways to do this: 1) In older individu-
als, the number of WPCs will be far higher than the number of PPCs. It would, therefore,
be possible to isolate distributions with the highest F values and, in essence, build mutant
distributions. Using these mutant distributions would allow for more accurate to F values
to be inferred. 2) The thresholds used for differentiating between wild-type, PPC and WPC
can be adjusted on a locus by locus basis. For example, the F cut off for a wild-type crypt
could be 0.1 or lower, the cut off for a WPC (on an X-linked locus in a male) could be 0.9
or higher and anything in between would be categorised as a PPC. These cut offs can be
informed by relatively small datasets such that young individuals will have majority wild-
type crypts and old individuals will have a substantial amount of WPC allowing for the data
to inform threshold values. Using one of these two methods would account for the error
generated by length distribution change when shifted. However, it should also be noted that
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at locus s9_8328, where significant changes in read distribution were observed, it was still
possible to differentiate between clones of different sizes with a high degree of accuracy
such that the presence of this error does not substantially affect the ability to identify mu-
tant clones. Thus suggesting that adjustment of F thresholds alone will be appropriate for
accurate interpretation of clone status.
As further sequencing of these loci is performed, a bank of mutant distributions for mul-
tiple loci can be developed such that estimates of clone size can continuously be improved
as more data is generated. Once these large in vivo datasets are generated, it would be in-
teresting to study these mutant distributions further to see if generic rules can be formulated
to accurately describe how a microsatellite read distribution will change as a function of its
length thus allowing for accurate generation of mutant distributions for loci with no previ-
ous data available. Therefore, adjustment of F thresholds is suitable in the short-term and
improvedF estimates with concomitant adjustment inF thresholds will improve sensitivity
and accuracy in the long-term.
The use of synthetic loci to perform mixing experiments was invaluable in ascertaining
the sensitivity of the current protocol. By performing mixing at various proportions of wild-
type reads, with as few as 500 plasmid copies, it was possible to distinguish clones differing
by as little as 10% wild-type proportions across a large range of plasmid copies (500 to
106 copies). Stochastic allele dropout effects are only clearly observed when plasmid copy
number is reduced to 165 copies; defining the lower limit of the assay for accurate clone
size quantification. Even at this low amount, the difference between mutant and wild-type
samples is clear suggesting that for simply ascertaining microsatellite length differences
the assay could be used at lower copy numbers. Overall, the use of synthetic loci mixing
provided in vitro validation of the method at accurately quantifying mutant population size
in samples containing copies equivalent to a single murine crypt and a single human crypt.
Previous attempts at revealing any amplification bias towards shorter microsatellite lengths
using qPCR was confounded somewhat by the need for larger copy numbers. The use
of 50:50 mixes of wild-type and mutant microsatellites at low copy number (165 plasmid
copies per reaction) revealed significant variability suggesting that allele dropout is present
when the copy number is reduced. An interesting observation in this experiment was the
F estimates appeared to cluster around 0.5 with no obvious trend towards error above or
below 0.5. This would suggest that allele dropout is entirely stochastic and that no amplifi-
cation bias, within the microsatellite lengths tested, is present at low template copy. This is
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consistent with the qPCR analysis performed in Section 3.10.2.
In addition to an in vitro validation of the method, the Rosa26-[CA]30-eYFP reporter
mouse was used to isolate YFP+ WPCs providing a priori knowledge of the presence of a
microsatellite mutation. 93 out of the 96 crypts picked matched the a priori knowledge of
mutation status providing in vivo validation of the method. The 3 crypts that generated spu-
rious results are likely to result from experimental error though the possibility of a low false
negative rate cannot be ruled out. As well as providing in vivo validation of the protocol, this
experimental approach was used to observe the effect of crypt washing in the improvement
of clone size estimates. The Rosa26-[CA]30-eYFP reporter mouse is thus a valuable tool in
the development of microsatellite sequencing protocols for clone size estimation.
Using YFP+ WPC sequencing a highly uniform mutation spectra was observed. Out of
48 crypts picked in the washing experiment, 47 had an expansion of microsatellite length
of one [CA] repeat and the one crypt that did not have an expansion mutation was inferred
as having no mutation at all and was likely to be a YFP- crypt picked in error. As all the
mutations lead to YFP expression, the microsatellite length change by definition had to
generate an in-frame length change thus the range of mutations was somewhat restricted.
Even with this in mind, it would appear that the observation of only one mutation event in
all YFP+ WPCs suggests a highly stereotyped mutational process most likely described by
small loop insertion-deletion events and restricted to stepwise, restricted mutation events
with large-scale mutation events being far less likely. This would suggest that the mutation
rate estimated by Kozar et al [54], though it will be twice as high at endogenous loci due
to biallelic presence compared with monoallelic presence in the transgenic mouse, may not
be greatly increased as a result of being able to observe mutations that do not lead to ’in-
frame’ mutations. This would further suggest that using small scale microsatellite changes
is a reasonable method of tracking clones in vivo.
Overall, I have provided clear validation of the sequencing and analysis protocol for
the accurate quantification of clone size from low template copy samples. Synthetic loci
and the Rosa26-[CA]30-eYFP reporter mouse were used for in vitro and in vivo validation
respectively. Through setting of accurate thresholds for differentiating between wild-type,
PPC and WPC, it will be possible to infer the proportion of PPCs and WPCs in mice at
differing ages. The next step in the development of this method is to show that the expected
intra-cryptal clone sizes can be observed through use of microsatellite sequencing alone.
Chapter 5
Identifying intra-cryptal clone size
variation in mouse colon using
microsatellite sequencing
In this chapter, I aim to show that the expected intra-cryptal clone sizes can be observed
using microsatellite sequencing. Previous experiments, in this dissertation, have shown that
microsatellite sequencing is able to accurately quantify clone size in vitro and in vivo. As
the age related clone size changes in the mouse colon have been well described, it will
be possible to validate microsatellite sequencing as a means of detecting these clone size
changes in a transgene-free, label-free manner.
As was discussed in Chapter 4, the mixture modelling inference relies upon the assump-
tion that a shifted reference distribution accurately predicts a mutant distribution. Though
the model robustly identifies mutant clones, interpretation of F values has to be adjusted on
a locus by locus basis to appropriately interpret the F value inferred by the model. In this
chapter, the approach used to define these thresholds is described.
Once set, these thresholds can then be used to interpret microsatellite sequencing of sin-
gle crypts and allow for the clone size and incidence to be established, in wild-type and
genetically altered epithelium. Firstly, clone incidence and size will be established in wild-
type mice to demonstrate the feasibility of the method in identifying intra-cryptal clone size
differences. Secondly, clone incidence and size will be established in mice with mismatch
repair deficiency. The increase in mutation rate associated with mismatch repair deficiency
will allow for observation of age related clone size change in a small cohort of mice. Us-
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ing simulations, the clone size distributions for different microsatellite mutation rates can be
predicted and used to validate observations made in murine colon with mismatch repair defi-
ciency. Furthermore, by comparing the clone size distributions observed using microsatellite
sequencing with the simulated data, it will be possible to infer the microsatellite mutation
rate in mismatch repair deficient epithelium.
In chapter 3, five loci were identified as being potentially germline variable, Figure 3.11.
Sequencing of single crypts will allow for observation of any somatic mutability observed
at these loci.
Finally, it has been hypothesised that microsatellites mutate via a loop insertion-deletion
mechanism. This mechanism leads to small alterations in microsatellite length with large
scale alterations rarely observed. As this method allows for observation of the mutational
spectra observed at these loci somatically, it will be possible to see if the mutational spectra
observed are consistent with a loop insertion-deletion mechanism of mutagenesis in both
wild-type and mistmatch repair deficient epithelium.
5.1 Setting F value thresholds for interpretation of intra-
cryptal clone size
As discussed in Chapter 4, at some loci, there is a slight change in the shape of the distribu-
tion as the length of the microsatellite changes. As the mixture modelling method used to
infer F relies upon predicting mutant distributions based on a shifted reference distribution,
this change in shape leads to inaccuracies in F estimation. This effect can be accounted for
by adjusting the value of F used as a threshold for calling a crypt as wild-type, partly pop-
ulated or wholly populated. As the extent of these changes is locus specific, it is necessary
to adjust the thresholds on a locus by locus basis.
5.1.1 Loci heterozygous for microsatellite length cannot be used for F
estimation
The mixture modelling method also assumes that, initially, a single length of microsatel-
lite is present at each locus thus any biallelic locus must be germline homozygous for
microsatellite length. It is, therefore, necessary to remove any loci that are germline het-
erozygous for microsatellite length. This was done by visual inspection, on a mouse by
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mouse basis, of data obtained from sequencing of reference material e.g. a tail clipping. An
example of reference samples prior to filtering is shown in Figure 5.1. In the mouse shown
in Figure 5.1, locus s15_7506 was excluded due to disparity between forward and reverse
reads, highlighted in Figure 5.2, the rest of the loci were homozygous, as would be expected
from an inbred laboratory mouse strain.
a10_2051 a19_4554 a2_2742 a4_1365 a6_4276 s15_7506 s16_4295 s2_1206 s8_2733 s8_3334 s8_6742 s9_6943 s9_8328 sX_1395
●●
●●●●●
●
●●
●●
●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●●
●●
●
●
●●
●●●●●●●●
●
●●●●●●
●
●●
●●●
●●
●
●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●●
●●●●●●●●
●●
●●●●
●
●●
●
●
●●
●●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●●
●●●●●●●●
●●●●
●
●●
●
●
●
●
●
●
●●
●
●
●
●
●
●●
●●
●
●●
●
●
●
●
●
●
●●
●●●●●●●●●
●●●●
●●
●
●●●
●
●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●
●●
●●●●●●●●
●●●●●●
●●
●
●
●
●
●●
●
●
●●
●
●●
●
●
●
●●
●
●
●
●
●●
●
●
●
●●
●●●●●●●●●
●●●●
●
●●
●
●
●
●
●●
●
●
●
●
●●
●●●
●
●
●
●
●
●
●
●
●●●
●●●●●●●●
●●●●●
●●
●●
●●
●
●
●
●
●●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●●
●●
●●●●●●●●●
●●●●
●
●●
●
●●
●●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●●
●●
●
●
●
●
●
●●●●●●
●●●●●
●●
●●
●●
●●
●
●
●
●
●
●
●
●●●
●●
●
●
●
●●
●
●
●●
●
●●●●●●●●
●
●●
●
●●●●●
●
●●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●●
●
●
●
●●
●●
●
●●
●
●
●
●
●
●●
●●●●●
●●●●●
●●
●●●
●
●●
●
●
●
●●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●●●●●●●●●●
●●
●
●
●●●
●●●
●●●
●●
●
●
●
●
●
●
●
●
●
●●
●
●
●●●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●●●●●●●●●●
●●
●●
●
●
●
●
●
●
●●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●●●●●●●●●●●
●●●●
●
●●
●
●
●●●●
●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●●
●
●●
●●
●
●●●
●
●
●●
●●
●●●●●●
●●●●●●●
●●
●
●●
●●●
●
●
●
●
●
●
●
●
●●
●
●
●
●●●
●
●
●
●
●
●
●
●
●●
●
●●●●●●●●
●●●●
●●●
●●
●
●
●
●
●●●●
●●
●
●
●
●
●●
●
●●●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●●
●●●●●●●●
●●
●
●●●●●
●●●
●●
●
●
●
●
●●
●●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●●●●●●●●
●●
●●
●
●●
●
●●
●●
●
●●●
●●
●
●
●●
●
●●
●
●
●
●●
●
●●
●
●
●
●
●
●●
●
●
●●
●
●
●●●●
●●
●
●●
●●●●●
●●●●
●●
●
●●
●●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●●●●●●●●●
●
●
●●
●●
●
●
●
●
●●●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●●●●●●●
●●●●●●●
●●
●●●
●●●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●●
●●
●
●
●
●
●
●
●
●●
●●●●●●●●●
●
●●
●●●●●
●
●●●●●
●●
●
●
●
●●●
●
●
●
●●
●
●
●
●●
●
●
●
●●●
●
●
●
●●
●
●●
●
●●●●●●
●●●●●●●●
●●
●
●
●●●
●●●
●
●
●
●
●
●
●●
●
●
●
●
●
●●
●
●
●
●
●●
●
●●●●●●
●●●●
●●
●●
●●●●●
●
●●
●●●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●●
●
●●
●
●●●●●●●●
●●●●●●●●
●●
●●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●●●●●●●
●●
●●●●
●
●
●●
●
●●
●●
●
●
●●
●●
●●●
●●
●
●●
●
●
●
●
●●
●●
●●
●●
●●●●●●●●●
●
●●●●
●●●●
●●
●●●
●
●
●●●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●●
●●●●●●●●
0.0
0.1
0.2
0.3
0.4
0.0
0.1
0.2
0.3
0.4
Forward
Reverse
20253035402025303540202530354020253035402025303540202530354020253035402025303540202530354020253035402025303540202530354020253035402025303540
[CA] repeat length
P
r
o
p
o
r
t
i
o
n
 
o
f
 
r
e
a
d
s
Sample type
●
●
Median value
Reference samples
Library SLX11488, Mouse 14−5007
Fig. 5.1 Scatter plot with line annotation showing representative distributions produced from reference material sequencing. The pipeline for calling
F values is only able to analyse single peaks thus loci displaying two peaks or disparity between forward and reverse reads were removed from
downstream analysis. Each reference distribution was formed from 8 technical replicates of reference material obtained from tail samples diluted
to the template copy equivalent of one murine crypt equivalent. Amplification and sequencing in parallel to single crypts from the same individual
was then performed. In this particular example, locus s15_7506 was excluded from downstream analysis, highlighted in Figure 5.2.
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5.1.2 Determining F value thresholds for interpretation of clone size
Before clone sizes for wild-type or Msh2 deficient epithelium could be interpreted, F value
thresholds had to be set to enable differentiation between wild-type, partly populated and
wholly populated crypts. These thresholds were varied on a locus by locus basis. Using
the data produced from sequencing of YFP+ and YFP- crypts, described in Section 4.4, the
spread of F estimates for YFP+ and YFP- crypts can be obtained. In addition, using the
model described by Kozar et al [54], it is also possible to simulate the predicted spread of
F estimates within the PPC population. The spread of wild-type (YFP-), wholly populated
(YFP+) and simulated partly populated crypts can be scaled to simulate the distribution of
F estimates expected in the colon of a 300 day old mouse, Figure 5.3A. However, when
the different populations are highlighted, the overlap between different populations can be
seen, Figure 5.3B. As a result, the setting of thresholds will likely label a proportion of
PPCs containing small clones as wild-type and another proportion of PPCs containing large
clones as WPC. This must be accounted for when modelling the clone size distributions.
The proportion of PPCs will remain constant with age whilst the proportion of wild-type
and wholly populated crypts varies with age. It is therefore necessary to capture the entire
wild-type and WPC population within each threshold or the PPC population will fluctuate
in size as a result of age related change in wild-type and WPC incidence. Due to overlap
of the PPC F distribution and the wild-type F distribution, the setting of a threshold that
includes all of the wild-type crypts will lead to a fraction of the PPC population being
labelled as wild-type. The proportion of PPCs labelled as wild-type will be far higher than
the proportion of PPCs labelled as WPC, Figure 5.4. This will need to be accounted for
when modelling the expected outcomes from crypt sequencing.
In wild-type epithelium, the majority of crypts are expected to have the wild-type length
of microsatellite due to a relatively low mutation rate. In Msh2 deficient epithelium, this
mutation rate is expected to be much higher with a concomitant increase in the clone inci-
dence. This can be observed when theF value distribution of crypts isolated from wild-type
mice and Msh2 deficient mice at 28 and 70 days post-induction of Msh2 knockout, Figure
5.5. Using this plot, thresholds were determined by visual inspection of the peak closest to
F = 0, which was interpreted as representing the crypts with wild-type microsatellite length.
Thresholds were set at the tail of these distributions thus classifying each F value as either
wild-type or mutant.
A second threshold was required to partition mutant crypts into those which were likely
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Fig. 5.2 Scatter plot with line annotation showing distribution of locus s15_7506 produced
from reference material sequencing. An enlarged version of the distribution shown in Figure
5.1 illustrates the disparity in forward and reverse read distributions. As a result, this dis-
tribution was removed from downstream analysis. The same manual exclusion of bimodal
distributions was performed on all loci and in all mice studied.
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Fig. 5.3F value estimate distributions for YFP+ and YFP- crypts generated from the method
described in Section 4.4 and a predicted PPC population F value spread generated from the
model described by Kozar et al [54]. The proportions of each population were scaled to
represent that expected in the colon of a 300 day old mouse and the mutation rate increased
10-fold so as to highlight the PPC and WPC. A) Histogram displaying the simulated spread
of F value estimates expected from the colon of a 300 day old mouse using actual data
generated for YFP+ and YFP- crypts and theoretical estimates ofF value spread in the PPC
population. B) Histogram displaying the simulated spread of F value estimates with the
different populations highlighted. It can be seen from this simulation that the setting of
thresholds at the tail end of wild-type or WPC peaks will likely included PPCs.
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Fig. 5.4 Schematic of the use of thresholds leading to a large proportion of PPCs with small
clones being labelled as wild-type and a smaller proportion of PPCs with large clones being
labelled as WPC. As a result, the insensitivity of the method for identifying PPCs containing
small clones needs to be accounted for in the model whilst the loss of PPCs containing large
clones is less significant.
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PPC orWPC. Particularly at 70 days post-induction of Msh2 knockout, there is a discernible
population of wild-type crypts, PPCs and WPCs. At the majority of loci, there was a clearly
discernible peak at F = 0.5 which was interpreted as being WPCs. The thresholds were
determined by visual inspection of the WPC peak and setting of a threshold at the tail of
this distribution. The threshold for differentiating between PPC and WPC can be seen in
Figure 5.6. Table 5.1 summarises the final F value thresholds set for all 15 loci.
Setting of thresholds relied upon the presence of a distinct peak at close toF = 0 formed
by wild-type crypts and another peak at F = 0.5 for biallelic loci or at F = 1 for monoal-
lelic loci formed by WPCs. This was possible for most loci though some thresholds were
approximated and are conservatively set to minimise identification of PPCs as wild-type or
WPCs. Therefore, if either of the wild-type or WPC peaks were not clearly discernible, the
loci were removed from the majority of analyses described in this chapter. The only analy-
ses where these loci were included related to the analysis of mutable loci, Section 5.5, and
analysis of mutation spectra, Section 5.6. Out of the 14 loci present in the multiplex group,
5 were excluded based on the absence of distinct wild-type and WPC peaks (loci s9_6943,
a4_1365, s9_8328, a6_4276 and s15_7506). The other 9 loci were taken forward for further
analysis in wild-type. The same 9 were analysed in Msh2 deficient epithelium along with
the transgenic [CA]30 which was also present.
Locus a19_4554 showed highly variable F value distributions at different time points
post-induction of Msh2 loss and a notable lack of a WPC peak albeit for 70 days post-
induction, Figure 5.7. Notably, the amount of mutant crypts in the wild-type mice (0 days
post-induction) is higher than that seen in the mouse 28 days post-induction. The reason for
the variability at this locus is unknown and was removed from downstream analysis. Thus,
including the loci previously excluded, a total of 6 loci were removed from downstream
analysis leaving 8 loci for analysis plus the transgenic [CA]30 locus also present in the
conditional Msh2 knockout mice.
The current method of estimating mutant distributions using a shifted reference distribu-
tion could be superseded by a method of using mutant reference distributions produced from
crypt sequencing. Locus a2_2742 at 70 days post-induction of Msh2 knockout had a par-
ticularly large proportion of crypts with an inferred shift of -1 (81 out of 210 crypts tested)
and, of those many had drifted to be a WPC (28 out of 81). When the distributions within
these crypts are pooled and a median value plotted, the comparison of a wild-type reference
distribution and a mutant reference distribution with a shift = -1 and a median F = 0.5 can
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Fig. 5.5 Histograms showing frequency of F values at different loci in crypts isolated from
wild-type and Msh2 deficient mice 28 and 70 days post-induction. The red line shows the
threshold used for differentiating between wild-type and mutant crypts.
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Fig. 5.6 Histograms showing frequency of F values at different loci in crypts isolated from
an Msh2 deficient mouse 70 days post-induction. The red line shows the threshold used for
differentiating between wild-type and mutant crypts. The blue line indicates the threshold
used to differentiate mutant crypts as being PPC orWPC. In X-linked loci, two blue lines are
present to account for monoallelic and biallelic presence in males and females respectively.
Out of the 14 loci amplified in the multiplex group, 5 loci were excluded due to the absence
of distinct wild-type andWPC peaks, these loci were: s9_6943, a4_1365, s9_8328, a6_4276
and s15_7506 and were removed from all downstream analyses.
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Fig. 5.7 Histograms showing the distribution of F values post-induction of Msh2 knockout
at locus a19_4554. The proportion of mutant crypts is highly variable at different time
points. The reason for this is unknown and the locus was excluded from further downstream
analysis.
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be observed, Figure 5.8. If, like in this example, mutant distributions could be inferred for
a range of shifts at multiple loci, the need for estimating the mutant distribution would no
longer be required and allow for more accurate calling of F. This would ultimately enable
better estimates of clone size and the ability to set tighter thresholds.
5.2 Identifying intra-cryptal clone size in wild-type epithe-
lium
Initially, sequencing was performed on wild-type crypts to show that clone size estimates
could be made in normal tissue. Using the observations made by Kozar et al [54], it is
possible to make predictions about the incidence of PPCs and the accumulation of WPCs
expected. These predictions are based on the observation of a monoallelic locus thus the
mutation rate is expected to be twice as high at a biallelic locus. In addition, mutations in
the transgenic [CA]30 microsatellite are only observed if the mutation shifts the YFP re-
porter in-frame. Whereas sequencing allows direct observation of all mutations and does
not require in-frame shifts. The exact frequency of non-in-frame mutation is unknown thus
this possibility was not included in the calculations. As a result, the predictions made about
clone size incidence are likely to be an underestimate. As can be seen in Table 5.2, ampli-
fying using the M13_33 multiplex group should lead to one WPC being observed for every
5 crypts sequenced and one PPC for every 16 crypts sequenced, in the colon of a 300 day
old mouse.
Mice at different ages were selected to see if the expected pattern of consistent PPC
incidence and WPC accumulation with age is observed. Two mice were initially sequenced:
one aged to 76 days and one aged to 735 days. Based on the same calculations used to
obtain the expected incidence in Table 5.2, and therefore assuming the same mutation rate
as for the transgenic [CA]30 locus, specific values were calculated to predict the incidence
of PPCs and WPCs in the colon of mice at those ages for the 8 loci surviving filtering in
Section 5.1.2. These values are outlined in Table 5.3.
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Locus WT-PPCThreshold
PPC-WPC
Threshold
(Female)
PPC-WPC
Threshold
(Male)
a10_2051 0.14 0.30 0.30
a19_4554 0.15 0.40 0.40
a2_2742 0.15 0.35 0.35
a4_1365 0.13 0.22 0.22
a6_4276 0.12 0.33 0.33
s1_eyfp 0.20 0.70 0.70
s15_7506 0.14 0.30 0.30
s16_4295 0.13 0.30 0.30
s2_1206 0.11 0.32 0.32
s8_2733 0.14 0.35 0.35
s8_3334 0.13 0.35 0.35
s8_6742 0.16 0.34 0.34
s9_6943 0.18 0.32 0.32
s9_8328 0.13 0.30 0.30
sX_1395 0.13 0.37 0.75
Table 5.1 Thresholds used to differentiate between wild-type, PPC and WPC crypts based
on the inferred F value.
Crypt Status Incidence 1x [CA]30
14x [CA]30
(# in M13_33)
WPC 1680 per 105 crypts 1 per 60 crypts 1 per 5 crypts
PPC 458 per 105 crypts 1 per 218 crypts 1 per 16 crypts
Table 5.2 Estimates of the number of WPCs and PPCs observed in the M13_33 multiplex
group. The estimates are adapted from Kozar et al [54] for colon of a 300 day old mouse.
The estimates account for autosomal loci being biallelic but only include the rate for in-
frame mutations as the rate of conversion to out of frame mutations is not known.
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Fig. 5.8 Scatter plot showing a wild-type reference distribution at locus a2_2742 with a
mutant distribution generated from crypt sequencing data. The crypts used to produce the
mutant distribution were inferred as having shift = -1 and F = 0.4 to 0.6
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PPC WPC
Age
(days) Incidence(per 105 crypts)
Expected incidence
(using filtered
M13_33)
Incidence
(per 105 crypts)
Expected incidence
(using filtered
M13_33)
76 458 1 per 27 crypts 425 1 per 29 crypts
735 458 1 per 27 crypts 4116 1 per 4 crypts
Table 5.3 Predicted WPCs and PPCs from wild-type sequencing of mice at 76 days versus 735
days from sequencing of 8 loci. The incidences take into account biallelic presence of endogenous
microsatellites but only accounts for in-frame mutations thus represent a conservative estimate.
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Sequencing of microsatellites in crypts from these two mice revealed incidences of PPCs
and WPCs lower than that predicted from inferences made from the Kozar et al dataset, Fig-
ure 5.9. A mean percentage of 3.3% of crypts were PPCs, equivalent to 1 in 30 crypts,
compared with the expected 1 PPC per 27 crypts. In the 76 day old mouse, 1.3% of crypts
were WPCs, equivalent to 1 in 71 crypts, compared with the expected 1 WPC per 29 crypts.
In the 735 day old mouse, 5.7% of crypts were WPCs, equivalent to 1 in 17 crypts, com-
pared with the expected 1 WPC per 4 crypts. This lower than expected clone incidence is
indicative of a mutation rate at endogenous loci lower than that observed at the transgenic
[CA]30 locus.
However, the clear WPC accumulation with age seen in these wild-type mice is precisely
what would be expected. A 2.1-fold increase in PPC incidence was observed between the
two mice. A 6.1-fold range of PPC incidence was observed in the Kozar et al [54] murine
colon dataset (range: 74.2 to 452.5 per 100,000) thus a 2.1-fold difference is well within the
expected range such that the increase in PPC incidence with age is likely due to sampling
error alone. This experiment serves as proof of principle for the detection and interpreta-
tion of intra-cryptal clone size variation based on microsatellite sequencing data alone and
suggests mutation rate heterogeneity between the transgenic and endogenous [CA]30 loci.
To enable observation of age related changes in clone size incidence in mice across all
loci, the same analysis was applied to mice with Msh2 deficient epithelium.
5.3 Identifying and interpreting intra-cryptal clone size in
Msh2 deficient epithelium
The expected incidence of clones in epithelium deficient in mismatch repair pathways is
not known but will be significantly higher than that seen in wild-type epithelium. However,
the same pattern of constant PPC incidence and WPC accumulation with age is expected,
as would be seen in wild-type epithelium. Furthermore, as values for the functional stem
cell number and stem cell replacement rate within the mouse colon are known, the expected
clone size distributions can be predicted, using the mathematical model described by Kozar
et al [54]. By combining observations of intra-cryptal clone size variation in Msh2 deficient
epithelium with simulated predictions of clone size distributions, it will be possible to vali-
date microsatellite sequencing as a viable means of observing expected intra-cryptal clone
size variation.
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Fig. 5.9 Histogram showing the number of PPCs and WPCs observed in a 76 day old mouse
(144 crypts tested) compared with a 735 day old mouse (176 crypts tested). The number
of PPCs remain relatively constant with age (2.1% of crypts tested in the 76 day old mouse
versus 4.5% of crypts tested in the 735 day old mouse, a 2.1-fold increase) whilst a 4.4-fold
increase in WPCs is observed (1.3% of crypts tested in the 76 day old mouse versus 5.7%
of crypts tested in the 735 day old mouse).
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Mice with a tamoxifen inducible Cre recombinase expressed from the intestinal epithe-
lium specific promoter Villin were induced leading to recombination and loss of function at
the Msh2fl/fl locus, described in Sections 2.1.3 and 2.1.4. Following induction, mice were
taken at varying time points (range = 28 days to 164 days) and single crypts were isolated
and microsatellite sequencing performed. As can be seen in Figure 5.10, across all loci, a
robust increase in the number of WPCs is observed and a relatively consistent frequency of
PPCs is seen at all time points post-induction of Msh2 knockout. It should be noted that
one of the 8 endogenous loci was removed from this analysis as only two time points were
available due to low read depth. However, the Msh2 knockout mice were also crossed onto
the Rosa26-[CA]30-eYFP strain thus the transgenic [CA]30 locus was also analysed in this
cohort. When an average PPC and WPC frequency across all loci is calculated, a pattern
of clone size dynamics expected from continuous labelling is observed, Figure 5.11. These
observations show that microsatellite sequencing and subsequent analysis can be used to
observe and interpret clone size distributions to produce a pattern of age related clone size
change close to what would be expected.
To confirm that the pattern of clone size distributions observed in Msh2 deficient ep-
ithelium fits with what would be expected from clone size distributions in murine colonic
tissue, simulations of clone sizes were performed using the model described in the Kozar
et al study [54]. In wild-type mice, the mutation rate at the transgenic [CA]30 locus is cal-
culated to be 1.1x10-4 mutation events per cell mitosis. As the loss of Msh2 is expected to
lead to a significant rise in microsatellite mutation rate, the incidence of PPCs and WPCs
is expected to rise. By adjusting the mutation rate input into the model, it is possible to
simulate clone size distributions within mouse colon at variable mutation rates. The output
of these simulations are shown in Figure 5.12.
Comparison of the simulated clone size distributions with the clone size distributions
observed from microsatellite sequencing shows a close similarity with simulated clone size
distributions at a 175-fold higher mutation rate, Figure 5.13. The accumulation of WPCs
closely matches the simulated data suggesting that the threshold for differentiating between
large clones andWPCs is effective. The frequency of PPCs is slightly lower than what would
be predicted by the model and indicates that the threshold for differentiating between wild-
type from PPCs is overly conservative, as expected and discussed in Section 5.1.2. Using
the simulated PPC clone size distribution, Figure 5.14, it can be seen that the majority of
clones are 1/7 and 2/7 in size (equivalent to a F value of 0.14 and 0.28 respectively, at a
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Fig. 5.10 Scatter plot showing relative changes in PPC and WPC percentages after induc-
tion of Msh2 knockout in intestinal tissues at each loci tested. Across all loci, there is a
trend towards PPC percentage remaining relatively constant with a distinct increase in the
percentage of WPC detected at each locus. One male mouse was analysed at each of the
following time points: 28, 70, 102, 121 and 164 days post-induction with a total of 141,
210, 96, 164 and 153 crypts analysed at each time point respectively.
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Fig. 5.11 Scatter plot showing relative changes in PPC andWPC percentages after induction
of Msh2 knockout in intestinal tissues. The values were calculated by averaging across all
loci tested with error bars depicting the standard deviation of estimates between loci at each
time point.
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Fig. 5.12 Smoothed distributions of PPC and WPC dynamics based on varying mutation
rates. These simulations were produced from the same model used by Kozar et al [54], with
varying input of mutation rate.
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monoallelic locus). The expectedF estimate for clone sizes of 1/7 and 2/7 at a biallelic locus
would be 0.07 and 0.14 respectively. The average threshold value for differentiating between
wild-type and PPC across the analysed loci is 0.143, therefore, it is highly likely that the
thresholds set will miss any clone of 2/7 in size or smaller. When this is accounted for in
the model, the data now fits well with the expected clone distribution, Figure 5.15. This
indicates that microsatellite sequencing is insensitive to small clone detection thus requiring
adjustments to the model to account for this. Nonetheless, with this adjustment, the observed
data closely matches the simulated data and indicates that the method is particularly effective
at identifying WPCs.
5.4 Observation ofWPC accumulation can be used to infer
microsatellite mutation rate in Msh2 deficient epithe-
lium
Using the model developed by Kozar et al [54], it is possible to infer the functional stem
cell number and stem cell replacement rate so long as the microsatellite mutation rate is
known. Using this model, Kozar et al inferred the number of functional stem cells per
murine colonic crypt to be 7 and the stem cell replacement rate in the murine colon to
be 0.3 per day. As these values have already been defined for the mouse colon [54], it is
instead possible to take these values and reverse the calculation to infer the microsatellite
mutation rate. This inference can be done by simulating different mutation rates to find the
simulated dataset that best fits our observations. Given that the PPC incidence is likely to
be underestimated, as discussed in Section 5.3, the WPC accumulation rate is likely to be
a more accurate indicator of the clone size distribution. As can be seen from Figure 5.16
and described in Section 5.3, the simulated data that best describes the WPC accumulation
rate seen in Msh2 deficient epithelium has a mutation rate approximately 175-fold higher
than that seen in wild-type epithelium. This equates to an average mutation rate across all
loci of 1.93x10-2 mutations per mitosis or 9.63x10-3 mutations per allele per mitosis. To
the best of my knowledge, this is the first approximation of microsatellite mutation rate in
Msh2 deficient epithelium.
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Fig. 5.13 Line graph depicting simulated clone dynamics based upon mutation rates 175-
fold higher than that seen in wild-type epithelium. The WPC accumulation seen in Msh2
deficient epithelium closely matches the dynamics observed when the mutation rate is 175-
fold higher than in wild-type epithelium. The PPC incidence observed from microsatellite
sequencing is lower than predicted.
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Fig. 5.14 Histogram displaying the breakdown of clone size in the simulated PPC popula-
tion. These estimates were produced from the model described by Kozar et al [54].
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Fig. 5.15 Line graph depicting simulated clone dynamics based upon mutation rates 175-
fold higher than that seen in wild-type epithelium and adjusted for small clone detection
insensitivity. The clone distribution seen in Msh2 deficient epithelium closely matches the
dynamics observed when the mutation rate is 175-fold higher than in wild-type epithelium
and adjusted for small clone detection insensitivity predicted from microsatellite sequenc-
ing.
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Fig. 5.16 Line graph depicting simulated WPC accumulation at different mutation rates
compared with Msh2 deficient epithelium. A 175-fold mutation rate increase has the closest
association with the observed WPC accumulation rate.
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5.5 Germline variability predicts somatic microsatellite mu-
tability in the mouse colon
Five loci were previously identified as being germline variable, Section 3.6. Using the clone
size estimates inferred from Msh2 deficient epithelium, the relative mutability of each locus
can be inferred by comparing the total percentage of mutant crypts per locus. As can be
seen in Figure 5.17, 4 of the top five mutable loci were previously identified as germline
variable. Furthermore, out of the top 8 loci, 6 had to be excluded from the analysis due
to a lack of distinct wild-type and WPC peaks, Section 5.1.2. The 2 remaining loci are
s2_1206 and the transgenic locus, s1_eyfp. This fits with previous wild-type data, Section
5.2, suggesting that the mutation rate at endogenous loci is lower than would be expected
based on observations of the transgenic locus. It must be noted that though the somatically
mutable loci excluded from this study are unusable in Msh2 deficient epithelium, once ac-
curate thresholds for these loci are set, these loci could be highly informative in wild-type
epithelium.
All mice in this cohort were male and, therefore, monoallelic for X-linked microsatel-
lites. As can be seen in Figure 5.17, the X-linked loci, sX_1395, has the lowest inferred
mutation rate. Thus the high mutation rate observed at the monoallelic transgenic [CA]30
locus is notable. As this locus is the only locus under a housekeeping promoter (Rosa26),
it is possible that the increased mutation rate is linked to the high transcriptional activity at
that locus.
5.6 Microsatellite mutational spectrum is locus specific and
conserved in Msh2 deficient epithelium
It has been hypothesised that microsatellites mutate via a loop insertion-deletion mecha-
nism. This indicates that the majority of microsatellite mutations will be small scale inser-
tions and deletions with larger changes less likely. The mismatch repair pathway is a key
effector in the repair of these small insertion-deletions. Thus, knockout of Msh2 should
expose this mutational process. As can be seen in Figure 5.18, there is a large bias towards
small insertions and deletions at all loci studied in both wild-type and Msh2 deficient crypts.
Only locus s8_6742 displayed any large scale mutations and was curiously only observed
in wild-type epithelium. These observations support a mechanism of mutation leading to
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Fig. 5.17 Histogram showing ranked loci based on percentage of mutant crypts in Msh2
deficient tissue. The frequency of mutant crypts is directly proportional to the mutation rate
at those loci. As can be seen from this ranking, loci that were identified as being germline
variable are also somatically mutable. Notably, other than locus s2_1206, all loci above the
YFP transgenic locus (s1_eyfp) were excluded from the analysis. This is inline with our
observations that the mutation rate is lower than expected at the endogenous loci included
in our analysis when compared with the transgenic locus. This is particularly surprising
when considering that the YFP locus is monoallelic; all other loci are biallelic albeit for
locus sX_1395 which has the lowest mutation rate of all the loci, as would be expected from
an all male cohort of mice.
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small scale insertions and deletions, in line with the hypothesised loop insertion-deletion
mechanism, and is the key mutational process in Msh2 deficient epithelium. All mutational
shifts across all loci are shown in Figure 5.19 highlighting the largely conserved spectrum
of mutation in wild-type versus Msh2 deficient epithelium. This is highly indicative of
Msh2 deficiency leading to reduced repair and no association with an increase in any other
mutation process.
5.7 Discussion
In this chapter, I have described the process used to determine thresholds for interpreting
F values generated from microsatellite sequencing data. Using these thresholds, wild-type
crypts were analysed and the expected pattern of intra-cryptal clone size variation was ob-
served. In Msh2 deficient epithelium, the incidence of clones was far higher. Simulated
data, based on known values for stem cell dynamics in the mouse colon, matched the WPC
accumulation observed in Msh2 deficient epithelium, based on a 175-fold increased mi-
crosatellite mutation rate. Based on these observations, the average mutation rate seen at
endogenous [CA]30 microsatellites was inferred and the mutational spectrum shown to be
conserved between wild-type and Msh2 deficient epithelium.
Prior to interpretation of F values, some loci were excluded because of the presence
of bimodal reference distributions. The most likely cause of this bimodal distribution is
heterozygous microsatellite length at these loci. Though sequencing or stereotyped ampli-
fication error cannot be excluded. The presence of heterozygous microsatellite length is a
relatively minor phenomena in inbred laboratory lines but this flags a potential problem in
applying the method to human epithelium where polymorphism is likely to be more preva-
lent. Therefore, it would be useful if future development of the analysis pipeline would
allow for use of bimodal distributions.
Observed F distributions in crypts from wild-type and Msh2 deficient epithelium 28
and 70 days post-induction of Msh2 knockout were used to set locus specific thresholds.
The use of all 3 datasets enabled a threshold to be determined that differentiated wild-type
crypts frommutant. Crypts at 70 days post-induction of Msh2 knockout were selected based
on the presence of clearly discernible peaks in F estimates consistent with WPC crypts (F
= 0.5 for biallelic loci and F = 1 for monoallelic loci). A second threshold was then set
to enable classification of mutant crypts as either PPC or WPC. For some loci, the wild-
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Fig. 5.18 Histograms showing range of shifts seen at different loci in wild-type crypts com-
pared with crypts in Msh2 deficient tissue. The mutational spectra appears to be largely
conserved between wild-type and Msh2 deficient epithelium.
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Fig. 5.19 Histogram showing the average range of shifts seen across all loci in wild-type
crypts compared with crypts in Msh2 deficient tissue. The mutational spectra appears to
be biased towards small scale changes, inline with a loop insertion-deletion mechanism of
mutagenesis, and is relatively conserved between wild-type and Msh2 deficient epithelium.
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type and WPC peaks were not clearly discernible and were removed from any analysis of
clone size distributions. Additionally, locus a19_4554 was removed due to variability in
the mutant fraction across different mice. The reason for this requires further study with
both biological and technical reasons possible. Nonetheless, using the thresholds set, it was
possible to interpret the F value estimated for each locus, in every crypt.
Sequencing of wild-type crypts revealed lower PPC and WPC incidences than that pre-
dicted by values calculated from the transgenic [CA]30 locus described in the Kozar et al
study [54]. This was further highlighted in Msh2 deficient crypts where the transgenic
[CA]30 locus had a far higher mutation rate compared to the majority of endogenous loci.
This is particularly notable considering the monoallelic presence of the transgenic locus
whilst all but one of the endogenous loci are biallelic. One possible explanation for this
discrepancy is the transcriptional activity of the Rosa26 locus predisposing the [CA]30 in
that region to an increased mutation rate.
Simulation of outcomes based on 7 functional stem cells and a replacement rate of 0.3
per day allows for predictions of age related change in clone incidence under differing mi-
crosatellite mutation rates. These simulations predicted the mutation rate in Msh2 deficient
epithelium to be approximately 175-fold higher than at the transgenic [CA]30 microsatellite.
The accumulation of WPCs seemed to robustly correlate with the predicted WPC accumu-
lation rate. However, the PPC frequency appeared to be underestimated. This disparity is
likely due to a conservative threshold being set for differentiating between wild-type and
partly populated crypts leading to some small clones being called as wild-type instead of
partly populated. This underestimate of PPC could be accounted for in two ways: 1) the
mathematical model used to predict outcomes from continuous labelling could be adjusted
so that only medium and large size clones are counted such that the insensitivity to small
clones is insignificant, as was shown to be an effective method in Section 5.3. 2) As more
data is generated using this method, mutant reference distributions can be generated reduc-
ing the inaccuracy in F estimates and allowing tighter thresholds to be set, as was shown
in Figure 5.8. This will increase the sensitivity of the method for detecting small clones.
Furthermore, as more data becomes available, the wild-type and WPC peaks are likely to
become more clearly discernible allowing for more accurate thresholds to be set. Ultimately,
a combination of improved modelling and larger datasets will enable more sensitive analy-
sis.
In addition to allowing more sensitive thresholding, the availability of more microsatel-
5.7 Discussion 157
lite sequencing data from wild-type epithelium will allow thresholds to be set at more mu-
table loci that had to be excluded from this analysis. Inclusion of more mutable loci will
be beneficial for two key reasons: 1) less loci will be excluded, therefore, allowing more
data to be generated per crypt. 2) The more mutable loci will have a higher clone incidence
thus contain more information regarding clone size distributions than the loci analysed in
the dataset presented in this chapter.
Nonetheless, simulated clone outcomes with a 175-fold increase mutation rate con-
firmed that the clone size distribution observed in Msh2 deficient epithelium is close to what
would be predicted. Furthermore, the presence of a robust correlation between simulated
and observed WPC accumulation allowed for an approximation of the average microsatel-
lite mutation rate in mismatch repair deficient epithelium, at 1.93x10-2 mutations per mitosis
per locus or 9.63x10-3 mutations per mitosis per allele.
During initial sequencing of loci from reference material in different mice, 5 loci were
identified as being germline variable. These loci were then included in the optimised mul-
tiplex group and analysed in both wild-type and Msh2 deficient crypts. Interestingly, these
loci were also among the most somatically mutable, in Msh2 deficient epithelium, as in-
ferred from an increased mutant crypt fraction seen at these loci. Unfortunately, in Msh2
deficient epithelium, the presence of a wild-type crypt peak was so low that setting thresh-
olds for these loci, and many of the other mutable loci, was unfeasible. These loci were
therefore removed from clone size distribution analysis. Though these loci are not useful
for clone size distribution studies in the presence of mismatch repair deficiency, they could
potentially be useful as sentinel loci for the detection of mismatch repair deficiency in nor-
mal epithelium or in tumour samples. It should also be noted that the lack of wild-type and
WPC peaks at these germline variable loci means that the thresholds set are approximations
thus the incidences of mutant crypts should not be considered absolute values and instead
should be considered relative to each other.
In addition to studying the clone size distribution and mutation rate in Msh2 deficient
epithelium, the spectrum of mutational shifts was also analysed. At the majority of loci,
there was a large bias towards small insertion and deletion events consistent with the loop
insertion-deletion mechanism of microsatellie mutation. Furthermore, this spectrum of mu-
tation was conserved in Msh2 deficiency supporting the notion that microsatellite length
change is a constant dynamic between mutation and repair that is biased towards mutation
in the absence of mismatch repair pathway competency.
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In this chapter, I have described the application of microsatellite sequencing to wild-
type and Msh2 deficient mouse colon. These studies have shown the ability to observe
and correctly interpret intra-cryptal clone size variation consistent with those expected from
continuous labelling studies. Through adaptation of the mathematical model used by Kozar
et al, and adjustment for only PPCs containing clones of 3/7 or above, it was shown that
the clone size distributions observed in Msh2 deficient epithelium are consistent with what
would be expected at microsatellite mutation rate 175-fold higher than that seen in wild-type
epithelium. Furthermore, through use of the same mathematical model, the microsatellite
mutation rate observed in Msh2 deficiency was inferred. Finally, the mutational spectrum
observed in wild-type and Msh2 deficient epithelium was assessed showing conservation
of small scale alterations in microsatellite length between wild-type and Msh2 deficient
epithelium. The next step in the development of this method is to show that intra-cryptal
clone size variation can be detected using microsatellite sequencing in patient material.
Chapter 6
Quantifying clone size in human crypts
using microsatellite sequencing
Microsatellite sequencing of single crypts in murine colon validated the approach as a
method for quantifying intra-cryptal clone size variation. In this chapter, I aim to trans-
late the microsatellite sequencing protocol for the amplification of [CA] dinucleotide mi-
crosatellites to human crypts. The translated method will then be used to quantify clone
size in patient material. The application of microsatellite sequencing to clone size quantifi-
cation to patient material will pave the way for larger scale studies for quantifying stem cell
dynamics in the human intestine.
The microsatellite sequencing protocol optimised for murine crypts will be translated
to human material. Previous mixing of 4000 plasmid copies (template copy equivalent to
a single human crypt), Section 4.3, showed a clear ability of the microsatellite sequencing
protocol to identify minor mutant microsatellite species. Therefore, the increased DNA con-
tent of the human colonic crypt should facilitate translation from mouse studies. However,
it was unknown as to whether sequencing of human genomic sequence containing [CA]
dinucleotide repeats would be feasible, for example, due to issues associated with human
specific sequence context of these regions or the prevalence of polymorphic microsatellites.
In addition, optimisation of the multiplex PCR protocol was done using mouse specific
primers so the effect of using human specific primers also remained to be seen.
Once the amplification of [CA] microsatellites from human crypts has been established,
it will be possible to amplify single human crypts isolated from patient material and identify
mutant clones. Using the same mixture modelling analysis, as described in Chapter 4, in-
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ferring clone sizes will be possible. Interpretation of any given clone as being WPC or PPC
will rely upon the presence of distinct wild-type and WPC peaks which would allow for the
setting of thresholds for F value interpretation. The microsatellite mutation rate in human
epithelium is expected to be similar to that seen in wild-type murine epithelium, therefore, a
distinct wild-type crypt peak would be expected allowing differentiation between wild-type
and mutant. The setting of a second threshold to classify mutant crypts as PPCs or WPCs
is likely to present novel issues as Msh2 deficient crypts cannot be used as was done for
mouse.
6.1 Adaptation of murine microsatellite sequencing proto-
col to human material
To translate microsatellite sequencing to human material, human specific primers needed
to be designed and appropriately sized amplicons obtained from human crypt equivalents,
with equal balance between amplicons within the multiplex group.
6.1.1 Design of human specific multiplex PCR primers
Initially, using the human reference genome (build hg38), 63 microsatellites were identified
between [CA]28 and [CA]32. Using the online primer design tool, BatchPrimer, primers
were designed for 58 of the loci of which 53 generated a single product at the expected
length when analysed using gel electrophoresis (91% success rate). These 53 successful
primer pairs were then taken forward for multiplex group design. Using the online tool,
MultiPLX 2.1, six multiplex groups were recommended (five of which contained 9 primer
pairs and one contained 8 primer pairs). An additional multiplex group was also tested
that only contained primer pairs that amplified [CA]30 microsatellites representing 8 out
of the 10 [CA]30 loci present in the human reference genome. Each multiplex group was
tested using reference human DNA diluted to the equivalent of a single human crypt and
amplified using the same multiplex PCR conditions used for mouse crypt amplification. Gel
electrophoresis was used to observe product formed at the expected length with comparison
of the relative primer-dimer levels compared with product formation. The groups with the
greatest amount of product relative to primer-dimer were combined together to expand the
number of primer pairs per group. The final multiplex group contained 21 primer pairs and
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contained 8 primer pairs that amplify [CA]30 microsatellites: this multiplex group is known
as hsM13_53. Information about the primers and the related genomic information can be
found in Appendix A and Appendix B respectively.
6.1.2 Sequencing of human crypt equivalents
Sequencing of human genomic DNA diluted to the template copy equivalent of one human
colonic crypt was done by first amplifying using the hsM13_53 multiplex group, sequencing
on the MiSeq platform before assessing the balance of read depth between amplicons. As
can be seen in Figure 6.1, this multiplex group displays some variability in amplicon repre-
sentation in initial sequencing. The protocol was used 3 times: each time the concentration
of each primer pair in the mutliplex group was adjusted to improve the representation of each
amplicon. In the final sequencing run, improved balance between amplicons is observed,
Figure 6.1. The multiplex group went through fewer iterations of primer concentration op-
timisation than the mouse work up but was informed by primer concentration optimisation
required in mouse studies. As such, it is possible to see that near equal representation of
each amplicon is observed despite undergoing fewer optimisation steps.
Sequencing of patient reference material diluted to the equivalent of a single human
crypt revealed consistency in read distributions between technical replicates comparable to
that seen when amplifying mouse crypt equivalents, Figure 6.2. Unlike the mouse sequenc-
ing data, there was far more heterozygosity observed at these loci, as may be expected from
a human population compared with an inbred laboratory mouse strain. In mice, between
one and five of the 14 loci amplified had to be excluded due to heterozygosity. In humans,
out of 21 loci amplified, 12 had to be excluded from one patient and 13 from the other. Fur-
thermore, only two of the loci had an allele at the length expected from the human reference
genome. The source of this disparity is likely to result from: 1) the low read depth sequenc-
ing used to build the human reference genome is prone to microsatellite length calling error
and 2) divergence of these loci within the human population as a result of the increased mu-
tation rate associated with microsatellites. The expected and observed microsatellite lengths
are summarised in Table 6.1.
Overall, it would appear that the pipeline for the design and validation of the multiplex
PCR protocol for the amplification and sequencing of microsatellite sequencing is robust
in mouse and human. The multiplex PCR can accurately call microsatellite length from
single murine crypts, shown in Chapters 3 and 5, and, as shown in this section, from human
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Fig. 6.1 Boxplot depicting the median read depth along with upper and lower quartiles and
lowest and highest values across all amplicons in hsM13_53 used for multiplex amplifica-
tion of single human crypts. The initial sequencing run was done using diluted reference
material leading to highly consistent DNA template input whilst the final sequencing run
was done using actual crypt material with larger variability in DNA template input. Thus
explaining the reduced spread of read depth when sequencing crypt equivalent samples.
However, the balance of read depth between amplicons is improved in the final sequencing
run. The multiplex group went through fewer iterations of primer concentration optimisa-
tion but was informed by primer concentration optimisation done in mouse multiplex group
optimisation. As such, it is possible to see that the near equal representation of each ampli-
con is observed despite undergoing fewer optimisation steps.
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Expected Observed (2 alleles)
Locus Reference genome length Patient 1 length Patient 2 length
s2_87089 28 13/23 13/25
s3_50602 30 19/19 19/23
s9_39733 30 19/22 21/21
s12_1242 30 28/32 29/29
s12_6308 28 22/22 22/24
s13_7008 29 25/30 28/31
s14_1937 28 14/23 19/22
s14_6560 30 27/27 23/27
s14_6792 28 26/26 26/28
s15_8821 30 17/17 17/17
s17_6742 30 19/26 21/24
s17_1170 28 16/21 16/16
s22_4402 29 14/26 27/31
a3_46762 28 18/26 25/25
a3_12858 28 23/23 20/30
a4_10696 31 28/28 21/31
a7_29069 29 20/24 22/22
a8_86853 30 22/22 22/22
a9_13528 28 N/A 27/27
a9_99288 28 12/16 12/16
a17_6874 28 14/19 16/26
Table 6.1 Table summarising reference genome microsatellite lengths compared with the
microsatellite lengths observed in two different patient samples. Only loci s14_6792 and
a4_10696 out of the 21 loci observed had an allele at the expected length.
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crypt equivalents. It is likely that this method could be expanded to study microsatellites
within other mammalian species. The sequence context of these microsatellites is likely to
be similar between mouse and human thus the use of this method in plants and other lower
organisms remains to be seen but should, theoretically, be feasible.
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Fig. 6.2 Scatter plot with line annotation showing the read distributions of 8 technical replicates produced by amplifying reference material from
one patient. Locus a3_46762 has a missing reverse read distribution due to low read depth.
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6.2 Quantification of clone size frommicrosatellite sequenc-
ing of single human crypts
Having established that microsatellite sequencing of human crypt equivalents is possible,
the feasibility of amplifying and microsatellite sequencing of actual single human crypts
and subsequent quantification of clone size needed to be validated. Two patients undergoing
radical colectomy for colorectal cancer donated their adjacent, normal colonic tissue to this
study. These tissue samples were processed as described in Sections 2.7.2 and 2.8.4. Lysate
containing single crypts were amplified using hsM13_53 and submitted for HiSeq 4000
sequencing.
The read distributions generated from sequencing of reference material, not previously
shown in Figure 6.2, are shown in Figure 6.3. In this patient, there is heterozgosity of
microsatellite length observed in 12 of 20 loci amplified. In the other patient sample, 13
out of 21 loci displayed heterozygosity. These loci are not amenable to mixture modelling
analysis thus have to be removed from downstream analysis. After filtering for bimodal
loci, the remaining distributions from the same patient displayed in Figure 6.3, are shown in
Figure 6.4.
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Fig. 6.3 Scatter plot showing reference distributions in one patient sample. 13 of the 21 loci display a bimodal distribution which is not amenable
to mixture modelling analysis thus have to be filtered from downstream analysis. Locus a3_46762 has a missing reverse read distribution due to
low read depth, as was also observed in the other patient.
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Fig. 6.4 Scatter plot showing reference distributions in patient sample after bimodal distributions were filtered out. Compared to mouse, the human
samples have far more loci filtered due to the presence of heterozygous [CA]n alleles.
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6.2.1 Setting F value thresholds for interpreting clone size in human
crypts
The estimates of shift andF values were inferred as previously described in Chapter 4 using
a mixture modelling analysis. Thresholds were defined on a locus by locus basis, as was
done for mouse loci in Section 5.1.2. Firstly, crypts were categorised as either wild-type
or mutant by setting a threshold at the tail end of the wild-type peak, Figure 6.5. This was
possible for the majority of loci except for locus s9_39733 which lacked a distinct wild-type
peak.
Two loci were homozygous in both patients and, therefore, amenable to analysis and
comparison between the individuals. Out of these 2 loci, one of the loci (s15_8821) pro-
duced a clone size distribution as would be expected, Figure 6.6. The second locus, a8_86853,
displayed an unusual disparity in F value distribution between the two patient samples. As
these inferences were based on deviation from reference distributions specific to each pa-
tient, this disparity cannot be explained by a germline mutation and must instead have a
somatic cause. In the 56 year old patient, virtually all of the crypts had a mutation at this lo-
cus whilst in the 74 year old patient, virtually all of the crypts contained a wild-type length
microsatellite. It is possible that the younger patient had an increased microsatellite mu-
tation rate in the tissue used for this study and this locus is a sentinel for this phenotype.
Regardless, use of this locus leads to large differences in clone size estimates between the
two patients and has to be considered with caution. For the purposes of this analysis and
discussion, locus a8_86853 will be excluded.
Following the setting of a threshold for differentiating wild-type from mutant crypts,
a second threshold was required to classify mutant crypts as PPC or WPC. In mouse, it
was possible to use the increased incidence of WPCs in mismatch repair deficient crypts to
define a threshold for differentiating between PPCs and WPCs. In human crypts, only locus
a8_86853 had a discernible WPC peak but, due to the clone incidence disparity between
patients, had to be filtered out. To set an approximate threshold, loci were categorised based
on their wild-type peak distributions, Figure 6.7. Loci from wild-type mice were categorised
in the same way, Figure 6.8. As accurate PPC-WPC thresholds had been ascertained for
wild-type murine loci, the average threshold value for each category of murine loci was
calculated (Category 1 F = 0.324, Category 2 F = 0.327 and Category 3 F = 0.315). The
human loci in the corresponding category had the PPC-WPC F value threshold set as the
average value calculated in mouse. The final F value thresholds are summarised in Table
6.2 Quantification of clone size from microsatellite sequencing of single human crypts 170
a3_12858 a4_10696 a7_29069 a8_86853 a9_13528
s12_1242 s12_6308 s14_6560 s14_6792 s15_8821
s17_1170 s3_50602 s9_39733
0.0
0.2
0.4
0.6
0.0
0.2
0.4
0.6
0.0
0.2
0.4
0.6
0.0 0.2 0.4 0.0 0.2 0.4 0.0 0.2 0.4
Phi value
Pr
op
or
tio
n 
of
 cr
yp
ts
Patient age
56 years
74 years
Fig. 6.5 Histogram showing frequency distribution of F values in human crypts from two
patients. The red line shows the F value used to differentiate between wild-type and mutant
crypts. Based on these plots, locus s9_39733 was excluded from future analyses.
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Fig. 6.6 Histogram showing frequency distribution of F values in human crypts at two loci
studied in two patients. The red line shows the F value used to differentiate between wild-
type and mutant crypts.There is a vast difference in the spread of F values between the two
patients at a8_86853. Locus s15_8821 has a clone size distribution close to what would be
expected. The difference in clone size distribution at locus a8_86853 is potentially due to a
difference in mutation rate at that loci between the two patients.
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6.2 and shown in Figure 6.9.
The number of crypts with a mutant locus was counted using the threshold defined for
differentiating between wild-type and mutant crypts. As 4 loci were analysed in the 56 year
old patient and 7 loci in the 74 year old patient, it is necessary to normalise the percentage
mutant crypts to the number of loci analysed in each patient. The normalised percentage of
mutant crypts is higher in the 56 year old patient (14.5% of crypts tested) compared with
the 74 year old patient (5.9% of crypts tested), Figure 6.10. More mutated crypts would be
expected in the older individual. Thus this result could be indicative of a mutator phenotype
in the intestinal epithelium of the 56 year old patient though sampling error cannot be ruled
out. Further crypt sequencing would be required to ascertain the normal level of clone
incidence variation with patient age.
Given the age of the two patients, a much larger proportion of WPCs, relative to PPC
frequency, would be expected in both patients. This may suggest that the use of the average
murine threshold associated with wild-type peak distributions, for differentiating PPCs and
WPCs, is not sufficient for correct interpretation of human data. For an accurate breakdown
of PPCs and WPCs from human data to be performed, a larger dataset would be required to
more accurately ascertain the different thresholds.
Despite the inability to accurately interpret the clone sizes, a significant proportion of
crypts were shown to have mutant loci indicating that microsatellite sequencing can be used
to quantify intra-cryptal clone size in human material. Observation of over two-fold more
mutant crypts in the 56 year old patient in conjunction with the observation of increased
mutation at locus a8_86853 is suggestive of an increased mutation rate in the epithelium
of this patient. Further sequencing of crypts from this patient and consideration within the
context of a larger study cohort would be required to shed light onto this hypothesis.
6.3 Discussion
In this chapter, I have described how the method developed for microsatellite sequencing
from low template copy samples in mice can be translated to human material. The pipeline
developed for the identification of microsatellites, of any nucleotide composition, and output
of a file suitable for use in the online primer design tool, BatchPrimer, is readily applicable
to any reference genome. BatchPrimer utilises multiple checks to predict primer efficacy
such that the primers designed using this tool had a 79% and 91% success rate in mouse
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Fig. 6.7 Histogram showing frequency distribution of F values in human crypts. Each
wild-type peak was used to group similar distributions together to form three categories.
Equivalent distributions were sought in murine loci to enable approximation of a PPC-WPC
threshold.
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Fig. 6.8 Histogram showing frequency distribution of F values in wild-type mouse crypts.
Each wild-type peak was used to group similar distributions together to form three cate-
gories in the same fashion as that done for human loci in Figure 6.7. The average PPC-WPC
F threshold value for each category was calculated using the murine loci.
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Locus WT/PPCThreshold
PPC/WPC
Threshold
(Female)
PPC-WPC
Threshold
(Male)
Category
a3_12858 0.06 0.324 0.324 1
a4_10696 0.15 0.315 0.315 3
a7_29069 0.15 0.315 0.315 3
a9_13528 0.20 0.315 0.315 3
s12_1242 0.13 0.315 0.315 3
s12_6308 0.15 0.315 0.315 3
s14_6560 0.12 0.315 0.315 3
s14_6792 0.10 0.327 0.327 2
s15_8821 0.06 0.324 0.324 1
s17_1170 0.08 0.327 0.327 2
s3_50602 0.06 0.324 0.324 1
Table 6.2 Thresholds used to differentiate between wild-type, PPC and WPC crypts based
on the inferred F value.
a3_12858 a4_10696 a7_29069 a8_86853 a9_13528
s12_1242 s12_6308 s14_6560 s14_6792 s15_8821
s17_1170 s3_50602 s9_39733
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Fig. 6.9 Histogram showing frequency distribution of F values in human crypts from two
patients. The red line shows the F value used to differentiate between wild-type and mu-
tant crypts. The blue line shows the F value used to classify mutant crypts as PPC or
WPC. Based on these plots, locus s9_39733 was excluded from future analyses and locus
a8_86853 was excluded due to disparity in clone incidence between the two patients.
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Fig. 6.10 Histogram showing percentage of crypts tested where a mutant loci was observed.
Based on the thresholds set, including a PPC-WPC threshold set based on murine data,
the predicted percentage of PPC and WPC are shown. A total of 48 and 128 crypts were
sequenced in the 56 year old and 74 year old respectively. A total of 4 and 7 loci were
analysed in the 56 year old and 74 year old respectively such that the percentage of crypts
analysed was normalised to the number of loci analysed in each crypt.
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and human respectively. It therefore seems more than likely that, if primers can be designed
for these loci, they can be successfully amplified. This opens up the possibility of using
this method in different species allowing for the multiplexed analysis of many individuals
within many different species for purposes such as ecological and evolutionary research.
When translated from mouse to human material, the consistency in distribution between
technical replicates was very high. This consistency allows for accurate reference distribu-
tions to be generated that can then be used for mixture modelling and estimation ofF values
for crypts of unknown clonal status. Being able to accurately infer F values, with appropri-
ate interpretation of clonal status, in many crypts from humans at different ages will allow
for observation of the age related change in clone size distribution in human tissues. Using
the same model described in the Kozar et al [54] study, the functional stem cell number and
stem cell replacement rate within the human colonic crypt could be inferred.
As well as its applicability to quantifying stem cell dynamics, the consistency between
replicates allows for comparison of genotypes between two samples of unknown related-
ness. This could be applied for straightforward genotyping requirements such as parental
testing. However, the ability to also be able to detect and quantify the presence of mi-
nor microsatellite species at differing lengths could allow applicability to forensic samples.
Overall, the ability to use Next Generation Sequencing technologies to perform these sorts
of analyses from low template samples could be an incredibly useful tool for forensic studies
and genotyping applications.
From sequencing of reference material from patient samples, a disparity between ref-
erence genome microsatellite length calls and the length calls seen in patient samples was
uncovered. The source of this discrepancy is likely to be due to sequencing methods used to
generate reference genomes which have poor fidelity when sequencing repetitive regions of
the genome. The method described in this dissertation provides a high fidelity method for
calling of microsatellite length at multiple loci in many different individuals. It could there-
fore be possible to generate more accurate microsatellite sequence information for reference
genomes using this method.
When sequencing microsatellites in mice, the majority of the microsatellites were ho-
mozygous in length and little length variation was seen between individuals. In contrast,
the human sequencing data revealed large polymorphism between individuals and heterozy-
gosity of microsatellite length at multiple loci. As a result, many of the loci sequenced in
human samples had to be removed from the analysis. This is an inefficient use of these
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datasets. Instead, the computational pipeline used to analyse this data could be adapted to
deal with loci with bimodal distributions. Alternatively, the multiplex groups used in future
studies could be expanded further so that redundancy in analysable loci does not greatly af-
fect the overall power of the method. Ultimately, a combination of improved computational
methods and expanded multiplex groups would be the ideal solution for dealing with the
prevalence of heterozygosity in human samples.
Interestingly, one locus showed a large disparity in F value distribution between the
two patients studied. Understanding the cause of this disparity would require further study
but could potentially be indicating an increased microsatellite mutation rate in the normal
epithelium of this patient with locus a8_86853 acting as a sentinel locus. This could also
explain the increased number of mutant crypts observed in this patient. Larger cohorts and,
preferably, sequencing of more material from this individual will enable greater insight into
this hypothesis.
The study presented here serves as a proof of principle for the quantification of clone size
within human intestinal crypts. In order to infer accurate stem cell dynamic metrics, larger
patient cohorts would be required. The use of the HiSeq 4000 and a custom sequencing
adaptor allows for expansion of the multiplexing capabilities of the approach which will
significantly lower the cost of any future study using this method. Overall, this method
provides an exciting opportunity to use an unbiased, transgene-free method for the study of
intestinal stem cell dynamics in humans.
Chapter 7
Discussion
Since the early pioneers of modern cellular biology in the late 19th century, much has been
learned and described of the homeostatic turnover of cells in all tissues of the human body.
The laboratory mouse has played a central role in these studies to allow unprecedented
insights into the workings of healthy and diseased tissues. The intestinal epithelium, with
its notable mitotic activity, has been a model system for the study of epithelium and cell
kinetics. In recent years, there has been a focus on the discovery of molecular markers for
different cell populations that has been fruitful in aiding the observation and description of
the underlying cellular behaviour of the crypt of Leiburkühn.
However, restriction of study to marked populations can lack specificity and can lead to
an unhelpful assumption that a stem cell marker associating with a particular cell state is
required for effective stem cell research. The development of the Rosa26-[CA]30-eYFP and
Rosa26-[CA]30-SynBglA mice, provide a system independent of such markers and chemi-
cal induction for the functional study of intestinal stem biology in mouse [54]. Inference of
functional stem cell number and stem cell replacement rate in these mice, revealed notably
fewer functional stem cells than previously thought and regional differences in stem cell
dynamics along the murine intestinal tract. Recent advances in DNA sequencing technolo-
gies presented an opportunity to use sequencing of endogenous [CA]30 tracts to perform the
same analysis in human tissues.
Existing strategies for studying human intestinal stem cell dynamics largely rely upon
the loss of a protein that can be detected and tracked using immunohistochemical, and re-
lated, techniques [17, 96]. Though these approaches are useful in the study of clonal patches
within the intestinal epithelium [40, 50], the neutrality of the loss of such proteins is cur-
rently unknown. Thus inferences about clonal drift and stem cell dynamics may be biased
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by the loss of such markers. The use of microsatellite length change provides a neutral
marker for clones within the intestinal epithelium.
In this dissertation, I have described multiple experiments validating the use of mi-
crosatellite sequencing for clone size quantification in murine and human crypts. Use of
synthetic loci and murine tissues allowed for validation of the method in well described
systems. In addition, an analysis pipeline was developed that utilises Illumina sequencing
data from single crypts to accurately infer clone size. Furthermore, through study of Msh2
deficient epithelium, microsatellite mutation rates at endogenous loci were calculated and
the spectrum of mutations, supporting a loop insertion-deletion mechanism of microsatel-
lite mutation, were observed. Finally, I provide evidence for the translation of this technique
into human tissues and the quantification of clone size in patient material.
The development of a multiplexed microsatellite sequencing protocol for single crypts
posed many technical challenges. Initially, a protocol was required for the reliable and con-
sistent isolation of single crypts. By using low adherence equipment and dispensing crypts
directly into lysis buffer, the technique for single crypt isolation was significantly improved.
Perhaps unsurprisingly, the use of paraformaldehyde fixation prior to crypt isolation ren-
dered the DNA unsuitable for amplification. Development of a reliable technique for single
crypt isolation has the potential for use in a range of experiments relating to single crypt
analyses.
Furthermore, steps were required to reduce the level of DNA contamination in single
crypt lysates. The potential sources of DNA contamination are: 1) cell free DNA con-
tained within the single crypt suspension media, 2) cell debris contained within the single
crypt suspension media and 3) constitutive contamination from surrounding cells that do not
contribute to epithelial lineages within the crypt. All of these sources are likely to lead to
contribution of microsatellite loci at wild type lengths leading to under estimation of mutant
clone size. Quantification of cell free DNA allowed for selection of optimal single crypt
suspension conditions. The passage of each single crypt through PBS droplets, so called
’crypt washing’, allowed for visual inspection for cell debris and selection of crypts with
minimal stromal attachment. Additionally, crypt washing was shown in later experiments
to be a powerful tool for the reduction of DNA contamination in crypt lysate and significant
improvement in mutant clone detection. These experiments were critical in improving the
sensitivity and reliability of the method. Again, these observations lead to critical improve-
ments in any experiment relating to single crypt analysis.
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Loop insertion-deletion is proposed to be the mechanism of microsatellite mutation in
vivo. A similar process of PCR ’stuttering’ has been described for regions containing mi-
crosatellites suggesting that the same mutational process is present in vitro. The presence of
in vitro polymerase slippage leading to reduced fidelity in the amplification of microsatel-
lites is a critical issue for the accurate inference of clone size from single crypt lysates.
The key breakthrough in addressing this issue was the observation of high fidelity and high
efficacy of the New Engand Biolabs Phusion DNA polymerase in amplifying microsatel-
lites from mouse genomic DNA. Intriguingly, the DNA polymerases that performed best
at microsatellite amplification contained the Sso7d domain commonly added to DNA poly-
merases to improve processivity. It is possible that the increased contact area between the
enzyme and DNA improves fidelity in highly repetitive stretches of DNA but this remains
to be formally addressed.
In addition to error during PCR, prior studies on sequencing of microsatellites using Il-
lumina technologies focussed on shorter microsatellites or those containing tetranucleotide
repeats that are commonly used for human genotyping studies. These shorter and more
complex microsatellites have lower mutation rates and are less affected by loop insertion-
deletion mutagenesis. Therefore, prior to this study, the performance of the Illumina se-
quencers in sequencing dinucleotide microsatellites was unknown. As can be seen from the
comparison of MiSeq and HiSeq sequencing data, there is a slightly different error profile
indicative of sequencing error contribution to overall error in microsatellite length calling.
The exact contribution of this error to the overall error remains to be quantified but, given
the relatively small amount of amplification present in Illumina sequencing relative to PCR
amplification, it seems likely that the majority of the error occurs during PCR with only a
small contribution from sequencing.
Using the HiSeq leads to a substantial increase in average read depth per amplicon com-
pared to the MiSeq which results in improved replicate consistency. Accurately calling
mutant distributions hinges upon the ability to reproducibly capture a reference distribution
with a high level of accuracy. With high levels of consistency between wild-type repli-
cates, it is possible to more confidently call deviations from this distribution as mutant and
therefore biologically meaningful. The high read depths used in this study minimises the
variability seen between replicates so that the only observable source of variation is that
caused by technical noise and/or biological differences in microsatellite length. Overall,
this will improve the sensitivity of the assay and accuracy of clone size estimates.
181
The development of plasmids containing murine genomic regions with differing lengths
of [CA]n microsatellites were a valuable tool for in vitro validation of the microsatellite
sequencing protocol. Initially, qPCR analysis was done to show that there was no amplifi-
cation bias towards microsatellites at shorter lengths. Mixing experiments show the ability
of microsatellite sequencing to deconvolute wild-type and mutant mixtures. Additionally,
mixes, particularly 50:50 mixes, of wild-type and mutant microsatellites displayed no am-
plification bias suggesting that small changes in microsatellite length do not lead to amplifi-
cation bias even at low template copies. Interestingly, estimates of mutant read proportion,
F, display a marked increase in variability when copies are reduced from 500 to 165 plas-
mid copies suggesting that allele dropout contributes significantly to F estimate error at
low template copies. This would be a major consideration when considering adapting this
protocol to samples with lower template copies, such as single cell experiments.
Current methods for analysing microsatellite sequencing data are tailored to estimat-
ing the dominant microsatellite length such that any information about minor microsatellite
lengths are assumed to be artifactual and discarded. As this minor microsatellite length is
crucial for inferring clone size, a custom script was designed to measure the length of the
[CA] repeat in each read contained within the sequencing data and compile a matrix display-
ing the number of reads containing [CA] repeats of differing lengths. Output from this [CA]
counting tool could then be used for analysis of mutant microsatellite length contribution,
in a locus and crypt specific manner. Mixture modelling was used to infer this contribution.
An assumption of the mixture model was that a shifted reference distribution would accu-
rately predict the mutant distribution. This was shown not be the case at some loci leading to
inaccuracies in F estimation. To account for this, the threshold for differentiating between
wild-type, partly populated and wholly populated crypts had to be adjusted on a locus by
locus basis.
Key to determining these thresholds was the use of F estimate distributions from wild-
type and Msh2 deficient crypts. A threshold for differentiating between wild-type and mu-
tant crypts can be achieved by setting a threshold at the tail end of the wild-type crypt
distribution. A second threshold is required to classify mutant crypts as either PPC or WPC.
In Msh2 deficient crypts, at 70 days post-induction of Msh2 knockout, a peak represent-
ing wholly populated crypts is clearly observable. Through visually inspecting each locus,
a second threshold could be set at the tail end of the WPC peaks. These thresholds can
then be used to call wild-type, PPCs and WPCs in wild-type epithelium and at a range of
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time points post-induction of Msh2 knockout. Though this is a viable option for murine
studies, collection of mismatch repair deficient human crypts is unfeasible such that larger
sequencing cohorts will be required before accurate PPC-WPC thresholds can be set.
In mouse, it is possible to use simulated data to predict the clone size distribution ex-
pected at different microsatellite mutation rates. The observation of WPC accumulation in
Msh2 deficient crypts robustly matches that predicted from simulation of clone size dis-
tribution with a microsatellite mutation rate 175-fold higher than that seen in wild-type
epithelium. The observed incidence of PPCs was slightly lower than predicted from the
simulated data. This underestimate of PPCs can be explained by the relative insensitivity of
the method in detecting clones at 2/7 size or smaller. Adjustment of the model to account
for this phenomena lead to close matching of the observed and predicted distributions. This
highlights robust detection of clones approximately 3/7 in size and larger with some diffi-
culties detecting smaller clones.
As more data is accrued, distributions observed in WPCs could be used as mutant distri-
butions. This would remove the need for prediction of mutant distributions, using wild-type
reference distribution shifts, and reduce the error observed in F estimate. This would allow
for thresholds to be set closer to the extremes of possibleF values and increase the dynamic
range of the assay which ultimately improves accuracy of clone size estimates. That being
said, the current method appears to be highly effective in differentiating between wild-type,
partly populated and wholly populated crypts such that the methods described above would
be subtle improvements rather than required modifications.
The current protocol is well positioned to be scaled. Firstly, the use of a custom se-
quencing adaptor set allows for expansion of the index set beyond the current limit of 384
unique indexes by simply synthesising a new set of adaptors with an increased number of
unique indexes. Secondly, the amenability of this protocol to HiSeq sequencing allows for
large amounts of data to be accrued in relatively short time scales. The only limit to this
would be ensuring all loci in all crypts are above the 1000 reads limit before signal to noise
becomes an issue. The current bottleneck in the scaling of this protocol lies in the collection
of single crypts. Currently, all crypts have to be manually picked and have an upper limit of
200 crypts per day per person. Adaptation of large particle flow cytometry protocols, such
as those currently used for sorting C. elegans, or the design of a custom microfluidic device
would be invaluable in the scaling of this protocol. Nonetheless, the current protocol has a
relatively high throughput allowing for hundreds of crypts to be isolated, lysed and prepared
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for sequencing in 3-4 days.
Based on the observations of the transgenic [CA]30 microsatellite in the Rosa26-[CA]30-
synBglA mouse, the frequency of PPCs and WPCs observed at endogenous [CA]30 mi-
crosatellites was lower than predicted. The likely cause of this is a reduced mutation rate
at these loci. As the transgenic [CA]30 is under a housekeeping promoter (Rosa26), it is
possible that transcriptional activity may influence microsatellite mutation rate. In Msh2
deficient epithelium, the transgenic [CA]30 locus is ranked as one of the most mutable loci,
consistent with our prediction that this locus displays an increased mutation rate. This is
particularly notable when considering that this locus is monoallelic such that the mutation
rate is half that expected at a biallelic locus. All but one of the other loci studied in mouse
were biallelic and the only other monoallelic locus had the lowest inferred mutation rate.
In addition to studying intra-cryptal clone size variation in wild-type epithelium, clone
size distributions were quantified in Msh2 deficient epithelium also. The VillinCreERT;
Msh2fl/fl mouse was utilised to induce Msh2 deficiency using tamoxifen. From this analysis,
expected clone size distributions were observed and the average mutation rate for endoge-
nous microsatellites in Msh2 deficiency was calculated to be 1.93x10-2 per mitosis per locus
or 9.63x10-3 mutation per mitosis per allele. This calculation shows the possibility of using
this method to infer mutation rates at many different loci based on known values for func-
tional stem cell number and stem cell replacement rate in the murine intestinal epithelium.
This could potentially be extended to other applications such as inferring the rate of single
nucleotide and structural variations. Though different approaches to amplifying DNA from
single crypt lysate would almost certainly be required.
During initial sequencing of loci from mouse genomic DNA, very stable microsatellite
lengths were observed across the majority of loci. Somewhat unexpectedly, five of the loci
were variable in length between individuals, termed ’germline variable’ loci. We hypothe-
sised that these loci may be more unstable and, therefore, have a higher mutation rate somat-
ically. Primer pairs for these loci were included in the final multiplex group and analysed in
both wild-type and Msh2 deficient crypts. Though the mutation rate in wild-type epithelium
was too low to comment meaningfully on these loci, these loci had an elevated mutation rate
in Msh2 deficient epithelium. So much so that defining thresholds for wild-type, PPC and
WPC was unfeasible at the majority of these loci. This indicates that these loci could be
highly informative for quantifying clone size in wild-type epithelium but would be unfit for
this purpose in a DNA repair deficient setting such as in tumours or patients with germline
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mutations in such pathways.
The use of germline variability as a means of predicting somatically mutable loci is a
useful tool in mice as, due to significant levels of inbreeding, these loci tend to be homozy-
gous in length despite increased germline variability. However, if such germline variable
loci exist in human populations, they are highly likely to be heterozygous and would be
unsuitable for the current analysis pipeline. Further development of the analysis pipeline
to allow use of heterozygous loci would enable testing of somatic mutability in germline
variable loci in humans.
The mechanism of microsatellite mutation is thought to be through loop insertion-deletion
leading to small scale, iterative changes in microsatellite length [46, 69, 107]. Observation
of the mutational shifts in wild-type epithelium supports this mechanism with a significant
bias towards smaller scale mutations. Interestingly, the bias of shifts differs between loci and
it seems likely the genomic context of the microsatellite influences the pattern of mutations
observed. Furthermore, observation of the same loci in Msh2 deficient crypts revealed the
same pattern of small scale changes. This supports the notion that there is dynamic interplay
between mutation and repair at microsatellites thus when repair mechanisms are deficient
there is a bias towards mutation. The nature of this mutation appears to genomically en-
coded and is independent of any other mutational process in Msh2 deficient epithelium.
Following in vitro and in vivo validation of microsatellite sequencing for clone size
quantification in mouse, the feasibility of translation to human tissue was assessed. The
increased DNA content of single human crypts theoretically aided the translation of this
protocol to human crypts. Indeed, it is possible that the number of PCR cycles could be
reduced to improve amplification fidelity of human crypt lysate in future. Furthermore,
initially optimising the protocol in mouse informed many of the steps in optimising the
protocol for human crypts such as primer design and optimal primer concentrations. Thus,
translation of this protocol from murine material to human material was successful.
These observations pave the way for further investigations of stem cell dynamics in
human colonic material. It should also be possible to quantify stem cell dynamics in dis-
eased colon also. This could allow for the quantification of stem cell dynamics in patients
suffering from inflammatory bowel disease or in a dysplastic adenoma. Insights into the
alteration of stem cell dynamics in the diseased setting could shed light onto: 1) the role of
perturbed stem cell dynamics in the aetiology and pathogenesis of disease; 2) identification
of individuals at heightened risk of colorectal cancer; 3) the potential for targeting perturbed
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cellular kinetics to specifically remove a pathological cell population or develop effective
chemopreventive therapies.
This method also has the potential for wider application beyond quantifying stem cell
dynamics. Firstly, the ability to perform massively multiplexed genotyping could allow for
adoption in fields such as forensic science or in parental testing [74]. Secondly, the ability
to infer kinship based on microsatellite length change could be used to inform hierarchi-
cal clustering at a population level in evolutionary or ecological studies [43]. Finally, the
identification of loci with higher mutation rates suggests that this method could be used to
ascertain hypermutability in sentinel loci. Sentinel loci are already used to ascertain the
presence of microsatellite instability in colorectal cancers [8, 56]; the method described
in this dissertation could allow for testing with higher sensitivity and without the require-
ment for large template copies, such as from circulating tumour DNA or fecal samples.
This could potentially be used to identify patients with loss of mismatch repair in the colon
through existing screening programmes.
In addition to sequencing microsatellites, the multiplexed protocol could potentially be
used to sequence known cancer mutation hotspots in genes such as KRAS or BRAF [19, 25].
With known parameters for functional stem cell number and stem cell replacement rate,
it would be possible to infer the mutation rates and spectrum of mutation at these loci.
Furthermore, it is plausible that if a large enough cohort was studied, it would be possible
to infer any biases in the maintenance of these mutations in normal epithelium, indicative
of biased drift, a phenomena already described in murine intestine.
Overall, evidence for the potential of this novel technique in the quantification of stem
cell dynamics in an unbiased, transgene-free way has been presented. This method is
amenable to use in large scale sequencing projects to ascertain human colonic stem cell
dynamics. Furthermore, the isolation, sequencing and analysis pipeline has the flexibility
such that each step has the potential for scalability to reduce the time and financial invest-
ment required for the application of this method to a wide range of applications beyond that
in quantifying intestinal stem cell dynamics.
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Appendix A
Primer sequences for mouse and human
microsatellite analysis
A.1 Next Generation Sequencing adaptors
Table A.1 gives the sequences of adaptors added to the 5’-end of the locus specific primers:
when a CS1/CS2 adaptor is present, the locus specific primer is given the prefix ’ADAP_’
whilst when the M13 adaptor is present, the locus specific primer is given the prefix ’M13_’.
Table A.2 gives the primer sequences of the custom made M13 indexing primers: i5 primers
are coupled with i7 primers to form a primer pair. By matching i5 primers with different i7
primers, it is possible to generate 384 unique indexing sequences.
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Adaptor Forward primer Reverse primer
CS1/CS2 ACACTGACGACATGGTTCTACA TACGGTAGCAGAGACTTGGTCT
M13 TGTAAAACGACGGCCAGT CAGGAAACAGCTATGACC
Table A.1 Sequence of Next Generation Sequencing adaptors added to the 5’-end of the
forward and reverse amplification primers as indicated.
Index name
Index
sequence
Primer
M13_i5_S502 CTCTCTAT AATGATACGGCGACCACCGAGATCTACACCTCTCTATTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S503 TATCCTCT AATGATACGGCGACCACCGAGATCTACACTATCCTCTTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S505 GTAAGGAG AATGATACGGCGACCACCGAGATCTACACGTAAGGAGTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S506 ACTGCATA AATGATACGGCGACCACCGAGATCTACACACTGCATATCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S507 AAGGAGTA AATGATACGGCGACCACCGAGATCTACACAAGGAGTATCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S508 CTAAGCCT AATGATACGGCGACCACCGAGATCTACACCTAAGCCTTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S510 CGTCTAAT AATGATACGGCGACCACCGAGATCTACACCGTCTAATTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S511 TCTCTCCG AATGATACGGCGACCACCGAGATCTACACTCTCTCCGTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S513 TCGACTAG AATGATACGGCGACCACCGAGATCTACACTCGACTAGTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S515 TTCTAGCT AATGATACGGCGACCACCGAGATCTACACTTCTAGCTTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S516 CCTAGAGT AATGATACGGCGACCACCGAGATCTACACCCTAGAGTTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S517 GCGTAAGA AATGATACGGCGACCACCGAGATCTACACGCGTAAGATCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S518 CTATTAAG AATGATACGGCGACCACCGAGATCTACACCTATTAAGTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S520 AAGGCTAT AATGATACGGCGACCACCGAGATCTACACAAGGCTATTCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S521 GAGCCTTA AATGATACGGCGACCACCGAGATCTACACGAGCCTTATCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i5_S522 TTATGCGA AATGATACGGCGACCACCGAGATCTACACTTATGCGATCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtgtaaaacgacggccagt
M13_i7_N701 TCGCCTTA CAAGCAGAAGACGGCATACGAGATTCGCCTTAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N702 CTAGTACG CAAGCAGAAGACGGCATACGAGATCTAGTACGGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
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M13_i7_N703 TTCTGCCT CAAGCAGAAGACGGCATACGAGATTTCTGCCTGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N704 GCTCAGGA CAAGCAGAAGACGGCATACGAGATGCTCAGGAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N705 AGGAGTCC CAAGCAGAAGACGGCATACGAGATAGGAGTCCGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N706 CATGCCTA CAAGCAGAAGACGGCATACGAGATCATGCCTAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N707 GTAGAGAG CAAGCAGAAGACGGCATACGAGATGTAGAGAGGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N710 CAGCCTCG CAAGCAGAAGACGGCATACGAGATCAGCCTCGGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N711 TGCCTCTT CAAGCAGAAGACGGCATACGAGATTGCCTCTTGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N712 TCCTCTAC CAAGCAGAAGACGGCATACGAGATTCCTCTACGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N714 TCATGAGC CAAGCAGAAGACGGCATACGAGATTCATGAGCGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N715 CCTGAGAT CAAGCAGAAGACGGCATACGAGATCCTGAGATGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N716 TAGCGAGT CAAGCAGAAGACGGCATACGAGATTAGCGAGTGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N718 GTAGCTCC CAAGCAGAAGACGGCATACGAGATGTAGCTCCGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N719 TACTACGC CAAGCAGAAGACGGCATACGAGATTACTACGCGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N720 AGGCTCCG CAAGCAGAAGACGGCATACGAGATAGGCTCCGGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N721 GCAGCGTA CAAGCAGAAGACGGCATACGAGATGCAGCGTAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N722 CTGCGCAT CAAGCAGAAGACGGCATACGAGATCTGCGCATGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N723 GAGCGCTA CAAGCAGAAGACGGCATACGAGATGAGCGCTAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N724 CGCTCAGT CAAGCAGAAGACGGCATACGAGATCGCTCAGTGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N726 GTCTTAGG CAAGCAGAAGACGGCATACGAGATGTCTTAGGGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N727 ACTGATCG CAAGCAGAAGACGGCATACGAGATACTGATCGGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
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M13_i7_N728 TAGCTGCA CAAGCAGAAGACGGCATACGAGATTAGCTGCAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
M13_i7_N729 GACGTCGA CAAGCAGAAGACGGCATACGAGATGACGTCGAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGcaggaaacagctatgacc
Table A.2 Sequences for indexing primers used for M13 indexing. Lower case lettering represents regions complimentary to the M13 adaptor.
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A.2 Mouse primers
All of the primers listed here were part of the final multiplex PCR group named ’M13_33’
or ’M13_33_YFP’ when primers for the transgenic [CA]30 were included. Each primer is
written in the conventional 5’ to 3’ direction. Sequencing adaptors are added at the 5’ end.
Loci Forward primer Reverse primer
Final
conc.
(µM)
Amplicon
length (bp)
a2_2742 TCTTGCTCTTTCCTACACTGTT CTCTGTGTTCCCAGCCCTAG 0.18 151
s16_4295 TTTGCATACTCAGGAAACCCA TCACAGACACTAGAGCAGCA 0.34 160
a4_1365 AAATCTCTGAACTTCCTCCCTG AGCTGTCACGTGATTCCAGA 0.26 152
s2_1206 GTAGTCAACCGAAATACACGAAA ACAAGATCAGCAAGCTCTCAAC 0.28 166
s8_3334 AGATGTCTTCTTCCAACCTCCA GGTCTGTTTGATTTCATGATGCC 0.16 156
s9_8328 GGACCATCACCCTAAGAAACAC GACACTGCCCCTTACACTGT 0.17 170
a6_42765 GGGTTGTTGGTCAGGTTTAAGGTAGCA CCCAAGACTTCATATATAACTGAGGC 0.09 184
sX_13950 TGGCCAATCCAAAAATACAGACACAG TGTTTGGGCACGAACCTTTATAAGCTG 0.23 170
a10_2051 GCATCTGTTGGAGAATGAATATGTTGT ACATCTGAGCCATCTTTGCAAGTCTGT 0.27 196
s8_6742 GAGGAGCTAGCTACACTCGG ACGGTGAGTTGGGTGTCTTT 0.43 174
s15_7506 TGTCCTCTGAACTTTGTATGCAG GCCCTTTCTTCTGTGCCAC 0.14 180
s8_27334 GCATCGATTTTCATGGGGATTTTGATA AAGTTTCCACTTCAATTTGCCTTCCTG 0.28 170
s9_69438 TAGTCTAATCAGAGAGCCCAGGCCAGT CAGGGAGAGCCAATGAATGAGTCAGTA 0.20 185
s9_4554 AGCTGTCAGTTTTACCCATGGTCATCA ATGGGCATACAGACAAACCAGTAGGTG 0.15 177
s1_EYFP TGTCATACTTATCCTGTCCCTTTTT AACAGCTCCTCGCCCTTG 0.57 176
Table A.3 Primer sequences for primer pairs contained within mouse multiplex group M13_33 and M13_33_YFP (when the group includes the primers
for the transgenic [CA]30).
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A.3 Human primers
All of the primers listed here were part of the final multiplex PCR group named ’hsM13_53’.
Each primer is written in the conventional 5’ to 3’ direction. Sequencing adaptors are added
at the 5’ end.
Loci Forward primer Reverse primer
Final
conc.
(µM)
Amplicon
length (bp)
s3_50602 AAAGGAATGTTGGCCAAGTG AAAGGAATGTTGGCCAAGTG 0.09 180
s9_39733 GAAATTTCATGCCAATTTTAATACA GAGTCCAGCACTGTCTGCAA 0.47 181
s12_1242 CAACCAGAGGTGCGGATACT AGACCCATTTCCTCCAATCC 0.32 181
s14_6560 TTCCATCTAGGATGCTGCAA TTGCAAAAATGTGGAACCAA 0.47 180
s15_8821 TCTCCCAGCTCCTCCTACCT CAGCCACAGAGTGGGACATA 0.05 169
s17_6742 CCTGCACCCAGGTGAAATAA GGGGTTCATTCTCCCATACC 0.32 180
a8_86853 TGCCCATGGGTAAATGAAAC TCCCAAGGGCACACTGTT 0.08 154
a3_12858 TACACCCTGGGAACGAGTTT TGGCAGGTGGTGATAATGAA 0.16 161
a9_99288 GGAGTAAAAGAAAGCCACCAAA AGCTGGGGTCACATCAGAAC 0.47 178
a7_29069 TCGGCAATTCATTGCTATCC AAAGAGTAGTAACTCAGAGCTGGAGA 0.08 183
a17_6874 CATTCCTTGGTTGCATGACT TCCTGGGTCTAGCATAAGTCTTAAA 0.32 185
s22_4402 CAGGATGGGCTCTAATCCAA TGTTCCTCGGCCTGTAGAAG 0.16 163
s14_1937 CCAATGATGAAACTGGCTCA GGAGGGTCTCTCTCCACTTTC 0.16 181
s2_87089 ATCGTTTCACATTTGAACTCTTT CTGCAACGGTCCCCTTCT 0.32 176
s13_7008 AGCAGTGCAAGAATGGAATAA CCCAGCCTGGACCTTAAATC 0.47 191
s12_6308 TTTCCCTCATGGCTACTCTTG AACTGCAGTGGCAAGAAACC 0.08 177
a3_46762 GGTTTGTAACACGTATGCAAGAA GAGCGAAACTCTGTCTCAAAAA 0.47 197
s14_6792 AAAGCAAGGACATAACCCACA GAGGACCTGCTGTAATTCCCTA 0.32 169
a9_13528 TCAACTGCCAGCAAAAGTTAAA CAAAACACGTAGAGGGTGGAA 0.32 177
a4_10696 AAAGGTGCCAAGAACATACATT TTTTTGTAGATGGTGAGAGATGG 0.32 175
s17_1170 CTGTCCTCAGAGGCCTTCC GAGGCTCTGTCAGGGTTACCT 0.05 172
Table A.4 Primer sequences for primer pairs contained within human multiplex group hsM13_53.
Appendix B
Genomic information for mouse and
human microsatellites used for clone size
analysis
All genomic loci were identified, using the custom Perl script described in Section 2.10.1,
in the mm9 build of the mouse reference genome and hg38 build of the human reference
genome. Each loci included for analysis in the final multiplex groups were searched for us-
ing the UCSC Genome Browser. The UCSC Genes genome annotation was used to identify
murine coding regions whilst the RefSeq genome annotation was used to identify human
coding regions.
B.1 Mouse microsatellite loci
Table B.1 gives the details of all loci analysed using the M13_33 multiplex group.
B.2 Human microsatellite loci
Table B.2 gives the details of all loci analysed using the hsM13_53 multiplex group.
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Chromosome Start End Type
Distance to
nearest gene
(nucleotides)
Nearest gene
2 27425428 274254988 Intergenic 23820 BC050122
2 120629581 120629641 4th intron 0 Ttbk2
4 136517568 136517628 Intergenic 30605 Epha8
6 42764938 42764998 Intergenic 2534 Olfr450
8 27334239 27334299 Intergenic 60968 Thap1
8 33339937 33339997 Intergenic 77570 AK143160
8 67422899 67422959 Intergenic 48307 Tmem192
9 69438634 69438694 Intergenic 99322 Anxa2
9 83283058 83283118 Intergenic 5664 Lca5
10 20517849 20517909 Intergenic 73347 Pde7b
15 75067328 75067388 Intergenic 20213 BC025446
16 42959516 42959576 2nd intron 0 Zbtb20
19 45540103 45540163 4th intron 0 Btrc
X 139502950 139503010 Intergenic 31136 Rgag1
Table B.1 Genomic information for all loci analysed within the M13_33 multiplex group.
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Chromosome Start End Type
Distance to
nearest gene
(nucleotides)
Nearest gene
2 87089769 87089829 Intergenic 67986 PLGLB1
3 46762346 46762406 Intergenic 44522 PRSS50
3 50602054 50602114 Intergenic 4442 CISH
3 128580366 128580426 Intergenic 39985 RPN1
4 106962493 106962553 1st intron 0 DKK2
7 29069768 29069828 9th intron 0 CPVL
8 86853133 86853193 Intergenic 13303 CNBD1
9 13528207 13528267 Intergenic 248643 MPDZ
9 39733059 39733119 Intergenic 80665 KGFLP2
9 99288207 99288267 Intergenic 66313 ALG2
12 6308773 6308833 Intergenic 3394 PLEKHG6
12 124203894 124203954 3rd intron 0 FAM101A
13 70082309 70082369 1st intron 0 KLHL1
14 19378602 19378662 Intergenic 0 POTEM
14 65602343 65602403 3rd intron 0 FUT8
14 67921563 67921623 7th intron 0 RAD51B
15 88212700 88212760 3rd intron 0 NTRK3
17 11707955 11708015 26th intron 0 DNAH9
17 67425203 67425263 1st intron 0 PITPNC1
17 68740442 68740502 Intergenic 127643 ABCA8
22 44021757 44021817 2nd intron 0 PARVB
Table B.2 Genomic information for all loci analysed within the hsM13_53 multiplex group.
